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Abstract 
Translin and TRAX are a highly conserved pair of proteins that have a close functional 
relationship with one another. Originally, these nucleic acid binding proteins were implicated 
in chromosomal translocation in human leukaemia cells, but subsequently, they have been 
shown to function in a wide range of biological processes, including RNA interference 
passenger strand removal, tRNA precursor processing, and neuronal mRNA transport and, 
more recently, in the degradation of microRNA in oncogenesis. This led to the proposal that 
they could be druggable targets for a large number of cancers. Moreover, it has previously been 
proposed that they function at telomeres, although no direct evidence has been provided to 
support this. Previous analysis on Schizosaccharomyces pombe orthologues of Translin and 
TRAX, Tsn1 and Tfx1, have shown no notable functional role (Saccharomyces cerevisiae has 
no tsn1/tfx1 orthologue). Given the link to RNAi regulation in higher eukaryotic organisms, a 
series of double mutants of tsn1 and tfx1 and RNAi regulatory genes, ago1 and dcr1, were 
generated to investigate whether Tsn1 and Tfx1 have a redundant role with the RNAi 
regulators. Different approaches were used to demonstrate that loss of Tfx1, but not Tsn1, can 
partially suppress the chromosomal instability caused by loss of Ago1, without restoring 
centromere heterochromatin formation. We extend this to reveal that deletion of four sub-
telomeric tlh genes also suppress the need for Ago1, as does the mutation of taz1—a factor that 
is required for telomere length control, although the mechanisms appear to be different. 
Extended analysis of Tfx1-and Tsn1-defective cells identify differential roles for these proteins 
in regulating the levels of distinct transcripts associated with the telomeres and sub-telomeres. 
These findings not only reveal two novel regulators of telomere dynamics, but also propose 
that modulating the transcriptional status at sub-telomeres partially suppresses the chromosome 
segregation defects conferred by loss of Ago1. This reveals a counterbalance between 
centromeres and telomeres in maintaining chromosome stability. Further analysis of Tsn1 and 
Tfx1 function led to the revelation of a novel and fundamentally important role for Tsn1 in the 
DNA damage recovery response in the absence of Dcr1, a function that may be linked to its 
original proposed role in generating chromosomal translocation. Our data not only separates 
the functions of Tsn1 and Tfx1 in S. pombe, but also reveals important functional roles for 
these paralogues in chromosome stability maintenance.  
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1. Introduction 
1.1 Genomic instability 
Genomic instability plays a crucial role in cancer development (Choi & Lee, 2013; 
McGranahan et al., 2012; Fragkos & Naim, 2017; Tubbs & Nussenzweig, 2017). Therefore, 
the maintenance of genome stability is vital to the proper functioning of cells (Yao & Dai, 
2014; Felipe-Abrio et al., 2015; Faggioli et al., 2011; Aguilera & García-Muse, 2013). The 
stability of the genome is threatened by a range of genetic modifications such as point 
mutations, chromosomal rearrangements, deletions and alterations in chromosome number, 
which may result in the gain or loss of complete chromosomes (Ferguson et al., 2015; 
McGranahan et al., 2012; Aguilera & Gomez-Gonzalez, 2008). In addition to alterations in the 
DNA sequence, epigenetic aberration can also lead to genomic instability by altering the 
chromatin assembly, including histone modifications and DNA methylation (Choi & Lee, 
2013; Katto & Mahlknecht, 2011). These changes in the structure and number of chromosomes, 
epigenetic alterations and gene mutations are hallmarks of most tumour cells, and they all play 
a crucial role in cancer initiation and progression (Aronica et al., 2016; Katto & Mahlknecht, 
2011; Gordon et al., 2012; Lord & Ashworth, 2012; McGranahan et al., 2012; Weberpals et 
al., 2011). In addition to DNA lesions, chromosomal instability is also caused by defects in 
some important natural processes, such as DNA replication, chromosome segregation, 
telomere maintenance and DNA damage repair  (Choi & Lee, 2013; Fragkos & Naim, 2017; 
Bartkova et al., 2005; Harrison & Foroni, 2002; Felipe-Abrio et al., 2015; Anderson, 2001).  
 
The human genome is frequently put at risk by a range of challenges by both exogenous and 
endogenous stresses (Choi & Lee, 2013; Fragkos & Naim, 2017; Tubbs & Nussenzweig, 2017). 
These genotoxic stresses require efficient cellular responses in order to preserve genomic 
stability because they can cause numerous problems or lesions in the DNA, including single- 
or double-strand DNA breaks (So et al., 2017; Choi & Lee, 2013). In order to respond to and 
correct these lesions, eukaryotic cells have developed a collection of DNA damage responses 
(DDR), including checkpoint activation, DNA repair and the activation of programmed cell 
death (apoptotic pathways) in the case of irreparable DNA damage (Choi & Lee, 2013; Yang 
et al., 2016; Talens et al., 2017).  
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Therefore, the lack of any of these defence mechanisms may result in genetic instability, which 
leads to cancer development evolution and ageing-related diseases (Figure 1.1) (Ferguson et 
al., 2015; Yang et al., 2016; So et al., 2017; Ohle et al., 2016; Lombard et al., 2005).  
Importantly, if DNA fails to replicate correctly, genetic recombination can take place, which 
may lead to chromosomal translocations and various other significant structural modifications 
if they are mediated through a wrong partner. These modifications can result in altered cell 
behaviour, leading to the possible development of diseases such as cancer. Thus, all 
mechanisms that occur during cell proliferation need to be perfectly coordinated to avoid 
generating genomic instability, including chromosomal rearrangements (Lord & Ashworth, 
2012; Labib & Hodgson, 2007).  
 
Figure 1.1  Cancer route in genome instability 
Failure to respond to DNA damage leads to instability in the genome, which could induce cancer. 
Checkpoints arrest proliferation in response to allow the cell to repair damaged sites of chromosome 
correctly and in time, which is done by various DNA repair mechanisms. However, if any defects exist 
in these defence mechanisms, the damaged cells undergo apoptosis to maintain genomic integrity 
(adapted from Choi & Lee, 2013). 
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1.2 Chromosomal translocations 
Chromosomal rearrangements are alterations in the structure of the original chromosome, 
which results in new arrangements of the chromosome through deletions, inversions and 
translocations (Figure1.2.A) (Harewood & Fraser, 2014). Chromosomal translocation is a 
major type of chromosomal rearrangements and contributes to genome instability (Nambiar & 
Raghavan, 2011). Translocation plays a significant role in cancer initiation and progression, 
particularly in lymphoma and leukaemia although the precise mechanisms of translocation 
generation are not well understood (Zheng, 2013; Nambiar & Raghavan, 2011). A chromosome 
translocation is an abnormality in a chromosome in which a chromosome breaks and is 
subsequently attached, either in whole or in part, to another chromosome. In other words, 
translocations occur due to abnormal recombination events between non-homologous 
chromosomes (Figure1.2.A) (Roukos & Misteli, 2014; Tucker, 2010).  
There are two main classes of translocations: reciprocal and non-reciprocal. Reciprocal 
translocations, which are the most typical form of translocation, can be described as the 
swapping of segments of material between a pair of non-homologous chromosomes, whereas 
non-reciprocal translocations occur when only a single segment of a chromosome is 
translocated to a non-homologous chromosome (i.e., one-way translocations) (Zhang et al., 
2010; Ferguson & Alt, 2001). Chromosome translocations are either balanced (i.e., reciprocal), 
in which chromosome sequences are translocated between the non-homologous chromosomes 
without the gain or loss of genetic material, or they are unbalanced, in which an unequal number 
of chromosome sequences is exchanged between the different chromosomes, resulting in the 
gain or loss of genetic material (Harewood & Fraser, 2014; Chang et al., 2013).  
 
Depending on the location of chromosome breakpoints, the translocation of chromosomes can 
result in the production of fusion genes or interrupt and inactivate the tumour suppressor genes 
(Roukos & Misteli, 2014; Nambiar & Raghavan, 2011; Hasty & Montagna, 2014). Moreover, 
translocations can also result in the activation of  proto-oncogenes, which are a set of genes 
that alters  the phenotype of cells from normal to cancerous when activated or mutated, all of 
which could give rise to a tumour (Figure1.2.B) (Zheng, 2013; Aquino et al., 2013; Nambiar 
& Raghavan, 2011; Gates & Fink, 2008; Roukos & Misteli, 2014). 
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Modifications in the key genes involved in DNA damage checkpoints or in the repair of double-
strand DNA breaks (DSBs) also cause translocation (Lengauer et al., 1998). DSBs are 
considered critical translocation-initiating events, and they can be induced through exogenous 
agents, such as ionising radiation (IR), or endogenous factors, such as stalled replication forks 
(So et al., 2017; Hogenbirk et al., 2016). In response to these errors or breaks, DNA repair 
mechanisms, including homologous recombination (HR) (see Section 1.6.2) are initiated by 
cells to rescue genomic stability by repairing these lesions. However, failures in repairing these 
lesions can lead to chromosomal rearrangement (Roukos & Misteli, 2014; So et al., 2017; 
Ferguson & Alt, 2001; Gelot et al., 2015). Therefore, defective chromosome replication can 
result in chromosomal translocations, the main causes of which are thought to be recombination 
at stalled replication forks (Labib & Hodgson, 2007). 
 
A typical example of a chromosomal abnormality is the Philadelphia chromosome, which 
induces protein fusion and causes chromosomal translocation between chromosomes 9 and 22 
at the BCR and ABL1 genes, creating a novel chimeric ABL/BCR fusion gene, which results in 
the abnormal tyrosine kinase (TK) activity of ABL1 protein. The t(9;22) is associated with 
chronic myelogenous leukaemia (CML) (Meaburn et al., 2007; Nambiar & Raghavan, 2011; 
Zheng, 2013; Tabarestani & Movafagh, 2016). Another well-understood example is the 
translocation between chromosomes 14 and 18 t(14;18), which leads to  the over production of 
BCL2, the anti-apoptotic protein. This over production results in a survival benefit for the cells 
and a potential gain in additional mutations and alterations that induce follicular lymphoma 
(FL) (Nambiar et al., 2008; Nambiar & Raghavan, 2011; Raghavan & Lieber, 2006; Bakhshi 
et al., 1985). 
 
Translin is a DNA binding protein that was first found to bind to breakpoint junctions of 
chromosomal translocations in various cases of lymphoid neoplasms in humans (see Section 
1.11) (Aoki et al., 1995; Kasai et al., 1997). This discovery led to proposals that Translin is 
involved in mediating chromosomal rearrangement breakpoints (Gajecka et al., 2006). 
However, the mechanistic importance of Translin binding to breakpoint junctions in cancer has 
not yet been elucidated.   
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Figure 1.2 Examples of chromosome rearrangement and consequences  
A. There are several types of chromosomal rearrangements, including deletion, inversion, and 
translocation. Deletion is known as the breakage of a chromosome, which leads to the removal of a 
segment of DNA. Inversion occurs when a segment of chromosome is disassociated from it, inverted 
180 degrees and then re-introduced into the same location as the chromosome without the loss of 
DNA. Chromosomal translocations occur when two segments of DNA are swapped from non-
homologous chromosomes.  
B. A translocation may lead to the generation of oncogenes by producing a chimeric fusion protein, 
via the interruption and inactivation of a tumour suppressor gene or by the fusion of a tumour-
promoting gene with a solid transcriptional promoter (adapted from Roukos & Misteli, 2014). 
   A. 
B. 
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1.3 DNA replication 
The cell cycle is composed of four distinct phases: G1, S, G2 and M. DNA replication is 
included in this process, which operates in the S phase when the parental DNA is copied before 
each cell division. Therefore, the faithful replication of DNA is crucial to ensure the correct 
transformation of genetic information to cell generations, which is essential in maintaining 
genomic stability (Gelot et al., 2015; Gadaleta & Noguchi, 2017; Kang et al., 2017; Stillman, 
2008; Lujan et al., 2016; Mladenov & Iliakis, 2011; Petermann et al., 2010). In eukaryotes, the 
replication of the genome starts at multiple origins (particular genomic start sites enriched in 
AT content) on the chromosome (Kang et al., 2017; Parker et al., 2017; Duzdevich et al., 2015; 
Fragkos & Naim, 2017). The formation and activation of various complexes at replication 
origins are necessary for replicating DNA (Aves, 2009). In the early G1 phase, these origins 
are recognised and bound by a complex called origin recognition complex (ORC). When ORC 
is bound at these origins, it then serves as a platform for the loading of another group of proteins 
called pre-replicative complex (pre-RC), which occurs in the late G1 phase (Kang et al., 2017, 
Duzdevich et al., 2015). The pre-RC contains the conserved core replicative helicase, the mini-
chromosome maintenance (MCM) protein complex. In addition to its activity in unwinding the 
double-stranded DNA at the origin (see later), MCM inhibits DNA from replicating more than 
once per cell cycle, and at least two copies of the MCM proteins are required to load at the 
replication origin to form a bidirectional replication fork (Remus & Diffley, 2009; Evrin et al., 
2009; Duzdevich et al., 2015; Burgers & Kunkel, 2017). The activation of the MCM proteins 
is dependent on protein kinase activity, including Cdc7-Dbf4 kinases (DDK) and S-phase 
cyclin-depedent kinases (CDK), which guides the DNA replication initiation and progression 
(Leman & Noguchi, 2013; Evrin et al., 2009; Kang et al., 2017; Chang & Stirling, 2017; 
Burgers & Kunkel, 2017; Lei, 2005). 
 
1.4 Replication fork progression 
The replication fork is the point at which the DNA duplex (dsDNA) is unwound into two DNA 
single strands (ssDNA). In this process, the DNA helicase enzyme uses the energy of ATP 
hydrolysis to break the inter-strand hydrogen bounds, creating a Y-shape (Figure 1.3). 
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The stability of the unpaired ssDNA is preserved by a heterotrimeric complex that is called the 
replication protein A (RPA) (Stillman, 2008; Branzei & Foiani, 2007).  
The two ssDNA strands, known as the leading and lagging strands, are the templates that are 
used by the replicative polymerases for base pairing in the synthesis of the new daughter 
strands. The leading strand is oriented in the same direction as the replication fork (3' to 5' 
direction), while the lagging strand is oriented away from the replication fork (5' to 3' 
direction); thus, the two strands are replicated in different processes. Because DNA replication 
proceeds in the 5' to 3' direction, the leading strand is replicated continuously, in which the 
primase enzyme adds a short RNA primer (10 nucleotides) to the 3' end of the strand. This 
short piece of RNA acts as the initial point of polymerase ε (epsilon) in the synthesis of the 
daughter strand (Figure 1.3). Because DNA polymerases can only synthesise DNA in one 
direction (5' to 3'), loops are formed on the lagging strand templates. The lagging strands are 
therefore replicated discontinuously (i.e., in a fragmented manner) in which multiple short 
RNA primers are added at different regions alongside the strand. Then pieces of DNA called 
Okazaki fragments (100–200 bases) are fused by polymerase δ (delta) between these RNA 
primers in the lagging strand (Figure 1.3). When both strands are made, all the RNA primers 
are removed from both strands by an exonuclease enzyme and then substituted by proper 
nucleotides. Next, the newly made strands are proofread in order to correct any mistakes and 
mispairings that may occur during this process. Finally, the Okazaki fragments are joined 
together by the DNA ligase enzyme to form two continuous double strands (Leman & Noguchi, 
2013; Pellegrini & Costa, 2016; Berti & Vindigni, 2016; Stillman, 2008; Lujan et al., 2016; 
Burgers & Kunkel, 2017; Clark & Pazdernik, 2012; Chilkova et al., 2007). 
. In addition to the indicated core factors, many other key protein complexes, such as the fork 
protection complex (FPC), the replication factor C clamp loader (RFC) and the proliferating 
cell nuclear antigen (PCNA) are involved in both the initiation and the replication fork 
progression to assemble an extensive conglomerate that is termed the replisome. Checkpoint 
proteins are also required, and they associate with the replisome, which functions as a 
surveillance mechanism in DNA replication and genome stability (Leman & Noguchi, 2013).  
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Replication fork monitoring and regulation are essential for the cell to preserve genomic 
stability such that interfering with the replisome could result in replication fork arrest (Kang et 
al., 2017; Lin & Pasero, 2012). Arrested forks are extremely recombinogenic. When they are 
subjected to the induction of unscheduled HR, chromosomal translocation could result, leading 
to cancer (So et al., 2017; Gelot et al., 2015; Gadaleta & Noguchi, 2017; Pryce et al., 2009; 
Duch et al., 2013; Castel et al., 2014; Brambati et al., 2015).  
The DNA replication fork is affected by DNA lesions that originate from various endogenous 
and exogenous sources (Berti & Vindigni, 2016; Jones & Petermann, 2012). In addition to 
DNA lesions, replication fork progression is blocked through  natural impediments that 
function as replication fork barriers (RFB) (Gadaleta & Noguchi, 2017), which inhibit or stall 
the progression of DNA forks, leading  to fork collapse, which promotes HR and drives genome 
instability if it is not controlled accurately (Gadaleta & Noguchi, 2017; Pryce et al., 2009; Lin 
& Pasero, 2012). An example of an element of natural impediment that could stall the DNA 
replication fork and induce genomic instability is the conflict between replication and 
transcription machinery, which may result in the replication stress that is associated with 
breakpoints and chromosomal instability  (Brambati et al., 2015; Koyama et al., 2017; Chang 
& Stirling, 2017; Ren et al., 2015; Fragkos & Naim, 2017; Garcia-Muse & Aguilera, 2016; 
Gaillard & Aguilera, 2016; Aguilera & Gaillard, 2014 ).  
Stalled DNA replication forks could also occur in response to drugs, such as the ribonucleotide 
reductase inhibitor hydroxyurea (HU), which blocks DNA synthesis by inhibiting dNTP 
synthesis (deoxyribonucleotide triphosphate) but permits the replicative helicase to carry out 
the process by unwinding the parental DNA duplex. This response may result in the collapse 
of the replication forks and consequently the formation of DSBs (Labib & Hodgson, 2007; 
Petermann et al., 2010; Aguilera & García-Muse, 2013). 
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Figure 1.3 Basic Schematic demonstration of a replication fork  
Replication of DNA proceeds in the 5' to 3' direction, resulting in the continuous replication of the 
leading strand and discontinuous replication in short sections of the lagging strand. The initiation of 
leading strand synthesis  as well as each Okazaki fragment on the lagging strand require the presence 
of  short RNA primers (green) (adapted from Leman & Noguchi, 2013).   
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1.5 Replication fork barriers and recombination 
In the S phase, the same DNA template is used by both the replication and the transcription 
machineries (Bermejo et al., 2012; Brambati et al., 2015; Duch et al., 2013; Lin & Pasero, 
2012). Therefore, interference between the two processes is unavoidable. A collision between 
the two activities may lead to stalling the replication fork, which may collapse if the issue is 
not resolved  (Felipe-Abrio et al., 2015; Koyama et al., 2017; Ren et al., 2015; Fragkos & Naim, 
2017; Lin & Pasero, 2012; Gadaleta & Noguchi, 2017; Aguilera & García-Muse, 2013).  The 
collapse of the replication fork may lead to  the formation of DSBs (Gadaleta & Noguchi, 
2017). The collapsed replication fork needs to be repaired by HR, which may  result in 
chromosomal rearrangements, including translocations  (Felipe-Abrio et al., 2015; Castel et al., 
2014; Lin & Pasero, 2012).  
 
Because the directional polarity of the synthesis of both DNA and RNA is the same, a head- 
to-head collision between replication and transcription occurs on the lagging strand template, 
whereas a co-directional collision (head-to-tail) between the two occurs on the leading strand 
template (Bermejo et al., 2012; Brambati et al., 2015; Oestergaard & Lisby, 2017).  Although 
both collisions affect the stability of the replication fork, head-on (head-to-head) collisions are 
thought to be more damaging (Bermejo et al., 2012; Brambati et al., 2015; Chang & Stirling, 
2017; Lin & Pasero, 2012). For example, recombination rates are higher due to head-on 
collisions than in co-directional collisions (Oestergaard & Lisby, 2017). 
 
 Transcription–replication conﬂicts have been examined extensively in a wide range of 
organisms, including bacteria and yeast. Several strategies and mechanisms have been 
identified as regulating the coordination between the two machineries and limiting the 
induction of recombinogenic lesions (Ren et al., 2015; Brambati et al., 2015; Bermejo et al., 
2012; Felipe-Abrio et al., 2015; Gadaleta & Noguchi, 2017). In bacteria, essential and highly 
transcribed RNA polymerase II genes are found on the leading strand template. Therefore, the 
transcription–replication co-orientation of the bacterial genome provides a feature that assists 
in avoiding head-on collisions between the two machineries, which leads to maintaining 
genomic stability (Brambati et al., 2015; Srivatsan et al., 2010; Bermejo et al., 2012; Felipe-
Abrio et al., 2015).  
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Nonetheless, bacteria develop various mechanisms to prevent and resolve the collisions 
between the two machineries. These mechanisms include the removal of proteins and/or R-
loops (DNA-RNA hybrids caused by the nascent transcript) by the accessory DNA helicases 
of the replisome. In addition, transcription regulators are involved in this process by rescuing 
stalled or backtracked RNA polymerases (Brambati et al., 2015). 
 
In eukaryotes, collisions between transcription and replication can be observed at distinct 
genomic loci: for example, tRNA genes and rDNA locus (Mirkin & Mirkin, 2007). Many tRNA 
genes have been identified in eukaryotic genomes, including 186 tRNA genes in 
Schizosaccharomyces pombe. In addition to their contribution to the  translation process, the S. 
pombe tRNA genes function as chromatin barriers in the centromeres (see Section 1.8) 
(Gadaleta & Noguchi, 2017). It has been noted that the sites of  tRNA genes (tDNA) display 
greater levels of genomic instability when DNA replication is inhibited, which may suggest 
that this instability is somehow linked to DNA replication. This effect was later confirmed by 
the finding that S. pombe tRNA genes inserted within ade6+ affected and slowed the 
progression of replication forks, and tRNA genes have been demonstrated to provide strong 
RFB activity (Pryce et al., 2009; Labib & Hodgson, 2007). Therefore, it is suggested that head-
on (head-to-head) collisions between RNA polymerase III, which mediates the transcription of 
tRNA genes and the replication machinery (i.e., replisome) results in the DNA replication fork 
instability (Bermejo et al., 2012; Mirkin & Mirkin, 2007; Pryce et al., 2009; Lin & Pasero, 
2012).  Importantly, the DNA replication-associated fragile sites in Saccharomyces cerevisiae 
have been found to be enriched for tRNA genes, which implicates these genes in the formation 
of recombinogenic lesions (Admire et al., 2006; Pryce et al., 2009).  
 
 
In eukaryotes, similar to bacteria, DNA helicases are necessary in replication to avoid obstacles 
that disturb the completion of the replication fork. For example, in S. cerevisiae, DNA helicase 
Rrm3 is required to resolve collisions between transcription and replication (Felipe-Abrio et 
al., 2015). However, unresolved collisions between replication and transcription may result in 
an accumulation of RNA polymerases that mediate transcription, which cause the fork to 
collapse, resulting in subsequent DNA damage and genomic instability (Ren et al., 2015; Castel 
et al., 2014). 
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In the fission yeast S. pombe, the RNA interference (RNAi) pathway is required in the 
pericentromeric heterochromatin to release the stalled RNA polymerase II (pol II), which is 
due to transcription–replication encounters during S phase. The failure to remove pol II is 
associated with stalled replication forks, which consequently induces genome stability (Castel 
et al., 2014; Ren et al., 2015; Zaratiegui et al., 2011).  
 
Outside the pericentromeric regions, a mechanism in S. pombe has been recently identified as 
resolving replication–transcription collisions, in which the RNAi component Dcr1, 
independent of the canonical RNAi pathway, induces the termination of transcription  at sites 
of replication stress and DNA damage (i.e., sites of collision),  which leads to preserving 
genome integrity (Ren et al., 2015; Castel et al., 2014). Dicer is an enzyme that possesses 
endonuclease activity, which cleaves  double-stranded RNA (dsRNA) molecules into 20–25 
nucleotide (nt)-long siRNA duplexes and then proceeds through the other components of the 
RNAi machinery to mediate gene silencing (see Section 1.10). Additionally, Dicer has been 
identified as a haploinsufficient tumour suppressor gene, and mutations of this gene are 
associated with cancer (see Section 1.14) (Kumar et al., 2009; Swahari et al., 2016). The 
specific role of S. pombe Dcr1 promotes the termination of transcription by releasing RNA 
polymerase II from the 3' end of the highly transcribed RNA pol II genes and, unexpectedly, 
from the antisense transcription of rDNA and tDNA (tRNA genes), which are mainly 
transcribed by RNA polymerase I and RNA polymerase III, respectively, leading to promotion 
of fork progression (Castel et al., 2014). However, in the absence of Dcr1, HR is necessary to 
resolve the collision between RNA pol II and the replisome, and restart the replication fork, 
which may lead to chromosomal instability and rearrangements, including translocations, 
contributing to tumorigenesis (Figure 1.4) (Castel et al., 2014; Brambati et al., 2015). In 
addition, Castel et al. (2014) found that the loss of Dcr1 results in the accumulation of 
RNA:DNA hybrids (R loops) at the rDNA locus, which is likely due to collision between 
replication and transcription  (Castel et al., 2014).  
RNA:DNA hybrids are formed when nascent RNA transcripts are re-annealed to their template 
DNA strand, forming an R-loop. R loops were thought to occur naturally during replication 
and transcription (Fragkos & Naim, 2017; Aguilera & Garcia-Muse, 2012; Felipe-Abrio et al., 
2015; Oestergaard & Lisby, 2017; Wahba et al., 2013; Mirkin & Mirkin, 2007; Ohle et al., 
2016; Santos-Pereira & Aguilera, 2015). 
   
 
13  
However, several studies on prokaryotes and eukaryotes have demonstrated that the 
accumulation of RNA:DNA hybrids are a major internal source of DNA damage, which can 
influence the functioning of cells and threaten genomic stability (Brambati et al., 2015; 
Aguilera & Garcia-Muse, 2012; Felipe-Abrio et al., 2015; Bermejo et al., 2012; Lin & Pasero, 
2012; Ohle et al., 2016; Santos-Pereira & Aguilera, 2015). The RNA:DNA hybrid is a central 
element that blocks progression of the replication fork and transcription elongation, which 
leads to replicative stress and the formation of DSBs (Bermejo et al., 2012; Castel et al., 2014; 
Lin & Pasero, 2012; Ohle et al., 2016). Moreover, the hybrids that accumulated at the sites of 
transcription–replication collision are highly recombinogenic, which results in recruiting HR 
factors, including Rad52, indicating that the misregulation of R-loops can potentially promote 
the initiation and progression of cancer (Castel et al., 2014; Wahba et al., 2013; Lin & Pasero, 
2012; Brambati et al., 2015). Thus, S. pombe Dcr1 plays a novel role in removing RNA:DNA 
hybrids, which also resolved transcription–replication collision. This new functional role of 
Dicer may be ascribed to its previously identified function as a tumour suppressor (Kumar et 
al., 2009; Swahari et al., 2016). Interestingly, many factors in the pathways that mediate the 
resolution of transcription–replication collision are tumour suppressors, including RAD52 
(Ren et al., 2015). 
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Figure 1.4 S. pombe  strategy  that resolves the replication–transcription collisions to preserve 
genomic integrity 
The RNA pol II mediates transcription (blue) –replisome (replication machinery) (green) collisions 
lead to replication fork progression stalling and the accumulation  of pol II at the template. At sites 
of collisions,  Dcr1  (orange) functions to terminate transcription by  releasing RNA pol II, leading 
to  the completion of  replication and the inhibition of the small RNA (sRNA) (yellow) generated by   
Dcr1  in loading into Ago1. However, in the absence of  Dcr1, HR is required to resolve the collision  
and restart the replication fork, which  may lead to chromosomal instability and copy number change, 
thus inducing cancer (adapted from Ren et al., 2015). 
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In order to avoid the formation of unscheduled RNA:DNA hybrids, eukaryotic cells have 
developed various mechanisms to degrade these hybrids, such as RNaseH proteins, which are 
a class of enzymes that destroy the RNA moiety of RNA:DNA hybrids, leading to the 
suppression of replication stress and the maintenance of  genomic integrity (Fragkos & Naim, 
2017; Wahba et al., 2013; Brambati et al., 2015; Ohle et al., 2016). Alternatively, these hybrids  
are degraded by RNA-DNA helicases, such as Sen1 in S. cerevisiae, by unwinding RNA-DNA 
hybrids or by minimising their formation (Santos-Pereira & Aguilera, 2015).  
Remarkably, a recent finding in S. pombe challenged the current proposal that the presence of 
RNA-DNA hybrids only induces DNA damage genomic instability. The findings indicated an 
unexpected positive role of these hybrids during the DNA repair process, which is essential to 
maintain genome integrity. It has been found that RNA:DNA hybrids are required in moderate 
amounts (not too much and not too little) in order to allow the proficient completion of the 
DSB repair facilitated by HR (see Section 1.6.2). Ohle et al. (2016) found that RNA:DNA 
hybrids regulated the end resection process, particularly in the recruitment of RPA complex to 
the resected DNA strand. This observation indicated that these hybrids need to be both 
produced and removed, a process that is mainly dependent on RNase H1 (Rnh1) and RNase 
H2 (Rnh2.1) (Figure 1.5) (Ohle et al., 2016; Plosky, 2016). This surprising observation should 
be confirmed in further intensive studies on S. pombe  and beyond to identify any other factors 
that contribute to the formation of RNA:DNA hybrids at breaks and to explore other roles 
played by these hybrids to preserve genome stability. Although many factors and mechanisms 
that inhibit RNA:DNA hybrid formation are well recognised, very little is known about the 
mechanisms that induce the formation of these structures (Wahba et al., 2013; Lin & Pasero, 
2012).  
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Figure 1.5 A Suggested model for the role of RNA-DNA hybrids in the repair of DSBs 
mediated by HR 
Once DSB is formed, the MRN complex is recruited to the broken DNA ends, and it interacts with 
other factors including exonuclease Exo1 to mediate (5'→3') resection at the DSB ends, resulting in 
the creation of single-stranded DNA (ssDNA) overhangs with 3' OH ends. RNA Pol II is recruited to 
the ssDNA overhangs and initiates transcription. The nascent RNA transcripts are reannealed to their 
template DNA strand (ssDNA), forming RNA:DNA hybrids, which in turn may control the end 
resection process by terminating RNA Pol II transcription, and recruiting the ssDNA-binding RPA 
complex to the resected DNA strand. Subsequently, these RNA-DNA intermediates are degraded by 
RNase H enzymes (RNase H1 and RNase H2) to obtain the complete loading of RPA on ssDNA 
overhangs and to allow the efficient completion of the process of DSB repair (see Section 1.6.2) 
(adapted from Ohle et al., 2016). 
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1.6 DNA double-strand breaks repair pathways 
The genome is continuously assaulted by various endogenous and exogenous sources, which 
can generate tens of thousands of DNA lesions, thus inducing DNA damage and genomic 
instability (Takagi, 2017; Brugmans et al., 2007; Tian et al., 2015; Davis & Chen, 2013).  
Therefore, to maintain genomic integrity, it is crucial for the cells to repair the DNA lesion 
rapidly and precisely to avoid the further mutations and genomic rearrangements that 
ultimately result in cancer (Uckelmann & Sixma, 2017; Tian et al., 2015; Davis & Chen, 2013; 
Mladenov & Iliakis, 2011). This damage includes DSBs, which are considered the most 
hazardous DNA lesion, in which both strands of DNA are broken, potentially leading to 
chromosome rearrangements (Schwartz et al., 2005; Chang et al., 2017; Davis & Chen, 2013; 
Mladenov & Iliakis, 2011; Ohle et al., 2016). DSBs can be generated by numerous external 
elements, including IR such as gamma rays and X-rays. However, programmed DSBs also 
occur naturally during certain recombination processes, such as meiosis and immune cell 
development (Brugmans et al., 2007; Takagi, 2017; Tian et al., 2015; Lieber, 2010). 
Additionally, during the normal S phase, DNA replication forks can be stalled when the DNA 
template is affected by damage, which results in the generation of non-programmed DSBs to 
restart the replication fork (Brugmans et al., 2007; Gadaleta & Noguchi, 2017; Lieber, 2010; 
Davis & Chen, 2013). To repair chromosomal DSBs, eukaryotic cells have evolved highly 
efficient specialised DNA repair pathways that are conserved from human to yeast, including 
homologous recombination (HR) and non-homologous DNA end joining (NHEJ) (Brugmans 
et al., 2007; Lieber, 2010; Davis & Chen, 2013; Zaboikin et al., 2017; Zhao et al., 2017; Ohle 
et al., 2016).  Whether HR or NHEJ is the pathway required to repair breaks is controlled partly 
by the cell cycle, and the incorrect choice of the repair pathway may lead to cancer. For 
example, in the S and G2 phases, the HR pathway precedes the DNA lesion because a 
homologous template (a sister chromatid) is available to be used as a repair template although 
NHEJ pathway can also be initiated during S/G2 when a homology donor is not available near 
a DSB.  However, NHEJ repair is predominant outside S/G2, by which the broken ends of 
DNA are directly re-joined without the need for template repair (i.e., a homology donor) 
(Brugmans et al., 2007; Takagi, 2017; Tian et al., 2015; Lieber, 2010; Davis & Chen, 2013; 
Zaboikin et al., 2017; Zhao et al., 2017).  
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1.6.1 The non-homologous DNA end joining repair pathway 
NHEJ is a direct and simple mechanism in which DNA integrity is restored by joining the two 
DNA ends without requiring a homologous template (Mladenov & Iliakis, 2011; Peng & Lin, 
2011). However, it is known as an error-prone repair system because it may be associated with 
small-scale mutations and chromosomal rearrangement. This repair pathway potentially 
mediates the re-ligation of any broken DNA ends. Unlike HR, its activation is not limited to a 
specific cell cycle phase (Davis & Chen, 2013; Daley et al., 2005; Zaboikin et al., 2017; Ohle 
et al., 2016; Peng & Lin, 2011). Numerous proteins are used in the NHEJ repair pathway to 
recognise, resect, polymerise and ligate the two broken DNA ends. However, in this process, 
faults can potentially result in translocations and telomere fusion (Chang et al., 2017; Espejel 
et al., 2002). These factors include the Ku heterodimer (Ku70-Ku80 subunit), DNA-dependent 
protein kinase catalytic subunit (DNA-PKcs), Artemis, X-ray repair cross-complementing 
protein 4 (XRCC4), DNA ligase IV (LigIV), and XRCC4-like factor (XLF) (Boboila et al., 
2012).  
 
In higher eukaryotes, the Ku70–Ku80 heterodimer initiates the process by recognising and 
binding to the free ends of the DSB DNA. The Ku heterodimer then acts as platform for the 
binding of the core factors of the NHEJ machinery to the target damage site, including DNA-
PKcs. When DNA-PKcs is recruited to the broken DNA ends,  an active Ku70/Ku80/DNA-
PKcs complex is formed, which leads to the phosphorylation and recruiting of  the 
endonuclease Artemis. The repair continues by cleaving any overhangs at the DNA ends, which 
make it compatible with the re-ligation process (Davis & Chen, 2013; Mladenov & Iliakis, 
2011; Boboila et al., 2012; Grabarz et al., 2012; Li & Xu, 2016; Khalil et al., 2012).  
It has been proposed that in many organisms the MRN complex (MRE11-RAD50-NBS1), 
which also mediates the HR pathway (see later), as well as DNA polymerases and other 
nucleases, may be required to process the ends before ligation (Boboila et al., 2012; Manolis 
et al., 2001). In the final step, XRCC4-DNA LigaseIV complex is recruited to ligate the DNA 
ends, which results in the restoration of the integrity of the DNA. 
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XLF interacts directly with XRCC4/ LigaseIV complex, but its precise function in NHEJ 
pathway repair is still unknown. However, it may be involved in stimulating the ligation 
activity of the XRCC4/ LigaseIV complex (Figure 1.6) (Grabarz et al., 2012; Davis & Chen, 
2013; Mladenov & Iliakis, 2011; Boboila et al., 2012; Khalil et al., 2012). 
  
 
 
  
                               
Figure 1.6 Summary of the main stages of the NHEJ repair pathway 
Broken DNA ends are recognised and bound by the Ku70/80 complex, which then recruits the DNA-
PKcs that stimulate the end processing by phosphorylating Artemis nuclease. Artemis processes the 
DNA ends to be appropriate for the ligation step. Finally, LigIV/XRCC4/XLF complex acts to re-
join the broken DNA ends (adapted from Mladenov & Iliakis, 2011).  
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1.6.2 The homologous recombination repair pathway 
HR is described as a high-fidelity repair pathway that requires a homologous template (e.g., a 
sister chromatid) for repairing DSBs. This mechanism has been recognised as generally error 
free (Zhao et al., 2017; Essani at al. et al., 2015; Khalil et al., 2012; Zhao et al., 2017). HR is 
crucial in maintaining genomic integrity and diversity by accurately repairing DSBs that are 
generated by exogenous factors, as well as repairing impaired DNA replication forks. In 
addition, it participates in telomere maintenance by repairing incomplete telomeres, such as in 
the absence of telomerase. Furthermore, HR is required during meiosis for chromosomal 
pairing and exchanging, which enables genetic diversity and reductional segregation 
(Symington & Gautier, 2011; Kasparek & Humphrey, 2011; McFarlane et al., 2011; Krejci et 
al., 2012; Biessmann & Mason, 1997; Li & Heyer, 2008).  
 
DSBs can be repaired by a number of HR repair pathways, including double-strand break repair 
(DSBR), synthesis-dependent strand annealing (SDSA), and break-induced replication (BIR) 
(Sakofsky et al., 2012). All the three pathways are initiated by the formation of a DSB that is 
detected by the conserved Mre11, Rad50 and Nbs1 (MRN complex) (Li & Heyer, 2008; Khalil 
et al., 2012), which may lead to the requirement of the checkpoint kinase Ataxia telangiectasia 
mutated (ATM). ATM then phosphorylates and activates different elements of DNA repair, 
including all members of the MRN complex. It also activates the full DNA damage response 
in the cell (Ohle et al., 2016; Peng & Lin, 2011; Khalil et al., 2012; Talens et al., 2017). In 
addition, the MRN complex interacts with exonuclease Exo1 or the Dna2-Sgs1/BLM complex 
to mediate (5'→3') resection at the DSB ends, which leads to the  creation of  single-stranded 
DNA (ssDNA) overhangs with 3ˈ OH ends (Ohle et al., 2016; Suwaki et al., 2011; Zhao et al., 
2017). The formed ssDNA tails are bound by the DNA replication protein A (RPA), which 
prevents the formation of a secondary structure that could interfere with RAD51 at the ssDNA 
tails (Heyer et al., 2010; Khalil et al., 2012; Suwaki et al., 2011). Rad52/BRCA2 function to 
aid in replacing the RPA complex by the pivotal HR protein RAD51, which forms a 
nucleoprotein filament on the  ssDNA (Ohle et al., 2016; Zhao et al., 2017; Talens et al., 2017).  
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The RAD51 recombinase filament searches for and invades a homologous intact duplex DNA, 
where it forms a displacement loop (D-loop) (So et al., 2017; Grabarz et al., 2012; Li & Heyer, 
2008; Suwaki et al., 2011). The 3' end of the invading strand, within the D-loop, is extended 
by DNA polymerases. Once the invading strand is extended, there are three main proposed 
pathways HR mechanism (Figure 1.7).  
 
In the DSBR pathway,  the extended invading strand can be annealed with  the other end of the 
DSB, and this annealing results in the formation of a double Holliday junction (dHJ) (Lord & 
Ashworth, 2016; Li & Heyer, 2008; Essani et al., 2015; Zhao et al., 2017). On one hand, the 
resolution of dHJ can be processed either by the detachment of the two sets of strands, which 
generates a non-crossover product, or by its endonucleolytic cleavage facilitated by resolvases, 
which results in a crossover event (Figure 1.7). On the other hand, the Holliday junction can 
be dissolved by a pathway that involves BLM-promoted branch migration and TOPOIIIα, 
resulting in non-crossover event (Khalil et al., 2012; Essani et al., 2015; Li & Heyer, 2008; 
Suwaki et al., 2011; Zhao et al., 2017). In the SDSA pathway, the D-loop can be unwound and 
the extended invading strand re-anneals with the second end of the DSB, and DNA synthesis 
completes repair by using the re-annealed strand as a template. Unlike DSBR pathway, only 
non-crossover event can be generated in the SDSA pathway, which decreases the possibility of 
generating chromosomal rearrangements (Figure 1.7) (Heyer et al., 2010; Sugiyama et al., 
2006).  However, in some cases, if there are collapsed replication forks or in lengthening of 
telomeres (in the absence of telomerase), for example, a broken DNA may have only one 
repairable end. This leads to the activation of the break-induced replication (BIR) pathway in 
order to rescue chromosomal integrity (Mehta & Haber, 2014; MalkovaIra, 2013; Sakofsky et 
al., 2012). In this pathway, the formed D-loop can become a replication fork that can copy 
DNA sequence distal to the site of the donor molecule up to the end of the chromosome. For 
complete DNA replication, BIR needs the synthesis of both leading and lagging strands (Figure 
1.7) (Llorente et al., 2008; Sakofsky & Malkova, 2017; Heyer et al., 2010; Malkova & Ira, 
2013).   
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BIR is thought to be responsible for mediating alternative lengthening of telomeres (ALT), a 
mechanism that is utilised by telomerase-compromised tumour cells to preserve their telomere 
length (Sakofsky et al., 2012; Roumelioti et al., 2016). In addition, a very recent finding has 
shown that DSBs that occur at sub-telomeric regions are repaired by BIR (Batte et al., 2017). 
Moreover, in S. cerevisiae, it has also been proposed that the accumulation of R-loops at DNA 
damage sites such as rDNA induces repair by BIR (Amon & Koshland, 2016). 
 
Although BIR is crucial for restarting the stalled replication forks and preserving telomeres, it 
can, however, induce chromosomal instability by causing an extensive loss of heterozygosity 
(LOH) (for example, when the DSB end invades a homologue rather than a sister chromatid 
molecule). In addition, BIR can generate complex genomic rearrangements, including non-
reciprocal translocations (for example, when the invasion of the broken DNA end is initiated 
at a non-allelic chromosomal  position) (Llorente et al., 2008; MalkovaIra, 2013; McEachern 
& Haber, 2006; Hastings et al., 2009; Sakofsky et al., 2012; Sakofsky & Malkova, 2017).  
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Figure 1.7 Schematic models of the DSB repair by HR pathways 
After recognition of the DSB, all three pathways initiated by 5'→3' resection at the broken ends. 
Once the homologous sequence is found, one ssDNA 3' end invades the homologous template which 
results in the formation of D-loop. After priming DNA synthesis, the extended invading strand can 
be annealed with the other end of the DSB, which results in the formation of a double Holliday 
junction (DSBR pathway). The resolution of HJ may be processed by a resolvase, such as GEN1, 
SLX1/4 Mus81-Eme1, which can lead to a non-crossover or a crossover recombination product. 
However, the dissolution of HJ is processed by a mechanism involving BLM/ TOPOIIIα complex, 
leading to non-crossover product. Alternatively, the extended invading strand may be unwound and 
re-anneals with the other end of the DSB, and DNA synthesis completes the repair (SDSA pathway), 
resulting in non-crossover products. In the BIR pathway, strand invasion can result in the creation 
of a complete (unidirectional) replication fork that can copy all DNA information distal to the site 
of homology until the end of the chromosome. Repair by BIR can lead to non-reciprocal crossovers. 
Arrowheads show 3’ ends and dashed lines represent newly synthesised DNA (adapted from 
Llorente et al., 2008). 
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1.7 Chromatin: a basic overview 
Chromatin is a highly organized nucleoprotein complex in which DNA is packaged and 
compacted (Shen et al., 2017; Nikolov & Taddei, 2016; Tadeo et al., 2013). This structure is 
fundamental for protecting genetic information as well as for controlling almost every aspect 
of genome dynamics (Li & Zhang, 2012; Sadaie et al., 2004). The basic component of 
chromatin is the nucleosome, which consists of an octamer comprising two molecules of each 
of the four core histones (H3, H4, H2A, H2B), surrounded by approximately 147 DNA base 
pairs (Li & Zhang, 2012; Ordog et al., 2012; Hammond et al., 2017; Koyama et al., 2017; 
Westhorpe & Straight, 2014). The nucleosomes are connected together by linker DNA (20-
80 bp) that is bound by another histone, Histone 1 (H1), which results in the formation of the 
highly structured chromatin within the nucleus (Koyama et al., 2017; Li & Zhang, 2012). Each 
histone has a flexible N-terminal tail, which is modified by a variety of enzymes, resulting in 
changes in chromatin structure, and consequently, DNA accessibility (Maeshima et al., 2014; 
Luger et al., 2012; Bauer & Martin, 2017; Hammond et al., 2017). Histone tails are subject to 
a number of post-translational modifications, including methylation and acetylation (Bauer & 
Martin, 2017; Hammond et al., 2017). Histone acetylation is mediated by histone 
acetyltransferases enzymes (HAT). These enzymes modify the chromatin structure by 
acetylating lysine residues in N-terminal histone tails, which results in changing the positive 
charge of the lysine to neutral. Because the neutral charge reduces the contact between the 
histone tails and the DNA, there is a disassociation of the DNA around the histones, and 
increased accessibility of the DNA by the transcription factors (TF) and other DNA binding 
proteins. In the reverse reaction, histone deacetylation occurs when histone deacetylases 
enzymes (HDAC) remove acetyl groups (Ac) from lysines, which results in the re-association 
of the DNA around the histones, causing gene repression. DNA can also undergo modification 
to regulate chromatin structure. DNA methylation at cytosine residues in gene promoters is 
mostly associated with gene silencing. DNA methylation is mediated by DNA 
methyltransferasaes enzymes (DNMT) in which a methyl group (CH3) is added to the 5' 
position of cytosine bases at the CpG islands (i.e., genomic regions of DNA mostly located in 
a promoter gene enriched in GC content) altering it to 5-methylcytosine. This process results 
in the association of DNA with histones, inhibiting the TF from binding to DNA and 
consequently shutting down gene expression (Figure 1.8) (Hegarty et al., 2016; Labbé et al., 
2016; Ballestar, 2011).  
   
 
25  
In addition to histone modifications, ATP-dependent chromatin remodelling complexes 
regulate the chromatin structure by restructuring nucleosomes (histone–DNA contacts). 
Several proteins are involved in this process by acting mainly in large complexes; for example, 
the conserved SWI/SNF complex. In this mechanism, the energy of ATP hydrolysis is used by 
these chromatin remodellers to change the assembly, compaction and positioning of 
nucleosomes, allowing the DNA to be more accessible to DNA binding factors, including TFs 
(Manning & Yusufzai, 2017; Zhang et al., 2015; Tang et al., 2010; Lusser & Kadonaga, 2003). 
 
 
Figure 1.8 Schematic demonstration of epigenetic modification of gene expression 
Epigenetic modification is regulated by a group of enzymes that modify chromatin structure, which 
affects gene expression. For instance, acetyl groups (AC) are added to histone H3 tails by histone 
acetylransferases enzymes (HAT), which leads to the loss of DNA around the histone, thus enhancing 
the transcription machinery. In the opposite effect, these ACs are removed by histone deacetylase 
enzymes (HDAC), which results in blocking gene expression. DNA methylation is the only epigenetic 
modification that directly targets the DNA. In this mechanism, DNA methyltransferases enzymes 
(DNMTs) methylate CpG islands. These methylated cytosines play a fundamental role in inhibiting 
transcription factors (TF) from binding, thus repressing gene expression. In addition, these methylated 
islands are involved in recruiting transcriptional repressor complexes that maintain  transcriptional 
repression by deacetylation. Ac = Acetyl group; CpG = cytosine-phosphoric acid-guanine motif; 
DNMT = DNA methyltranferase; HAT = histone acetyltransferase(s); HDAC = histone deacetylase(s); 
Mbp = myelin basic protein (adapted from Hegarty et al., 2016). 
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Epigenetic modifications play a fundamental role in the assembly of chromatin structures, and 
thus, influence gene expression or silencing, which are reliant on the state of chromatin (Alper 
et al., 2012; Tadeo et al., 2013). Such epigenetic processes play a crucial role in regulating gene 
activation and silencing transcription at the chromatin level by directing how DNA and histones 
are compacted into the chromatin complex. For instance, DNA sequences that are loosely 
connected with histones have a more ‘open’ chromatin structure and are generally 
transcriptionally active; this is generally referred to as ‘euchromatic’. In contrast, DNA 
sequences that are strongly associated with histones in a highly folded chromatin structure are 
transcriptionally inactive, and are associated with specific markers; these regions are generally 
referred to as ‘heterochromatin’ (Figure 1.9) (Gan et al., 2007; Woolcock & Buhler, 2013; 
Creamer & Partridge, 2011; Nikolov & Taddei, 2016). Thus, gene expression is influenced by 
the state of chromatin. Genes located within heterochromatic loci, including centromeres and 
telomeres, are transcriptionally silent. However, most genes found in euchromatin regions are 
transcriptionally active (Goto & Nakayama, 2012; Li & Zhang, 2012; Creamer & Partridge, 
2011).  
The best studies post-translational modifications that promote epigenetic regulation occur at 
histone H3 tails, important regulatory residues being H3 lysine 4 (H3K4) and H3 lysine 9 
(H3K9) (Creamer & Partridge, 2011; Goto & Nakayama, 2012). Euchromatic formation is 
characterised by methylation of H3 lysine 4 (H3K4me) and acetylation of H3 lysine 9 
(H3K9ac) (Yang & Ernst, 2017; Creamer & Partridge, 2011). However, methylation of H3 
lysine 9 (H3K9me) is the core event in the establishment of heterochromatin (Alper et al., 2012; 
Creamer & Partridge, 2011; Audergon et al., 2015; Wang et al., 2016a; Buhler & Gasser, 2009; 
Tadeo et al., 2013), and this site is bound by the conserved Heterochromatin Protein 1 (HP1) 
(Figure 1.9) (Goto & Nakayama, 2012; Kusevic et al., 2017; Stunnenberg et al., 2015, 
Audergon et al., 2015; Tadeo et al., 2013). 
Heterochromatin formation and maintenance are critical for controlling many genomic 
functions, including gene expression, and optimal centromere and telomere functions (Li & 
Zhang, 2012; Lejeune et al 2010; Cusanelli & Chartrand, 2015; Tadeo et al., 2013; Zocco et 
al., 2016). Heterochromatin assembly has conserved features in higher and lower eukaryotes, 
including humans and yeast (Zocco et al., 2016; Goto & Nakayama, 2012). The mechanisms 
of heterochromatin assembly were best characterized in the fission yeast S. pombe (Tadeo et 
al., 2013; Moazed, 2009).  
  
   
 
27  
Several loci in the S. pombe genome are heterochromatic, including centromeres, sub-
telomeres, and the mating type locus (Figure 1.10) (Alper et al., 2012; Creamer & Partridge, 
2011; Wang et al., 2016a; Tadeo et al., 2013). In S. pombe, heterochromatin loci are 
characterised by methylation of  H3 lysine 9, which then functioned as the binding site for 
heterochromatin proteins, including Swi6 (the HP1 orthologue).  
The RNA interference (RNAi) machinery is also required for the formation of heterochromatin, 
particularly at centromeres (see Section 1.10) (Greenwood & Cooper, 2012; Li & Zhang, 2012; 
Kanoh et al., 2005; Tadeo et al., 2013). Defects in the RNAi machinery significantly influence 
heterochromatin structures at centromeres (Sadeghi et al., 2015; Buhler & Gasser, 2009; Volpe 
et al., 2003; Volpe et al., 2002; Tadeo et al., 2013; Kanoh et al., 2005; Chan & Wong, 2012) 
but have only a weak effect on heterochromatin (Swi6 localisation) at telomeres (Kanoh et al., 
2005; Tadeo et al., 2013). This indicates that factors or mechanisms other than RNAi contribute 
to the establishment of heterochromatin at the end of chromosomes (Kanoh et al., 2005). 
Additional studies revealed that the telomere‐associated protein Taz1 (an orthologue of 
mammalian telomere repeat factors) is involved in heterochromatin formation at telomeres by 
inducing methylation of H3 lysine 9 by the histone methyltransferase Clr4, which results in the 
creation of a binding site for Swi6 (Buhler & Gasser, 2009; Kanoh et al., 2005). Additionally, 
mutation of taz1, a gene encoding a telomere length regulator, and any RNAi genes, such as 
dcr1, results in the loss of Swi6 localisation to the telomere, indicating that RNAi and Taz1 
work in redundant pathways to establish heterochromatin (Swi6 localisation) at the telomere 
(Kanoh et al., 2005; Tadeo et al., 2013). 
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Figure 1.9 Chromatin modifications that lead to the formation of euchromatin or 
heterochromatin 
Euchromatin formation is achieved by H3K9 acetylation and H3K4 methylation. In contrast, H3K9 
methylation occurs in heterochromatin, which is an extremely compacted chromatin structure that 
appears to be located in the densely stained nuclear regions, as shown in mouse cells stained with 
DAPI (adapted from Goto & Nakayama, 2012). 
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1.8 Centromeres 
During the eukaryotic cell cycle, proper chromosome segregation is crucial for transferring 
genetic material accurately to daughter cells (Mutazono et al., 2017; Brouwers et al., 2017). 
Failure in this process is associated with a wide range of genetic diseases such as cancer 
(Santaguida & Amon, 2015). Each chromosome of the eukaryotic genome has distinct regions 
that are essential for ensuring accurate segregation of chromosomes, including centromeres 
(Steiner & Henikoff, 2015; Westhorpe & Straight, 2014; Chan & Wong, 2012; Tadeo et al., 
2013). A centromere is a chromosomal locus that provides a site where a multi-subunit 
structure, the kinetochore, is assembled, and which then serves as an attachment point for 
spindle microtubules. Thus, centromeres are essential for accurate segregation of chromosomes 
during mitosis and meiosis (Moreno-Moreno et al., 2017; Thakur et al., 2015; Buhler & Gasser, 
2009; Westhorpe & Straight, 2014). Failure in maintaining centromere structure or function 
can cause mis-segregation via loss or gain of chromosomes, an outcome that is implicated in 
cancer (Volpe et al., 2002; Lee et al., 2013; Ekwall et al., 1999; Carmichael et al., 2004; 
Santaguida & Amon, 2015). Centromeres, which are in highly repetitive DNA regions, are 
heterochromatic and undergo H3K9 methylation (Buhler & Gasser, 2009; Schoeftner & 
Blasco, 2009; Zeng et al., 2010; Stimpson & Sullivan, 2010; Zocco et al., 2016; Wang et al., 
2016a; Chan & Wong, 2012; Tadeo et al., 2013). Heterochromatin establishment at 
centromeres is vital for kinetochore function, and therefore, it is essential for the accurate 
segregation of chromosomes (Mutazono et al., 2017; Buhler & Gasser, 2009; Schoeftner & 
Blasco, 2009; Zeng et al., 2010; Stimpson & Sullivan, 2010; Schmidt & Cech, 2015). The 
RNAi machinery is required for mediating transcriptionally silenced heterochromatin 
formation at centromere regions in many organisms, including S. pombe, and thus, mutation of 
the central players of the RNAi pathway influences the functions of heterochromatin at the 
centromere. (Buhler & Gasser, 2009; Volpe et al., 2002; Chan & Wong, 2012; Tadeo et al., 
2013). In S. pombe, centromeres range in size from 35–110 kb. They contain three different 
regions, including the central core (cnt) where the assembly of the kinetochore occurs. The cnt 
region consists of unique non-canonical nucleosomes that contain CENP-A (Cnp1) instead of 
H3. The cnt region is surrounded by two inverted innermost repeats (imr) containing transfer 
RNA (tRNA genes) that function as heterochromatin barriers (boundary elements) between the 
Cnp1 (cnt) and the Swi6  heterochromatic loci (Figure 1.11).  
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The imr regoins are additionally flanked by outer repeat regions (otr), which consists of two 
types of repeat sequences, dg and dh, which play a key role in the establishment of centromeric 
heterochromatin. In these repetitive sequences, Swi6 binds to H3K9me to initiate 
heterochromatin formation, and then the pericentromeric regions undergo silencing (Figure 
1.11) (Takahashi et al., 2000; Creamer & Partridge, 2011; Buhler & Gasser, 2009; Shiroiwa et 
al., 2011; Thakur et al., 2015; Goto & Nakayama, 2012). Therefore, reporter genes, such as 
ura4+, inserted into any of the centromere heterochromatic regions, will be affected by the 
heterochromatic status of transcription (Allshire et al., 1994; Buhler & Gasser, 2009). 
Additionally, mutation of any gene coding central RNAi components, including ago1 and dcr1, 
influences centromeric transcripts from these repetitive sequences (otr), which results in the 
loss of centromeric H3K9 methylation and Swi6 localization, an outcome that causes mis-
segregation of chromosomes (Buhler & Gasser, 2009; Volpe et al., 2002; Holoch & Moazed, 
2015; Creamer & Partridge, 2011; Chan & Wong, 2012). 
                             
 
Figure 1.10 A map of the S. pombe chromosomes 
There are only three chromosomes (three centromeres) in the S. pombe genome. They consist of 
3.5, 4.6, and 5.7 Mb with different regions of heterochromatin, including centromeres, telomeres, 
the mating type (mat) and rDNA (adapted from Mizuguchi et al., 2015). 
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Figure 1.11 Schematic demonstration of  S. pombe Centromere 1  
The centromeric regions consist of two distinguishable regions, cnt (yellow) and imr (green). These 
regions are surrounded by the otr  (light blue / purple) region, which consists of two repetitive 
sequences, dh (purple)  and dg (light blue).  The vertical lines within the imr regions represent the 
boundary elements (tRNA genes). 
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1.9 Telomeres  
The ends of linear eukaryotic chromosomes are highly repetitive in nature, and covered with 
unique nucleoprotein-like structures termed telomeres (Chatterjee, 2017; Zocco et al., 2016; 
Wang et al., 2016a; Kupiec, 2014; Lorenzi et al., 2015). Telomere maintenance is regulated by 
a specialized reverse transcriptase enzyme termed telomerase, which is required for DNA 
extension at the ends of chromosomes (Hsu & Lue, 2017; Buhler & Gasser, 2009; Ohno et al., 
2016). Telomeres protect the ends of chromosomes from degradation and from being 
recognised as DSBs (Maestroni et al., 2017; Vancevska et al., 2017; Schoeftner & Blasco, 
2009; Buhler & Gasser, 2009; Lorenzi et al., 2015). In addition, telomeres are required for the 
attachment of chromosomes to the nuclear envelope (NE), which assists in localising and 
organising the chromosomes inside the nucleus (Chikashige et al., 2009; Kupiec, 2014; Li et 
al., 2017). Telomeres are associated with specific protein complexes, termed shelterins, that 
facilitate telomere functions, including telomere length regulation, in order to avoid 
dysfunction of the ends of chromosomes. (Maestroni et al., 2017; Vancevska et al., 2017). 
Thus, telomeres are critical for many aspects of genome dynamics, and failure in maintaining 
telomere and telomerase functions, and components are associated with many genetic diseases, 
including cancer (Chatterjee, 2017; Sarek et al., 2015). Because of their heterochromatin state, 
telomeres were initially thought to be transcriptionally inactive (Buhler & Gasser, 2009; 
Schoeftner & Blasco, 2009; Novo &  Londoño-Vallejo, 2013; Lorenzi et al., 2015). However, 
it was later revealed that telomeres are transcribed into large non-coding G-rich telomeric 
repeat-containing RNA (TERRA) molecules, which are transcribed by RNA polymerase II 
(RNA Pol II) from the subtelomere towards the telomere (Feretza et al., 2017; Azzalin & 
Lingner, 2015; Cusanelli & Chartrand, 2015; Rippe & Luke, 2015; Maicher et al., 2014; Wang 
et al., 2015). TERRA was first identified in humans (Schoeftner & Blasco, 2008; Azzalin et 
al., 2007), and has been implicated in numerous aspects of telomere-associated functions, 
including DNA damage response, telomere length control, telomerase activity regulation, and 
telomeric heterochromatin formation (Azzalin & Lingner, 2015; Cusanelli & Chartrand, 2015; 
Maicher et al., 2014; Rippe & Luke, 2015; Wang et al., 2015). The regulation of TERRA 
expression is crucial for maintaining genome integrity and stability (Cusanelli & Chartrand, 
2015). 
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In addition to TERRA, S. pombe generates distinct transcripts associated with telomeres and 
sub-telomeres, including TERRA antisense transcript C‐rich telomeric RNA repeats termed 
ARIA, as well as ARRET and αARRET, which are transcribed from the subtelomeric 
heterochromatic region and which lack telomeric sequences (Figure 1.12) (Bah et al., 2012; 
Greenwood & Cooper, 2012; Azzalin & Lingner, 2015; Lorenzi et al., 2015). In S. pombe, 
TERRA was recently shown to be required for telomerase association and telomere elongation 
(Moravec et al., 2016). Although RNAi is required for heterochromatin establishment at sub-
telomeric regions of S. pombe that are enriched in the heterochromatin modifications H3K9me 
and Swi6, mutation of the RNAi genes ago1 or dcr1 does not affect these telomeric and sub-
telomeric transcript levels (Greenwood & Cooper, 2012) to the same degree observed in 
centromeric heterochromatin. Further investigation revealed that S. pombe transcripts are 
regulated by the core components of shelterin, i.e. the double-strand telomere-binding proteins 
Taz1 and Rap1, as mutation of any one of these proteins results in elevation of all telomeric 
and subtelomeric transcripts (Greenwood & Cooper, 2012). Furthermore, Taz1 is also required 
for suppressing the sub-telomeric RecQ-like tlh genes (orthologous to the human BLM gene) 
(Hansen et al., 2006), which are normally silent, with unknown function, although they have 
been implicated in the metabolism of telomeres during crises initiated by the loss of telomerase 
(Mandell et al., 2005). Similar to the regulation of telomeric transcripts, tlh expression is not 
highly influenced by mutation of RNAi components, including ago1 and dcr1 (Hansen et al., 
2006). In addition to its role in repressing transcription at telomeres and subtelomeres, the 
telomere‐associated protein Taz1 is involved in a wide range of functions at the ends of 
chromosomes, including telomere length maintenance, DNA damage response, and regulation 
of telomerase recruitment (Pan et al., 2015; Harland et al., 2014). 
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Figure 1.12  Biogenesis of RNA species produced at chromosome ends in fission yeast 
S. pombe telomeric repeats are associated with a multiprotein complex that consists of shelterin 
components, including Taz1, Rap1, Rif1, Poz1, Tpz1, Pot1, and Ccq1, that binds to and protects 
telomeres. Although the chromosome ends of S. pombe are enriched in heterochromatin factors such 
as H3K9me3 and Swi6, S. pombe produces TERRA that is mainly transcribed by RNA Pol II, 
promoted from subtelomere regions (black arrow) towards the ends of the chromosome (telomeres), 
which remaining connected to the telomeres, perhaps via Taz1. In addition to TERRA, the 
chromosome ends of S. pombe generate other distinct molecules, including ARIA, ARRET, and 
αARRET (adapted from Bah et al., 2012). 
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1.10 RNA interference  
RNAi regulates gene expression in a wide variety of eukaryotic organisms at the transcriptional 
and/or post-transcriptional level (Kalantari et al., 2016; Chan & Wong, 2012; Li & Zhang, 
2012; Holoch & Moazed, 2015; Kanoh et al., 2005). The process uses small, non-coding RNA 
molecules, approximately 20–30 nucleotides long, to regulate the activity of genes by 
controlling whether they are translated or their transcripts are degraded/ not translated (Holoch 
& Moazed, 2015; Castel & Martienssen, 2013; Meng & Lu, 2017; Bayne et al., 2010). These 
short RNAs regulate gene expression via two pathways. The first is post-transcriptional gene 
silencing (PTGS), which silences target mRNAs within the cytoplasm to stop them being 
translated. The second mechanism is chromatin-dependent gene silencing (CDGS), which 
represses specific genes at the level of transcription by promoting the generation of 
heterochromatin (Creamer & Partridge, 2011; Moazed, 2009; Castel & Martienssen, 2013). 
Several types of short regulatory RNAs have been recognised: first, short interfering RNAs 
(siRNAs), which induce transcriptional degradation; second, microRNAs (miRNAs), which 
induce translational repression; and third, PIWI-interacting RNAs (piRNAs), which are 
implicated in transposon transcription in the germlines of animals (Castel & Martienssen, 2013; 
Holoch & Moazed, 2015; Moazed, 2009). The main mediators, siRNAs and miRNAs, are 
involved in both PTGS and CDGS. However, piRNAs are implicated in the inhibition of 
‘parasitic’ DNAs. These small non-coding RNA molecules play a crucial role as a guide in the 
RNAi pathway (Pushpavalli et al., 2012; Moazed, 2009). 
The process of RNAi (PTGS) is initiated with long double-stranded RNA (dsRNA) molecules, 
which are generated via a number of ways, including antisense transcription and long-hairpin 
RNAs. This induces an enzyme called Dicer, which possesses endonuclease activity, to cleave 
the dsRNA molecules into 20–25 nucleotide (nt)-long siRNA duplexes. Next, the duplex 
siRNA is integrated into a complex called RNA-induced silencing complex (RISC). RISC, 
which includes effector proteins such as Argonaute, possesses endoribonuclease activity and is 
an essential factor for RNAi processes. Once the process of loading the duplex siRNA into the 
Argonaute protein (RISC) is completed, one strand, acting as the ‘guide’, remains bound to 
RISC while the other strand, the ‘passenger’, is discarded. Then, the guide strand directs the 
RISC complex, including Argonaute, to cleave and silence the target mRNA.  
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This occurs via precise binding through sequence-specific base-pairing between siRNA and 
mRNA, as the siRNA has perfect complementarity with its target mRNA, resulting in 
transcriptional degradation (Castel & Martienssen, 2013; Moazed, 2009; Kalantari et al., 2016; 
Swarts et al., 2014; Volpe & Martienssen, 2011; Kawamata & Tomari, 2010; Malone & 
Hannon, 2009). A complex of two proteins Translin/ Trax (see Section 1.11), known as 
component 3 promoter of RISC (C3PO), has been shown to act as an endoribonuclease in the 
cleavage of the passenger strand of the siRNA, following the loading of duplex siRNA onto 
the Argonaute protein (RISC). This has been observed in both Drosophila melanogaster and 
human cells (see Section 1.13) (Ye et al., 2011; Tian et al., 2011; Liu et al., 2009; Kalantari et 
al., 2016). 
In addition, RNAi processes can specifically affect individual genes by regulating epigenetic 
modifications of chromatin leading to transcription repression and/or heterochromatin 
formation. This includes acting on histones and DNA methyltransferases, termed 
transcriptional gene silencing (TGS) (Holoch & Moazed, 2015; Castel & Martienssen, 2013). 
RNAi pathways that mediate heterochromatin formation are best characterised in S. pombe 
(Caste & Martienssen, 2013; Holoch & Moazed, 2015; Alper et al., 2012; Reyes-Turcu & 
Grewal, 2012; Pushpavalli et al., 2012). In this organism, nuclear siRNA RNA mediates 
heterochromatin formation by targeting nascent centromeric RNA molecules that are generated 
by RNA polymerase II (Holoch & Moazed, 2015; Castel & Martienssen, 2013). S. pombe has 
single-copy genes from the RNAi pathway, including Argonaute (ago1), Dicer (dcr1), and 
RNA-dependent RNA polymerase (rdp1), and mutation of any of these genes influences the 
functions of heterochromatin at the centromere via loss of H3K9 methylation and Swi6 (HP1) 
localization (Buhler & Gasser, 2009; Volpe et al., 2002; Holoch & Moazed, 2015; Creamer & 
Partridge, 2011; Chan & Wong, 2012). In S. pombe, the process of RNAi (CDGS) begins with 
the action of RNA polymerase II (RNA Pol II), which transcribes the pericentromeric DNA 
repeat into dsRNA, with the assistance of an RNA-dependent RNA polymerase complex 
(RDRC). Then, these dsRNAs are processed by the ribonuclease Dicer into siRNAs, which 
then bind to the Argonaute siRNA chaperone complex (ARC). Next, they are loaded onto the 
RNA-induced transcriptional silencing (RITS) complex, which contains Ago1, Chp1, and 
Tas3. Subsequently, the RITS complex binds to nascent RNA transcripts from DNA repeats 
(centromere) through the Chp1 chromodomain protein, resulting in the recruitment of the Clr4-
Rik1-Cul4 (CLRC) complex to the centromeric repeats. The CLRC complex contains Clr4 
(histone methyltransferase), which methylates H3 on lysine 9.  
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The modified histone (H3K9me) forms a binding site for the Swi6 protein, which is required 
for heterochromatin assembly and spreading. Finally, the RDRC complex (Rdp1) is recruited 
by Chp1 to create more dsRNAs, which are then cleaved by Dcr1 for further methylation. 
(Figure 1.13) (Tadeo et al., 2013; Castel & Martienssen, 2013; Creamer & Partridge, 2011; 
Holoch& Moazed, 2015; Creamer& Partridge, 2011; Kalantari et al., 2016;  Zocco et al., 
2016). 
 In addition to the main heterochromatin loci in S. pombe, RNAi (RITS) is also required for the 
formation of heterochromatin at other genomic sites, such as transposon long terminal repeats 
(Woolcock et al., 2011). Additionally, RNAi contributes to silencing two meiotic genes, mei4 
and ssm4. In this mechanism, RITS is recruited by the Mmi1 RNA surveillance machinery to 
degrade these specific meiotic mRNAs (Hiriart et al., 2012; Tashiro et al., 2013; Egan et al., 
2014).  
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Figure 1.13 A model for RNAi in heterochromatin assembly in S. pombe 
The RITS complex, which contains siRNA, Ago1, and Chp1, targets nascent transcripts (long blue 
line) via siRNA base pairing, resulting in the inhibition of RNA Pol II transcription by an unidentified 
mechanism (shown by the question mark). The interaction between Chp1 and H3 on lysine 9 leads 
to the recruitment of Clr4 to methylate histone H3 at lysine 9 at target loci, which then serves as a 
binding site for Swi6. The resultant double-stranded RNA (dsRNA), which consists of siRNA and 
the nascent strand, is used by the RDRC complex (Rdp1) to generate more dsRNAs, which are then 
cleaved by Dcr1 into siRNA. The cycles of RNA and H3K9me are strongly connected through the 
RITS complex to facilitate effective heterochromatin assembly (adapted from Castel & Martienssen, 
2013). 
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1.11 Translin and TRAX 
Analysis of the breakpoint junctions of chromosomal translocations common in lymphoid 
malignancies in humans has identified a novel DNA binding protein, Translin, which binds to 
the single-stranded consensus nucleotide sequences motifs 5'-ATGCAG-3' and 
GCCC(A/T)(G/C)(G/C)(A/T). These translocation breakpoint junctions include 1p32, 3q27, 
5q31, 8q24, 9q34, 9q34.3, 10q24, 11p13,14q11, 14q32, 14q32.1, 17q22, 18q21, 19p13, and 
22q11 (Aoki et al., 1995; Kasai et al., 1997; Kasai et al., 1994). Translin is also implicated in 
a type of sarcoma (liposarcoma) as Translin consensus binding sequences have been identified 
at the breakpoints of reciprocal translocations between fused in sarcoma (FUS) on the short 
arm of chromosome 16 and CHOP on the long arm of chromosome 12 (Kanoe et al., 1999; 
Hosaka et al., 2000). DNA binding sites of Translin were also identified in other kinds of 
cancer-associated chromosomal translocation breakpoints, hot spots of human male meiotic 
recombination and various other chromosomal rearrangement breakpoints in humans (Chalk et 
al., 1997; Abeysinghe et al., 2003; Wei et al., 2003; Visser et al., 2005; Gajecka et al., 2006a; 
Gajecka et al., 2006b). The existence of Translin-binding sites at chromosomal translocation 
breakpoints led to the proposal that Translin is implicated in the initiation and regulation of 
recombination (Jaendling & Mcfarlane, 2010; Parizotto et al., 2013), but a direct mechanistic 
role in this process has not yet been demonstrated. However, this proposal was later challenged 
by the finding that Translin-null mutants, in some eukaryotic organisms including mice, 
Drosophila and S. pombe, show no apparent errors and defects in mechanisms involving 
recombination such as meiotic recombination and DNA damage recovery, or NHEJ 
(Chennathukuzhi et al., 2003; Yang et al., 2004; Claussen et al., 2006; Jaendling et al., 2008; 
Jaendling & Mcfarlane, 2010).  
Translin (whose name was derived from the word ‘translocation’) is a 26 KDa human protein 
comprising 228 amino acids (Lluis et al., 2010; Jaendling & Mcfarlane, 2010 ). The Translin 
gene in mice was discovered independently as the gene that encodes the testis–brain RNA-
binding protein (TB-RBP) (Wu et al., 1997), which has also been implicated in mRNA 
regulation in neurons and spermatogenesis (Li et al., 2008; Moazed, 2009; Jaendling & 
McFarlane, 2010). 
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In support of the involvement of Translin in the neuronal mRNA processing, several studies 
on mice and fruit flies that are deficient in Translin showed multiple neurological and 
behavioural abnormalities (Chennathukuzhi et al., 2003; Stein et al., 2006; Suseendranathan et 
al., 2007; Jaendling et al., 2008). 
 
Using Translin as ‘bait’ in a yeast two-hybrid system identified a second protein, called 
Translin-associated factor X, or TRAX (a 33 KDa) protein, whose amino acid sequence is 
paralogous to Translin (Aoki et al., 1997), indicating a close relationship between Translin and 
TRAX. Subsequently, it has been shown that TRAX stability depends on the stability and 
presence of Translin, highlighting the close functional association between the two pairing 
proteins. This feature is observed in different organisms, including mice, Drosophila and S. 
pombe. Consistently, all eukaryotic organisms that have a Translin orthologue also have a 
TRAX orthologue (Chennathukuzhi et al., 2003; Yang et al., 2004; Claussen et al., 2006; 
Jaendling et al., 2008; Jaendling & Mcfarlane, 2010). Translin regulates TRAX levels post-
transcriptionally. This was discovered by deleting the gene encoding Translin ( in mice and S. 
pombe) and then comparing the levels of TRAX mRNA and protein, which resulted in a 
substantial reduction in TRAX protein levels but no change in its mRNA level (Yang et al., 
2004; Jaendling et al., 2008). Although Translin is necessary for the stability of TRAX, the 
stability of Translin is not dictated by TRAX (Claussen et al., 2006). As found with S. pombe 
tsn1 (Translin)-null mutants, S. pombe tfx1 (TRAX) mutants did not show any measurable 
defects in recombination in standard genetic background assays (Jaendling et al., 2008). 
However, it has not yet been examined whether Translin and/or TRAX have a redundant role 
in recombination and DNA repair processes, which could account for their proposed role in 
translocation formation (Jaendling & Mcfarlane, 2010). Translin and TRAX are highly 
conserved in evolution from human to fission yeast, indicating that they likely play a 
fundamentally important biological role (Laufman et al., 2005; Martienssen et al., 2005; 
Jaendling & Mcfarlane, 2010). Since their first identification, Translin and TRAX have been 
implicated in numerous biological functions, including genome stability, DNA damage 
response, cell growth regulation, RNA interference, the control of mRNA transport and 
translation, tRNA maturation and more recently in the degradation of microRNA in 
oncogenesis, which led to the proposal that both proteins could be druggable targets in 
oncology (Aoki et al., 1995; Wu et al., 1997; Jaendling et al., 2008; Liu et al., 2009; Jaendling 
& McFarlane, 2010; Tian et al., 2011; Li et al., 2012; Asada et al., 2014; Eliahoo et al., 2014). 
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Biochemical, crystallographic and electron microscopy studies have shown that the native 
Translin protein forms an octameric ring structure (Kasai et al., 1997), which is very similar to 
the structures of the family of helicase enzymes that are linked to DNA repair, recombination 
and replication processes (VanLoock et al., 2001; Ishida et al., 2002; Jaendling et al., 2008; 
Fukuda et al., 2008; Jaendling & Mcfarlane, 2010). Translin in this multimeric form binds 
single-stranded DNA, but not double-stranded DNA, and it has been suggested that this 
octameric ring structure of Translin is responsible for the recognition of the DNA ends at 
recombination hotspots in human genome (Kasai et al., 1997; Eliahoo et al., 2014). More 
recently, crystallographic studies have shown that TRAX and Translin form a 2:6 barrel-like 
octamer (Ye et al., 2011; Tian et al., 2011; Parizotto et al., 2013; Zhang et al., 2016) that was 
recently recognised as C3PO (component 3 promoter of the RNA-induced silencing complex 
[RISC]), which is involved in RNA silencing (see Section 1.13)  (Sahu et al., 2014; Liu et al., 
2009).  
 
Translin binds to single-stranded DNA (ssDNA) or RNA, and initially it was assumed that its 
capability to bind to ssDNA is an indication of its involvement in the process of DNA repair. 
This proposal was later supported by numerous studies (see Section 1.12) (Aoki et al., 1995; 
Kasai et al., 1997; Gajecka et al., 2006; Tian et al., 2011; Gupta & Kumar, 2012; Eliahoo et 
al., 2014). Translin and TRAX form a heterodimeric complex that has RNase activity 
dependent on TRAX, and this heteromeric complex has a greater ability to bind to ssDNA 
sequences but a reduced ability to bind to ssRNA sequences compared to the Translin octomer 
on its own, which is able to bind to ssRNA sequences (Liu et al., 2009; Jaendling & Mcfarlane, 
2010; Lluis et al., 2010; Parizotto et al., 2013; Fu et al., 2016). Translin has been shown to have 
RNase activity in vitro, but no DNase activity has been identified (Wang et al., 2004).  
 
TRAX does not bind to nucleic acids on its own, and is usually localised in the cytoplasm, 
whereas Translin is found in both the nuclear and cytoplasmic compartments (Chennathukuzhi 
et al., 2001; Li et al., 2008; Eliahoo et al., 2014). More recently, TRAX has been shown to bind 
directly to ssDNA in the form of a heteromeric Translin-TRAX complex (Gupta & Kumar, 
2012). An early study showed that mouse TRAX inhibits mouse Translin (TB-RBP) from 
binding to RNA, and enhances the binding of Translin to specific ssDNA sequences 
(Chennathukuzhi et al., 2001).  
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It has been shown that human Translin has a great affinity to bind to single-stranded 
microsatellite GT repeats (d[GT]n) and G-strand telomeric repeats (d[TTAGGG]n), which 
indicates a possible functional role in microsatellite repeat or telomere dynamics (Jacob et al., 
2004; Laufman et al., 2005; Jaendling et al., 2008; Yu & Hecht, 2008), although no evidence 
of this was established prior to this current study. In contrast to human Translin, S. pombe Tsn1 
has been shown to have a stronger affinity for G-rich ssRNA than for G-rich ssDNA, leading 
to the proposal that its role is more likely to be in the regulation of RNA metabolism rather 
than DNA metabolism (Laufman et al., 2005; Yu & Hecht, 2008; Jaendling & Mcfarlane, 
2010).  
 
Numerous lines of evidence have implicated Translin and TRAX in the regulation of mRNA 
in both spermatogenesis and neuronal dynamics. For example, mouse Translin was involved 
in the transport and/or stabilisation of mRNA in the brain and testis cells, in which it binds to 
precise RNA sequences in the end of 3′-UTRs (untranslated regions) of target mRNAs (Han et 
al., 1995; Han et al., 1995). Additionally, Translin was shown to bind and stabilise a precise 
miRNA in germ cells, indicating a possible functional role for Translin in posttranscriptional 
regulation of gene expression in male germ cells (Yu & Hecht, 2008). Moreover, in mammalian 
cells, the complex of Translin and TRAX has been shown to mediate the targeting of brain-
derived neurotrophic factor (BDNF) mRNA to neuronal dendrites, and mutation in the Translin 
and TRAX binding region within BDNF mRNA has been associated with human neurological 
disorders (Chiaruttini et al., 2009), implying a role for Translin and TRAX in the function and 
progress of the nervous system (Jaendling & McFarlane, 2010). 
 
 In mammalian cells, Translin and TRAX have been shown to be essential for controlling 
mitotic cell proliferation (Yang et al., 2004; Yang & Hecht, 2004). In support of this, studies 
aiming to compare basal expression levels of different proteins when the cells are dividing 
mitotically have determined that there is a relationship between the level of Translin and the 
rate of cell proliferation. It was found that overexpression of the Translin gene (TSN) led to an 
acceleration in the level of cell proliferation (Ishida et al., 2002).  
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Moreover, it has also been shown that the expression of TSN occurs periodically during the cell 
cycle: it is initiated in the S phase and during the G2/M phase it reaches its optimum, indicating 
a potential functional role for Translin in replication of DNA and acceleration of cell division 
(Ishida et al., 2002). Further analysis using confocal microscopy suggested the involvement of 
Translin in accelerating the organisation of microtubules and segregation of chromosome 
during mitosis (Ishida et al., 2002). However, loss of S. pombe Tsn1 and Tfx1 resulted in a 
slight increase in the rate of cell proliferation (Laufman et al., 2005), indicating that both 
proteins are not essential for the fission yeast (Jaendling & Mcfarlane, 2010). Together, these 
findings indicate that Translin and TRAX may have fundamentally important biological roles 
involved in various essential genetic pathways.  
 
1.12 Evidence for the roles of Translin and TRAX in DNA repair 
There is sufficient evidence to implicate Translin and TRAX in DNA repair processes. Firstly, 
in a range of experiments involving HeLa cells treated with etoposide or mitomycin C, Translin 
was found to localise from the cytoplasm to the nucleus, indicating a signalling mechanism 
taking place in the damaged cells (Kasai et al., 1997; Jaendling & Mcfarlane, 2010). 
Additionally, it has been shown that Translin-deficient mice have hematopoietic stem cell 
recovery problems after exposure to X-rays, which potentially indicates a tissue specific role 
for Translin in DNA damage recovery (Fukuda et al., 2008; Jaendling & Mcfarlane, 2010). 
However, similar experiments that aimed at identifying the repairing role of Translin in mice 
embryotic fibroblasts (MEFs) did not establish any difference between TB-RBP-null 
fibroblasts and unexposed cells in terms of the number of DNA gaps and breaks, nor in the 
survival of these cells (Yang et al., 2004). Moreover, S. pombe tsn1-null mutants (and tfx1-null 
mutants) previously showed no sensitivity to a wide range of DNA damaging chemicals, 
including mitomycin C (Jaendling et al., 2008). The fact that Translin lacks a nuclear 
localisation signal (NLS) has led to the proposal that the nuclear transport of Translin depends 
on its interaction with other proteins that carry a NLS such as TRAX (Aoki et al., 1997; Aoki 
et al., 1997; Laufman et al., 2005). 
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There are several studies showing that Translin and TRAX bind to other proteins that 
participate in the response to DNA damage. For example, using a yeast-two hybrid system, 
murine Translin was shown to bind to the apoptosis inhibitor protein GADD34 (a DNA 
damage-inducible and growth arrest protein) (Hasegawa & Isobe, 1999, Jaendling & 
Mcfarlane, 2010). GADD34 was implicated in the initiation of translation (Patterson et al., 
2006), and this led to the suggestion that the function of Translin in conjunction with GADD34 
may be somehow linked to an RNA-processing/binding activity rather than a direct 
involvement with DNA damage (Jaendling & Mcfarlane, 2010), although it has been assumed 
that GADD34 may participate in the transport of Translin from the cytoplasm to the nucleus in 
response to damaged cells (Hasegawa & Isobe, 1999; Hasegawa et al., 2000). 
 
Following exposure to gamma radiation, TRAX was found to interact directly with the DNA-
dependent protein kinase (DNA-PK) activator, C1D protein, which participates in DNA repair 
in both HR and NHEJ pathways (Erdemir et al., 2002; Li et al., 2008). Nonetheless, the direct 
role of TRAX in DNA damage repair remains largely unidentified. More recently, however, a 
central functional role for murine TRAX was found in the repair of DNA damage by interacting 
with ATM-mediated pathway for DSB repair, and stabilising the MRN complex at DSBs 
(Wang et al., 2016b). These findings also show that the dysfunction of TRAX leads to 
inactivation of ATM, indicating that TRAX is a key factor involved in DNA damage repair 
(Wang et al., 2016b). However, a functional role for Translin in this response, if any, has not 
been demonstrated.  
 
1.13 Translin and TRAX: RNAi interference  
In more recent studies, the Translin/TRAX hetero-octamer complex has been shown to have a 
critical role in the regulation of RNA interference (RNAi) in both Drosophila and human cells 
(Liu et al., 2009; Ye et al., 2011). Specifically, the TRAX subunits in these hetero-octamers 
have been described as having ribonuclease activity (Tian et al., 2011; Parizotto et al., 2013; 
Eliahoo et al., 2014), thus, point mutation of the main catalytic residues in TRAX eliminates 
the RNase activity of the Translin/TRAX complex (Tian et al., 2011; Fu et al., 2016).  
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RNAi is mediated by small interfering RNAs (siRNAs) with involvement of the RNA-induced 
silencing complex (RISC) (see Section 1.10). In order to activate the RISC and enhance 
silencing activity, the passenger strand of the siRNA precursor duplex must be removed to 
allow the guide strand directing RISC (Ago2) to cleave and silence targeted mRNAs. The 
precise mechanism of removing the passenger strand has not yet been revealed, however, the 
Translin/TRAX complex (C3PO), was recently identified as functioning as an 
endoribonuclease in the cleavage of the passenger strand of siRNA, following loading of 
duplex siRNA onto the Argonaute protein (Figure 1.14 ) (Liu et al., 2009; Ye et al., 2011). 
 
C3PO does not function in RNAi in the yeast S. cerevisiae, as C3PO orthologues and other 
regulators of RNAi are deficient in this species (Laufman et al., 2005; Jaendling & Mcfarlane, 
2010). Moreover, the role of C3PO in RNAi may be limited to specific animal eukaryotic 
species. For example, C3PO is not involved in RNAi in the filamentous fungus Neurospora 
crassa. Instead, however, N. crassa C3PO has been shown to function as a ribonuclease in the 
processing of tRNA, specifically in the maturation of pre-tRNAs to tRNAs. Following 
ribonuclease P (RNase P) processing of pre-tRNAs, C3PO  removes sequences at the 5' end of 
the pre-tRNA (Li et al., 2012). In addition, Li et al. (2012) revealed that C3PO is also implicated 
in the processing of tRNA in mouse embryonic fibroblast cells (Li et al., 2012). 
 
 
Surprisingly, very recent observations have suggested that C3PO could have reverse influences 
on silencing activity that is facilitated by siRNAs and miRNAs. It has been found in vitro that 
C3PO degrades pre-miRNAs, indicating that C3PO functions to reduce miRNA that mediates 
silencing, which is opposite to the effect it has in enhancing silencing in Drosophila (see 
Section 1.14) (Asada et al., 2014; Fu et al., 2016). 
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Figure 1.14 Schematic diagram of the role of Translin and TRAX in the Drosophila RNAi 
pathway 
The diagram shows the translocation of the small interfering RNA (siRNA) duplex (consisting of the 
passenger and the guide strands) from complex B to RLC (RISC loading complex), which contains 
Dcr-2 and R2D2. After this, C3PO (Translin and TRAX) is joined with the RLC complex, along with 
the RISC complex, which contains a complex of components, including Ago2 and Dcr-1, which result 
in the generation of the holoRISC by a Drc-2–Ago2 interaction. Next, the endoribonuclease activity 
of C3PO induces the removal of the passenger strand from the siRNA duplex. Finally, holoRISC 
complex targets the selected mRNA (adapted from Jaendling & Mcfarlane, 2010). 
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1.14 The role of Translin and TRAX in oncogenesis 
In addition to its roles in other cellular processes, Dicer is most known for its function as a 
riboendonuclease enzyme in the generation of small RNAs, including siRNA and miRNA. 
Dicer is a critical regulator for the biogenesis and maturation of most miRNAs. The RNaseIII 
Dicer processeds precursor miRNA (pre-miRNA) to mature miRNA, which in turn directs 
Argonaute to mediate translational suppression of selected mRNAs (Asada et al., 2014; 
Fiorenza & Barco, 2016; Hata & Kashima, 2016; Mei et al., 2016; Svobodova et al., 2016; 
Song & Rossi, 2017). miRNAs are involved in the modulation and regulation of approximately 
30% of human gene expression, and deregulation of these small non-coding RNAs is frequently 
observed in numerous human cancers. miRNAs inhibit various tumour-suppressive and 
oncogenic mRNAs, which has led to the proposal that these small RNAs function as both 
oncogenes or tumour suppressor genes (Zhang et al., 2007; Kumar et al., 2009; Gurtner et al., 
2016; Hata & Kashima, 2016; Voglova et al., 2016). The accumulation of pre-miRNAs and the 
reduction of mature miRNAs have been identified in human cancer tissue in comparison to 
normal tissue (Gurtner et al., 2016). In addition, the complete deletion of the miRNA- 
generating enzyme Dicer is harmful to tumour formation and progression (Kumar et al., 2009; 
Asada et al., 2016). Dicer deficiency is seen in up to 40% of cancers and is linked to poor 
patient prognoses. Therefore, Dicer is described as a haploinsufficient tumour suppressor 
(Kumar et al., 2009; Asada et al., 2014; Foulkes et al., 2014; Asada et al., 2016; Gurtner et al., 
2016; Hata & Kashima, 2016). 
It is known that Dicer deficiency results in a depletion of miRNA levels and their tumour 
suppressor activities through impaired miRNA processing activity (Asada et al., 2014; Fu et 
al., 2016; Hata & Kashima, 2016). However, it has been recently found that the miRNA 
depletion with Dicer deficiency is not only due to the loss of miRNA-generating activity, but 
it is in combination with a catalytic function of Translin/TRAX (TSN/TSNAX). Remarkably, 
the C3PO complex was found to function as an RNase enzyme, in that it degrades pre-miRNAs 
in Dicer1 haploinsufficiency. These findings also showed that genetic inhibition of C3PO 
results in a restoration of both miRNA and tumour suppression (Asada et al., 2014).  
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Collectively, these remarkable observations indicate that the C3PO complex plays an 
oncogenic role in Dicer1 haploinsufficient cancer, and this has led to the proposal that both 
proteins could be druggable targets for miRNA function restoration in tumours and emerging 
Dicer deficiencies (Figure 1.15) (Asada et al., 2014; Asada et al., 2016).  
 
 
  
        
 
Figure 1.15 Translin/TRAX complex is a potential druggable target in tumours 
Translin/TRAX (TSN/TSNAX) complex is a possible therapeutic solution for restoring normal 
silencing function. A normal level of Dicer processes pre-miRNA to mature miRNA, which 
maintains tumour suppression. However, with Dicer haploinsufficiency, the ribonuclease complex 
TSN/TSNAX degrades pre-miRNAs, which leads to tumour development. Significantly, genetic 
inhibition of TSN/TSNAX would rescue loss of both miRNA and tumour suppression in Dicer 
deficiency (adapted from Asada et al., 2016). 
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1.15 S. pombe as a model eukaryote 
The fission yeast S. pombe is a brewing yeast found in Africa. Linder extracted this yeast from 
millet beer and termed it ‘Pombe’, meaning ‘beer’. It was later developed as an experimental 
model in the 1950s (Nurse, 2002). The genome of S. pombe is approximately 13.8 Mb in size, 
and carried by three chromosomes consisting of 3.5, 4.6, and 5.7 Mb (Wood et al., 2002; 
Koyama et al., 2017). Sequencing of the S. pombe genome, which contains approximately 5000 
genes, was completed in 2002 (Wood et al., 2002). Various genes are conserved between S. 
pombe and humans, but are absent in other model organisms such as the budding yeast S. 
cerevisiae (Wood et al., 2002; Koyama et al., 2017). Importantly, S. pombe has recently been 
utilized as an effective tool for exploring RNAi and cellular epigenetics (Tadeo et al., 2013; 
Buhler & Gasser, 2009; Koyama et al., 2017). S. pombe has single-copy genes from the RNAi 
pathway, including ago1, dcr1, and rdp1 (Martienssen et al., 2005; Holoch & Moazed, 2015). 
The structure and regulators of S. pombe telomeres exhibit a high degree of similarity with 
those of humans, which makes this organism a perfect model for studying telomere dynamics 
(Lorenzi et al., 2015; Jain & Cooper, 2010; Koyama et al., 2017). More recently, S. pombe has 
been used as an important model organism for identifying the roles and regulators of TERRA 
molecules in telomere function, which is an emerging area of interest (Greenwood & Cooper, 
2012; Bah et al., 2012). More importantly, the C3PO complex (consisting of Translin and Trax) 
has been proposed as an anti-cancer drug target (see Section 1.14) (Asada et al., 2014). This 
complex is found in S. pombe but not in S. cerevisiae. S. pombe is a genetically tractable 
organism and is genetically manipulated more easily than other organisms, including humans. 
Thus, this yeast can be used as an experimental model organism for investigating the complex 
genetic functions.  
 
1.16 Overarching aim of this study 
We aimed to investigate whether Tfx1 (Trax) and Tsn1 (Translin) function in genome 
maintenance pathways. 
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Chapter 2: Materials and Methods 
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2. Materials and Methods   
2.1 Media and strains used in this study 
Media used in this study are listed in Table 2.1. Strains of S. pombe and Escherichia coli used 
in this study are listed in Tables 2.2 and 2.3. De novo deletion (direct gene mutation) was used 
in this study to construct all appropriate mutation strains (Bähler et al., 1998), and correct 
deletions were confirmed by PCR analysis of genomic DNA. 
 
Media and supplements required in this study were purchased from Difco (Becton Dickinson) 
and Sigma. At a final concentration of 200 mg/L, the appropriate amino acid supplements were 
added to the minimal media. An antibiotic concentration of 100 µg/mL was utilised in the 
relative media. Nourseothricin (Warner BioAgents), Ampicillin (Sigma), Geneticin (G418) 
(Sigma), and Hygromycin (Sigma) were the antibiotics used in this study. 
 
2.2 Plasmid Extraction from E. coli 
Plasmid extraction from E. coli was carried out using the QIAGEN Miniprep kit. E. coli strains 
that were stored at -80°C were streaked on Luria-Bertani (LB) agar containing ampicillin and 
incubated overnight at 37°C. A single colony was inoculated into 5 mL LB liquid media 
containing ampicillin and incubated overnight at 37°C in an orbital shaker incubator. Cells 
obtained were centrifuged at 3000 g for 5 minutes and then resuspended in 250 µL P1 buffer 
containing RNase A. This mixture was then transferred to an Eppendorf tube, and 250 µL of 
P2 lysis buffer was used in the cell lysis step. Invert mixing was performed 4-5 times; after 
that, 350 µL N3 buffer (neutralising/binding buffer) was added in the same tube. Invert mixing 
was again performed 4-5 times to homogenise the contents of the tube. The tube was then spun 
at a speed of 12,000 g for 10 min; the pellet was removed, while the supernatant was transferred 
to a QIAprep tube (QIAGEN), which was again centrifuged at the same speed for 30-60 
seconds. The supernatant was removed, and the pellet was washed with 500 µL PB buffer 
(washing buffer) and then spun at 12,000 g for 30-60 seconds. After that, the supernatant was 
removed, and the pellet was washed with 750 µL PE buffer and spun at 12,000 g for 30-60 
seconds. Following this, the supernatant was discarded, and the plasmid DNA was eluted from 
the filter by adding 50 µL of elution buffer (EB). 
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Table 2.1 Yeast and bacterial media recipes   
YEA  
 Yeast extract 
 Glucose  
 Agar 
Per 1 litre add: 
5 g  
30 g  
14 g 
LBA 
 Tryptone  
 Yeast extract  
 Sodium chloride  
 Agar 
 
Per 1 litre add: 
10 g  
 5 g  
10 g  
14 g 
 
NBA 
 Nitrogen base 
 Glucose 
 (NH4)2 SO4 
 Agar 
Per 1 litre add: 
1.7 g 
10 g 
5 g 
24 g 
  
 
Drugs 
Thiabendazole (TBZ) (Sigma)  
Methyl Methanesulfonate (MMS) (Sigma)   
  Mitomycin C (Sigma) 
  Phleomycin (Sigma) 
  Hydroxyurea (HU)  (Sigma) 
  Camptothecin (Sigma)  
 
Concentrations 
(12, 13, 14, 15 ug/ml)  
(0.005, 0.0075, 0.01%) 
(0.15 mM) 
(2.5, 3, 4, 5, 8 ug/ml) 
(8, 10 mM) 
 (1, 1.2, 1.4, 1.8  ug/ml)  
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2.3 S. pombe gene deletions using the PCR method  
From the S. pombe genome, different genes were selected to be knocked out; the method for 
this was adapted from the Bähler approach (Bähler et al., 1998). In this protocol, pFA6a-
natMX6, pFA6a-kanMX6, and pFA6a-hphMX6 were the plasmids used as template DNAs for 
PCR amplification of the antibiotic-resistant marker. The primers used in the PCR contain 80 
bp homologous sequences directly to the upstream and downstream of open reading frame of 
target genes to be deleted and contained 20 bp homologous sequence to the target antibiotic 
resistant marker (plasmids). The oligonucleotide sequences used in these experiments are 
shown in Table 2.4. The Bähler lab genome regulation software was used to design these 
primers:  
http://www.bahlerlab.info/cgi-bin/PPPP/pppp_deletion.pl 
 
The plasmid and primer were diluted 10-fold in 1X TE buffer (1.0 M Tris-HCl maintained at 
8.0 pH and EDTA 1.0 M) prior to the PCR. The 50-μL PCR reactions contained: 1 μL high 
fidelity Phusion polymerase (NEB), 1 μL of DNA template (20 ng of plasmid DNA), 1 μL of 
10 x dNTPs, 1 μL of 20 ng/μL each of forward and reverse primers, 10 μL 5x Phusion™ GC 
buffer, 32.5 μL of sterile distilled water, and 2.5 μL of DMSO. The chosen marker cassettes 
were amplified using the following program: 98°C for 1 min followed by 30 cycles of 10 s at 
98ºC, 30 s at 59ºC, as well as 1 min 50 s at 72ºC, which was then extended to 5 min at 72ºC. 
The PCR products were then purified using the phenol/chloroform method.  
 
2.4 Phenol/Chloroform Purification of DNA 
The DNA was mixed with equal amounts of phenol/chloroform and 0.1 M NaCl (with 1:1 ratio) 
in an Eppendorf tube. This mixture was then centrifuged at 12,000 g for 15 min. The aqueous 
layer formed on top of the solution was poured off into another Eppendorf containing 100% 
ethanol. DNA precipitation was achieved by freezing the cells at -80ºC for 1 hour. The 
precipitated DNA was spun at 12,000 g for 30 min at 4ºC; after that, the supernatant was 
removed, pellet was washed with 70% ethanol by centrifuging at 12,000 g for 15 minutes, and 
the ethanol was completely removed. DNA was resuspended in 40 µL of 1X TE buffer. The 
DNA cassette was then stored at -20ºC. Transformation of the products into S. pombe was 
carried out using the lithium acetate (LiAC) method. 
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Table 2.2  S. pombe strains utilised in this project 
Strain 
number 
                           Genotype Source  
  BP90 hˉ ade6-M26 ura4-D18 leu1-32 McFarlane, 
Bangor 
University 
  BP118 hˉ ade6-M216 ura4-D18 leu1-32 taz1::ura4+ McFarlane, 
Bangor 
University 
BP743  
 
hˉ  rad3-136  
 
McFarlane, 
Bangor 
University 
 BP1079  
 
hˉ ade6-M26 ura4-D18 leu1-32 tsn1::kanMX6 McFarlane, 
Bangor 
University 
BP1080  
 
hˉ ade6-M26 ura4-D18 leu1-32 tsn1::kanMX6 
 
McFarlane, 
Bangor 
University 
BP1089  
 
hˉ ade6-M26 ura4 -D18 leu1-32 tfx1::kanMX6 
 
McFarlane, 
Bangor 
University 
  BP1090 hˉ ade6-M26 ura4 -D18 leu1-32 tfx1::kanMX6 McFarlane, 
Bangor 
University 
  BP1478 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 
McFarlane, 
Bangor 
University 
  BP1508 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 
McFarlane, 
Bangor 
University 
  BP1534 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 (pSRS5) 
McFarlane, 
Bangor 
University 
  BP1535 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 (pSRS5) 
McFarlane, 
Bangor 
University 
  BP1685 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 swi1::ura4 (pSRS5) 
McFarlane, 
Bangor 
University 
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 BP1687 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 swi1::ura4 (pSRS5) 
McFarlane, 
Bangor 
University 
BP2746  
 
hˉ ade6-M26 ura4-D18 leu1-32 dcr1::ura4+  
 
McFarlane, 
Bangor 
University 
  BP2748  
 
hˉ ade6-M26 ura4-D18 leu1-32 tsn1:: kanMX6 
dcr1::ura4+  
 
McFarlane, 
Bangor 
University 
BP2749  
 
hˉ ade6-M26 ura4-D18 leu1-32 tsn1:: kanMX6 
dcr1::ura4+  
 
McFarlane, 
Bangor 
University 
BP2750  
 
hˉ ade6-M26 ura4-D18 leu1-32 tfx1:: kanMX6 
dcr1::ura4+  
 
McFarlane, 
Bangor 
University 
  BP2757 hˉ ade6-M26 ura4-D18 leu1-32 ago1::ura4+ 
  
 
 
 
McFarlane, 
Bangor 
University 
BP2758  
 
hˉ ade6-M26 ura4-D18 leu1-32 ago1::ura4+ 
 
McFarlane, 
Bangor 
University 
BP2759  
 
hˉ ade6-M26 ura4-D18 leu1-32 tsn1:: kanMX6 
ago1::ura4+  
 
McFarlane, 
Bangor 
University 
  BP2761 hˉ ade6-M26 ura4-D18 leu1-32 tfx1::kanMX6 
ago1::ura4+ 
McFarlane, 
Bangor 
University 
  BP2762 hˉ ade6-M26 ura4-D18l eu1-32 tfx1::kanMX6 
ago1::ura4+ 
McFarlane, 
Bangor 
University 
BP3246  
 
hˉade6-M26 ura4-D18 leu1-32 tfx1:: kanMX6 
ago1::ura4+ tsn1::natMX6  
 
McFarlane, 
Bangor 
University 
  BP3247 hˉade6-M26 ura4-D18 leu1-32 tfx1:: kanMX6 
ago1::ura4+ tsn1::natMX6  
 
McFarlane, 
Bangor 
University 
  BP3248 hˉ ade6-M26 ura4-D18 leu1-32 tfx1::kanMX6 
tsn1::natMX6  
 
McFarlane, 
Bangor 
University 
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  BP3249 hˉ ade6-M26 ura4-D18 leu1-32 tfx1::kanMX6 
tsn1::natMX6 
McFarlane, 
Bangor 
University 
  BP3250 hˉ ade6-M26 ura4-D18 leu1-32 tsn1:: kanMX6 
dcr1::ura4+ tfx1::natMX6  
 
McFarlane, 
Bangor 
University 
  BP3273 hˉ ade6-M26 ura4-D18 leu1-32 tlh1::ura4+ 
tlh2::kanMX6 tlh3::kanMX6 tlh4::ura4+ 
 
C. Norbury 
collection 
 
  BP3274 hˉ ade6-M26 ura4-D18 leu1-32 tlh1::ura4+ 
tlh2::kanMX6 tlh3::kanMX6 tlh4::ura4+ ago1::hph 
 
This study 
  BP3275 hˉ ade6-M26 ura4-D18 leu1-32 tlh1::ura4+ 
tlh2::kanMX6 tlh3::kanMX6 tlh4::ura4+ ago1::hph 
 
This study 
  BP3278 hˉ ade6-M26 ura4-D18 leu1-32 tlh1::ura4+ 
tlh2::kanMX6 tlh3::kanMX6 tlh4::ura4+ tfx1::natMX6 
This study 
  BP3279 hˉ ade6-M26 ura4-D18 leu1-32 tlh1::ura4+ 
tlh2::kanMX6 tlh3::kanMX6 tlh4::ura4+ tfx1::natMX6 
This study 
  BP3282  hˉ ade6-M26 ura4-D18 leu1-32 tlh1::ura4+  
tlh2::kanMX6 tlh3::kanMX6 tlh4::ura4+ ago1::hph 
tfx1::natMX6 
 
This study 
  BP3283 hˉ ade6-M26 ura4-D18 leu1-32 tlh1::ura4+ 
tlh2::kanMX6 tlh3::kanMX6 tlh4::ura4+ ago1::hph 
tfx1::natMX6 
This study 
  BP3285 hˉ ade6-M26 ura4-D18 leu1-32 ago1::ura4+ 
taz1::natMX6 
 
This study 
  BP3286 hˉ ade6-M26 ura4-D18 leu1-32 ago1::ura4+ 
taz1::natMX6 
 
This study 
 BP3287 hˉ ade6-M26 ura4-D18 leu1-32 ago1::ura4+ 
taz1::natMX6 
 
This study 
  BP3288 hˉ ade6-M26 ura4-D18 leu1-32 tsn1::kanMX6 
taz1::natMX6 
 
This study 
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  BP3289 hˉ ade6-M26 ura4-D18 leu1-32 tsn1::kanMX6 
taz1::natMX6 
 
This study 
  BP3291 hˉ ade6-M26 ura4 -D18 leu1-32 tfx1::kanMX6 
rap1::natMX6 
This study 
  BP3293 hˉ ade6-M26 ura4-D18 leu1-32 tsn1::kanMX6 
rap1::natMX6 
 
This study 
  BP3294 hˉ ade6-M26 ura4-D18 leu1-32 tsn1::kanMX6 
rap1::natMX6 
 
This study 
  BP3295 hˉ ade6-M26 ura4-D18 leu1-32 tsn1::kanMX6 
rap1::natMX6 
 
This study 
  BP3296 hˉ ade6-M26 ura4 -D18 leu1-32 tfx1::kanMX6 
rap1::natMX6 
This study 
  BP3297 hˉ ade6-M26 ura4-D18 leu1-32 ago1::ura4+ 
bqt4::natMX6 
 
 
This study 
  BP3298 hˉ ade6-M26 ura4-D18 leu1-32 bqt4::natMX6 This study
  
  BP3301 hˉ ade6-M210 ura4-D18 leu1-32 his3-D1 Otrt::his3 J. P Cooper 
collection 
 
  BP3313 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 dcr1::natMX6 
This study 
  
  BP3314 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 dcr1::natMX6 tsn1::kanMX6 
This study
  
  BP3322 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 tsn1::kanMX6 (pSRS5) 
This study
  
  BP3324 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 dcr1::natMX6 (pSRS5) 
This study
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  BP3325 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 dcr1::natMX6 (pSRS5) 
This study
  
  BP3326 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 dcr1::natMX6 tsn1::kanMX6 (pSRS5) 
This study
  
  BP3327 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 dcr1::natMX6 tsn1::kanMX6 (pSRS5) 
This study
  
  BP3328 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 tsn1::kanMX6 (pSRS5) 
This study
  
  BP3335 hˉ ade6::tRNAGLU (1) his3-D1 ura4–18 lys1–37 leu1–
32 tsn1::kanMX6 
This study
  
  BP3336 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 tsn1::kanMX6 
This study
  
  BP3343 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 dcr1::kanMX6 
This study
  
  BP3344 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 tsn1::kanMX6 (pSRS5) 
This study
  
  BP3345 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 tsn1::kanMX6 (pSRS5) 
This study
  
  BP3348 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 dcr1::kanMX6 (pSRS5) 
This study
  
  BP3349 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 dcr1::kanMX6 (pSRS5) 
This study
  
  BP3362 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 tsn1::kanMX6 dcr1::natMX6 
This study
  
  BP3364 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 tsn1::kanMX6 dcr1::natMX6 (pSRS5) 
This study
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  BP3365 hˉ ade6::tRNAGLU (2) his3-D1 ura4–18 lys1–37 leu1–
32 tsn1::kanMX6 dcr1::natMX6 (pSRS5) 
This study
  
Table 2.3 E. coli strain and plasmid utilised in this project 
Bangor strains 
number 
E.coli strain and plasmid  Source 
BE9 pARC782 (kanMX6 amp R)   McFarlane, Bangor University 
BE122 DH5α (pSRS5) 
 
McFarlane, Bangor University 
BE183 pYL16 (natMX6 amp ᴿ) E. Hartsuiker, Bangor 
University 
BE193 pFA6a (hphMX6 amp ᴿ) Oliver Fleck, Bangor 
University 
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2.5 Transformation of S. pombe cells using lithium acetate (LiAC)  
2.5.1   Transformation of S. pombe strains using a DNA knockout cassette 
A single colony of S. pombe was grown overnight with shaking at 30ºC in 5 mL YEL 
containing supplemental adenine (200 mg/L). The next day, 100-200 µL of the culture was 
inoculated in 100 mL of YEL containing supplemental adenine (200 mg/L) to a density of 1x 
107 cells/mL and cultured overnight. The cells obtained after culturing were spun at 3,000 g 
for 5 minutes and then washed using sterile dH2O; they were then centrifuged again at 3,000 g 
for 5 minutes. The cells were resuspended in 1 mL sterile dH2O and transferred to 1.5 mL 
Eppendorf tubes; after that, they were washed once with 1 mL 0.1 M LiAc/1X TE. After 
washing, the cells were resuspended in LiAC/TE to maintain the cellular concentration at 2 x 
109 cells/mL. Following this, 100 µL of the cell suspension was removed and mixed with 2 µL 
of 10 mg/mL sheared herring testis DNA (Invitrogen) and 10-20 µg of cassette DNA . 
Following 10 minutes of incubation at room temperature, 260 µL of 40% PEG/LiAC/TE 
(maintained at pH 7.3) was introduced. The mixture was mixed gently and incubated for 1 hour 
in a water bath at 30ºC after which, 43 μL of DMSO was added, and cells were heat shocked 
for 5 minutes at 42ºC in another water bath. The mixture was then allowed to cool at room 
temperature for 10 minutes, and then washed with 1 mL sterile dH2O by centrifuging for 3 
minutes. The cells were then resuspended in 0.5 mL sterile dH2O and plated onto YEA (100 
µL of the mixture per plate). The plates were then incubated for 18 hour at 30ºC. Finally, the 
plates were replicated onto YEA plates (containing selective antibiotic drugs) and incubated at 
30ºC for 3-4 days. 
 
  2.5.2   Transformation with plasmids 
 The lithium acetate (LiAC) procedure described in Section 2.5.1 was used for the 
transformation of S. pombe strains with plasmids except that only 1 µg of plasmid DNA was 
used, and cells were plated onto selective NBA for selection of transformants after which they 
were incubated for 2-4 days at 30ºC. 
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2.6 Genomic DNA Extraction 
Single colonies were inoculated into  mL YEL containing supplemental adenine (200 mg/L) 
and allowed to grow overnight with shaking at 30ºC until cell saturation occurred. The cells 
obtained after culturing were spun at 3,000 g for 5 minutes and then washed using sterile dH2O 
and transferred to 1.5 mL screw cap tubes and again centrifuged for 1 minute. Then, 200 µL of 
lysis buffer (containing 5 mL 10% SDS, 1 mL Triton X-100, 0.5 mL of TE100X, and 5 mL of 
1 M NaCl) along with 100 µL chloroform, 100 µL phenol, and acid washed beads weighing 
0.3 g were added to the tubes. Cells were disrupted for 30 seconds by a Bead-Beater 
(FastPrep120, ThermoSavant.) and spun at 12,000 g for 15 minutes. The aqueous layer formed 
on top of the solution was aspirated off into another Eppendorf tube containing 100% ethanol. 
The mixture was left at -20oC for 1 hour and then centrifuged at 12,000 g for 12 minutes. The 
pellets formed were washed using 1 mL 70% ethanol and then air-dried. After that, 100 µL 1X 
TE buffer was used to resuspend the final cell pellet.  
 
 
2.7 Confirmation of Gene Knockout by PCR Screening 
After extracting the genomic DNA for the knock out strain, appropriate primers were designed 
for the knockout cassettes and target genes; oligonucleotide sequences used in these 
experiments are shown in Table 2.5. The PCR reaction mixture (for a 25 μL reaction) was as 
follows: 12.5 µL MyTaq™ Red Mix (BioLine), 0.5 µL of 20 ng/μL forward as well as reverse 
primers, 1 µL of the extracted genomic DNA (10% dilution), and 10.5 µL of sterile dH2O. The 
PCR machine was set at the following program: at 96°C for 1 min followed by 35 cycles of 1 
minute at 96°C, 30 seconds at X °C, and 30 seconds at 72°C. An extension was set at 72°C for 
5 minutes. The annealing temperature (X) was set, based on the sequence of the primers. 
Finally, the PCR- amplified products were run on a 1% agarose gel to obtain an estimate of the 
product sizes.  
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2.8 Drop Tests for Drug Sensitivity  
A single colony of S. pombe was inoculated in 5 mL YEL containing supplemental adenine 
(200 mg/L) and grown overnight with shaking at 30°C. The next day, cells were counted using 
a light microscope (40X) by adding 10 µL of the cells to the end of the coverslip of a 
haemocytometer; they were then resuspended with sterile dH2O to obtain a concentration of 5 
x 106 cells/mL. 
 Four serial dilutions of the cell mixture were performed, and 10 µL of each dilution was 
spotted onto YEA plates containing supplemental adenine (200 mg/L) with the required, 
appropriate drugs (complete details of drug concentrations are shown in Table 2.1). A set of 
control plates was made by replacing the drugs with drug solvents (either DMSO or H2O). The 
plates were incubated at an appropriate temperature for 3-4 days. 
 
 
2.9 Storage of S. pombe Strains 
Single colonies were introduced into 5 mL of YEL containing supplemental adenine (200 
mg/L) and allowed to grow with shaking until cell saturation occurred. To achieve a final 
concentration of 30%, glycerol was added to 700 µL of the cultures and vortexed. The cultures 
were then stored at -80oC. 
 
 
2.10 Ultraviolet (UV) irradiation of S. pombe  
Serial dilutions of S. pombe strains were set up as previously described in section 2.8, and 10 
µL of each dilution was spotted onto YEA plates containing supplemental adenine (200 mg/L) 
and allowed to dry. Plates were then exposed to UV irradiation (CL-1000 UV cross linker) 
using a range of doses including 50, 60, and 70 J/m2. The plates were then incubated at an 
appropriate temperature for a period of 3-4 days. 
 
 
 
 
 
   
 
63  
2.11 DAPI staining (Ethanol Fixation) and Microscopy  
Single colonies were introduced into 5 mL of YEL containing supplemental adenine (200 
mg/L) and allowed to grow with shaking to mid-log phase. Cells obtained were centrifuged at 
1159 g for 3 minutes at 4°C, and then the supernatant was removed. The formed pellets were 
then resuspended in 70% ethanol (1 mL) and incubated at room temperature for 10 minutes. 
The mixture was centrifuged at 3000 g for 1 minute, and the supernatant was removed. The 
pellets were washed using 1 mL of 1X PBS buffer. The last step was repeated three times. Cells 
were then resuspended in 100 µL of 1X PBS, and the tubes were kept on ice. After that, 1 µL 
of cells were mixed with 1 µL of DAPI (50 µg/mL) on poly-l-lysine slides (Sigma P8920). The 
mixtures were then covered with a cover slip (22x22 mm) and sealed using nail polish. The 
slides were then ready for examination under a fluorescent microscope. 
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Table 2.4 PCR primers utilised to delete target genes 
Primer name 
 
                     Sequence Notes 
Ago1HphMX6-
F  
 
5′-TAT GAT GAG TCC TAA TCT AGG 
GTT TGG TAT ATA TAA GCT TCC 
AAC CGC CAA AGC GAA TTG TCT 
TCA GCC AAC TCG TCC TTT ATG 
ATT CAG AGT GAG TAG GCG GAT 
CCC CGG GTT AAT TAA-3′  
              
Forward primer for 
the Hygromycin 
cassette for ago1 
replacement 
Ago1HphMX6-R 5′-AAA AAC AGA AGC AGA TTT 
AAT AAG GAA GTA AAA GTT GTG 
GGC AAT CCA GTA GTC AAT CGT 
ATA TCT ATT TCA TTA CTT ATT 
GCA TGC AAT CCA TCA AAC AGA 
ATT CGA GCT CGT TTA AAC-3′  
                                      
Reverse primer for the 
Hygromycin cassette 
for ago1 replacement 
Tfx1NatMX6-F          5′-TAT AGA CTT ATA CAT TTA TAC 
CTT CCA CAC GGC TTT GCT GAA 
TTG AGG ATA TTA TAA AAC TTT 
AAC CGA ATT TGC CAA ATC GGA 
TCC CCG GGT TAA TTA A -3′  
 
Forward primer for 
the Nourseothricinᴿ 
cassette for tfx1 
replacement 
Tfx1NatMX6-R          5′-ATT ATG ATT TTC AAA AGC TGC 
AAA ACA GAA AAA CTT TTA ATA 
AAC TAG TAA GGT GTC TGT CGA 
GAG CTG TCG ATC ATA TAT GAA 
TTC GAG CTC GTT TAA AC -3′  
 
Reverse primer for the 
Nourseothricinᴿ 
cassette for tfx1 
replacement 
Taz1NatMX6-F          5'-CTA AGG GAT TAT GAT AAT TTT 
ATA ATT GTT TAG TGA AAT TCG 
TAA TTC AAC CT CTT TCA CCA 
TAC AAT CGA GGG CAG TTG CGG 
ATC CCC GGG TTA ATTAA-3' 
 
Forward primer for 
the Nourseothricinᴿ 
cassette for taz1 
replacement 
Taz1NatMX6-R          5'-ATT AAC AAA ACT ATC CGA 
GTC TTG TCA ATA TTA TTC ATT 
AAA AAA GCA ATC ATG AAC AAA 
CTC TAT CCG GAG ACG AAA AAG 
AAT TCG AGC TCGT TTA AAC-3'   
 
Reverse primer for the 
Nourseothricinᴿ 
cassette for taz1 
replacement 
Rap1NatMX6-F          5'-CCA GCA TTT CTT GAT TGT AAA 
GTA AAT TAC TTA TTT TTT AAC 
TCA TTT TTA CGC GCA AAA AAA 
GAA TAA AAG TAT GAA CTC GGA 
TCC CCG GGT TAA TTA A-3' 
Forward primer for 
the Nourseothricinᴿ 
cassette for rap1 
replacement 
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Rap1NatMX6-R          5'-TAT GCA TAA AAA GAT TCG 
TAA TAT TGT ACA AGT TTA GGT 
CTC TTT AGA GAA ATA GAA TTT 
GGG CAG AGA TGC TCG GCA ATG 
AAT TCG AGC TCG TTT AAAC-3'   
 
Reverse primer for the 
Nourseothricinᴿ 
cassette for rap1 
replacement 
Bqt4NatMX6-F          5′-TAC ATA AAC GTT GTA AGA 
GAG GAA TTA TAC AAA CGT CGA 
CGA CGG CGA TTA ATT GTT ACC 
TTT CCC CTT AAT TGA ATA CCC 
GGA TCC CCG GGT TAA TTA A-3′ 
 
 
Forward primer for 
the Nourseothricinᴿ 
cassette for bqt4 
replacement 
 
Bqt4NatMX6-R          5′-TAC ATC AAC AAA TTA AAG 
CAC ATA TGT CAC ATT AAA TTC 
TAA CAT CCA GTA GTT TCA AAA 
TGG TAA AGG GCC CTA TTA AAG 
AAT TCG AGC TCG TTT AAA C-3′ 
Reverse primer for the 
Nourseothricinᴿ 
cassette for bqt4 
replacement 
Tsn1-Kan-F          5′-TTA TTT GCA TAC TGA AAA 
CATCAT TCG AAT ATC AAC ACT 
ACTCAA CAG CAT ACA TTA CAG 
ATTAAG TCG ACG GAT CCC CGG 
GTT AAT TAA-3′ 
 
Forward primer for 
the Kanamycin 
cassette for tsn1 
replacement 
Tsn1-Kan-R 5′-ATA TTA AAA AAG CAA TTT 
TATCGG CTC AAT TTT AGT CAA 
GCGTAC AGC TGG CAA ATA AAT 
TGTTAG CAA TGA ATT CGA GCT 
CGT TTA AAC-3′ 
 
Reverse primer for the 
Kanamycin cassette 
for tsn1 replacement 
Dcr1NatMX6-F  
 
5′-ACA TAT GCA TGT TTA TTT GAA 
TAG CTT AGG ATT CAT TAT TTT 
TTA AGA GAC AAA TTT CTC GTC 
AAT TGA ATG AAA CCT TCC GCC 
TTT ATT TTC TTT TTG ACG GAT 
CCC CGG GTT AAT TAA-3′  
 
Forward primer for 
the Nourseothricinᴿ 
cassette for dcr1 
replacement 
Dcr1NatMX6-R 5′-AAT ATC ACG AAA GGA TCC 
GTG CTT TGG AGA CCC AAA TTG 
AAA GTT TGA AAA GTT ACA AGG 
GCC GCG GTC ATA AAA AAT GAA 
ATA CTG TAT ATT TCA AGT CGA 
ATT CGA GCT CGT TTA AAC-3′  
 
Reverse primer for the 
Nourseothricinᴿ 
cassette for dcr1 
replacement 
Dcr1-Kan-F          5′-ATA GCT TAG GAT TCA TTA TTT 
TTT AAG AGA CAA ATT TCT CGT 
CAA TTG AAT GAA ACC TTC CGC 
CTT TAT TTT CTT TTT GA C GGA 
TCC CCG GGT TAA TTA A-3′ 
 
Forward primer for 
the Kanamycin 
cassette for dcr1 
replacement 
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Dcr1-Kan-R 5′-GCT TTG GAG ACC CAA ATT 
GAA AGT TTG AAA AGT TAC AAG 
GGC CGC GGT CAT AAA AAA TGA 
AAT ACT GTA TAT TTC AAG TCG 
AAT CGA GCT CGT TTA AAC-3′ 
 
Reverse primer for the 
Kanamycin cassette 
for dcr1 replacement 
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2.12 RNA Extraction and DNase treatment 
Single colonies were inoculated into 5 mL of YEL containing supplemental adenine (200 
mg/L) and allowed to grow with shaking to exponential phase (OD600 of 0.6–0.8); after that, 
RNA was extracted using the MasterPure™ Yeast RNA Purification Kit (Epicentre). 
Following this, 1.5 mL of mid-log cultures was centrifuged at 3000 g for 1 minute, and the 
supernatant was removed. The formed pellets were vortexed, and 300 µL of a mixture, 
containing 300 µL of extraction reagent for RNA and 1 µL of 50 μg/μL proteinase K, was 
added to the tubes, vortexed, and incubated at 70°C for 15 minutes (tubes were vortexed and 
mixed every 5 minutes). Tubes were placed on ice for 3 minutes, and 175 µL of MPC protein 
precipitation reagent was added to the tubes and vortexed. Mixtures were centrifuged at 10,000 
g for 10 minutes at 4°C. The supernatant was then transferred to another Eppendorf tube. After 
this, 500 µL of isopropanol was added to the tubes, inverted, and then centrifuged again at 4°C 
for 10 minutes at 10,000 g. Residual isopropanol was removed, and the pellets were completely 
resuspended in 200 µL of DNase I solution (containing 20 µL of 10X DNase buffer, 175 μL of 
deionized water, and 5 μL of RNase-free DNase I) and incubated at room temperature for 15 
minutes. After that, 200 μL of 2X T and C Lysis Solution along with 200 μL of MPC protein 
precipitation reagent was added to the tubes, vortexed, and placed on ice for 3 minutes. 
Mixtures were then centrifuged at 4°C for 10 minutes at 10,000 g. The supernatant was then 
transferred to another Eppendorf tube; 500 µL of isopropanol was added to the tubes, inverted, 
and centrifuged again at 4°C for 10 minutes at 10,000 g. The residual isopropanol was carefully 
removed, and pellets were carefully washed twice, using 1 mL of 70% ethanol. Residual 
ethanol was completely removed, and the RNA was resuspended in 350 μL of TE buffer; after 
that, 1 μL of RiboGuard™ RNase Inhibitor was added to the RNA. Quality and concentration 
of the RNA was assessed using a NanoDrop (ND_1000) spectrophotometer. 
Finally, the RNA was treated with RNase-free DNase (Promega) by mixing 1 μg of RNA with 
1 μL of RNase-Free DNase 10X reaction buffer along with 1 μL RNase-Free DNase, and up 
to 10 μL nuclease-free water was added to the tube. The tubes were incubated for 30 minutes 
at 37°C. Then, 1 μL of DNase Stop Solution (Promega) was added to the mixture, which was 
further incubated at 65°C for 10 minutes. RNA was then stored at -20°C. 
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2.13 Reverse Transcription PCR 
In this stage, 1 μg of RNA was reverse transcribed by mixing 10 μL of primer mix (containing 
1 μL of 10 mM dNTP mix, 1 μL of 2 pmol/µL specific primer, and up to 10 μL nuclease-free 
water). For no-primer control reaction, the same volume of sterile dH2O replaced the primer. 
Then, the RNA was denatured in the presence or absence of primers at 90°C for 1 minute. After 
that, 7 μL of the reverse transcriptase mix was added to the RNA tube after incubation at 55°C 
for 50 minutes. The RT mix contained 4 μL 5X RT buffer, 1 μL 0.1 M DTT, 1 μL 
RNaseOUT™, and 1 μL SuperScript™ III RT (Invitrogen, 18080-051). The tube was then 
incubated at 85°C for 5 minutes before it was placed on ice for 1 minute and spun briefly. 
Finally, 1 μL of RNase H was added to the tube followed by incubation at 37°C for 20 minutes. 
cDNA was then stored at -20°C.  
For the TERRA and ARRET RT–PCR experiments, 2 µL of the cDNA was used for PCR 
amplification using MyTaq™ Red Mix (Bioline). PCR with subtelomeric primers at 10 
pmol/µL was performed with the following program: 95°C for 3 minutes followed by 35 cycles 
of 30 seconds at 95°C, 20 seconds at 62°C, and 30 seconds at 72°C. An extension was set at 
72°C for 5 minutes. PCR with act1 primers was conducted using the same cycling condition at 
an annealing temperature of 58°C for 25 cycles. 
For TERRA and ARRET qRT–PCR experiments: cDNA was PCR amplified using the 
QuantiTect SYBR Green PCR Kit (Qiagen; 204054) on a CFX96 real-time system (Bio-Rad) 
according to the manufacturer’s protocol. The reaction mixture (for a 20 μL reaction) was as 
follows: 10 µL of SYBR™ Green master mix, 2 µL of 10 pmol/µL forward as well as reverse 
primers, 4 µL of the diluted cDNA (containing 1.5 μL cDNA and 2.5 µL of nuclease-free 
water), and 2 µL of sterile dH2O. Samples (in three replicates) were loaded into 96-well PCR 
plates (BioRad) and amplified using the following program: 3 minutes at 95°C, followed by 40 
cycles of 10 seconds at 95°C, 30 seconds at 60°C, and 10 seconds at 95°C. Oligonucleotide 
sequences used in these experiments are shown in Table 2.5.  
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2.14 Determination of Recombination Frequency (Fluctuation test) 
The plasmid-by-chromosome recombination assay (Fluctuation test) was conducted using 
pSRS5 plasmid, which carries a recombination marker ade6 mutant allele (ade6-ΔG1483) 
which was constructed by deleting a guanine at nucleotide position 1482 within the ORF of the 
ade6 gene (Pryce et al., 2009).  
A single colony of S. pombe strains to be tested was inoculated into 5 mL of an appropriate 
liquid medium (for plasmid retention) and grown overnight with shaking at 30°C. An 
appropriate dilution of the growing cultures was plated onto an appropriate solid medium (for 
plasmid retention) and incubated at 30°C until micro-colonies were visible. For one repeat, 
seven whole micro-colonies were inoculated individually into distinct 5 mL of an appropriate 
liquid media (for plasmid retention) and allowed to grow with shaking at 30°C until the cultures 
were saturated. After that, serial dilutions were made, and 100 L of the lower concentration 
dilutions (10 to 10-2) were plated onto YE+guanine plates (containing 100 g/mL guanine final 
concentration from 20 mg/mL guanine dissolved in 0.35 M NaOH/ddH2O stock, final plate pH 
adjusted to 6.5 with 1 M HCl) to measure the adenine prototroph counts (Ade+ recombinant 
totals) within the culture (high concentrations of guanine inhibit the growth of non-recombinant 
ade- cells). In addition, 100 L of higher concentration dilutions (10-3 to 10-5) were plated onto 
YEA plates to measure the viable cells counts within the culture. Plates were incubated at 30°C 
for 3 days; after that, the colonies were counted. This experiment was conducted 3 times, and 
the mean value of the three independent median values (adenine prototrophs/viable cell) of 
each strain were utilised for calculating the recombination frequency.  
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      Table 2.5 Sequence of PCR primers used in this study 
Primer name                                  Sequence Notes 
 Tfx1 check-F  5′-CAAATAGTCATCTTGATTTGC-3′ Upstream of tfx1 ORF  
 Tfx1 check-R  5′-TCTAACATATAGAAAGCAGCG-3′  Downstream of tfx1 ORF  
 Tfx1-int-F  5′-ATAAGAGGGAGAAAATTATTC G-3′  Forward primer inside 
 tfx1 
 Tfx1-int-R  5′-CTCCTCGGGAGGAGTTGC -3′  Reverse primer inside 
 tfx1  
 HphMX6-F 5′-CTGTGTAGAAGTACTCGCCG-3′ 
 
Forward primer inside  
Hygromycin cassette   
 HphMX6-R  5'-AACTTCTCGACAGACGTCGC-3′ Reverse primer inside  
Hygromycin cassette   
Tsn1 check-F 5′-GAT CTA AAC AAC CCA AGC G-3′  
 
Upstream of tsn1 ORF 
Tsn1 check-R 5′-GCATTCATCATAGGACTGCC-3′  
 
Downstream of tsn1 ORF 
 Tsn1-int-F  5'-AAACTGACTGCAGAGGTC G-3'  Forward primer inside  
tsn1  
 Tsn1-int-R 5'-GAACACAGAGATAGTACTGC- 3'  Reverse primer inside  
tsn1 
 NatMX6-F  5′-CATGGGTACCACTCTTGACG- 3' Forward primer inside 
Nourseothricinᴿ cassette   
 NatMX6-R  5′-CTCAGTGGCAAATCCTAACC- 3' Revers  primer inside 
Nourseothricinᴿ cassette   
 Ago check-F 5′-ACTTATGTTGCGTTTGCGTGC - 3' Upstream of ago1 ORF  
 Ago check-R 5′-AGCTATCAACAGTGGATAGAGC-3′  Downstream of ago1 ORF  
 Ago1-int F  5′-AGGTACTTGTTAGCTTCATTCG-3′  Forward primer inside 
ago1  
 Ago1-int R  5′-AGTACCGACATTATTGCGATGC-3′  Reverse primer inside 
 ago1  
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Taz1 check-F          5′-ACAGTTCCTTTCTTTTCGCTT G-3' 
 
Upstream of taz1 ORF  
Taz1 check-R          5′-TGCATACTTCGGACAATTAACG-3′ 
 
Downstream of taz1  
ORF  
Taz1-int-F        5′-ACAGGCTTGATTGATCTCCT-3′ 
 
Forward primer inside 
 taz1 
Taz1-int-R       5′-ACTCGCTCACGAAGCCTGTT-3′ Reverse primer inside 
 taz1 
Rap1check-F          5′-GCCTTCTGCTTATTCGCATACT-3′ 
 
Upstream rap1 ORF  
Rap1check-R          5′-TGGACCTGCTCCAATTTTATTT-3′ 
 
Downstream of rap1  
ORF  
Rap1-int-F       5′-AGTCGCAGAAGATGAACGCG-3′ 
 
Forward primer inside 
rap1 
Rap1-int-R       5′-ACTTATAATGTTGCCGCCAG-3′ 
 
Reverse primer inside  
rap1 
Bqt4 check-F          5′-ATCCCAACAGAAAAGCGTAAAA-3′ 
 
Upstream bqt4 ORF  
Bqt4 check-R          5′-GGTCTCCAATCCCAAATCATAA--3′ 
 
 
Downstream of bqt4 ORF  
Bqt4-int-F       5′-GTACGCGCTTCCCGAAATTA-3′ 
 
Forward primer inside 
 bqt4 
Bqt4-int-R       5′-CCATAGTCCAGCAACACGTT-3′ 
 
Reverse primer inside 
 bqt4 
KanMX6-F 5′-CGGATGTGATGTGAGAACTG-3′  
 
Forward primer inside  
kan R cassette  
 
KanMX6-R 5′-CAGTTCTCACATCACATCCG-3′  Reverse primer inside  
kan R cassette  
 
Dcr1 check-F  
 
5′-AGTATTCTGCTCGTGTGATTG-3 Upstream of dcr1 ORF 
Dcr1 check-R  
 
5′-TGATTGAAACTCGAGATGCTTTG-3′ Upstream dcr1 
ORF 
Dcr1-int-F  
 
5′-ATTCGACGAATGTCATCATGC-3′  Forward primer inside 
 dcr1  
Dcr1-int-R  5′-AGACGATATCATCAGTCACACG-3′ Reverse primer 
inside dcr1  
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oC   5′-GTAACCCCTGTAACCGTAACCC-3′ Telomeric primer used for 
the first strand cDNA 
synthesis for TERRAs. 
See Figure 4.3A 
o3 5′-GTGTGGAATTGAGTATGGTGAA-3′ 
 
Sub-telomeric primer used 
for the first strand cDNA 
synthesis for ARRETs. 
See Figure 4.3A   
o2 5′-GTGTAATACAGTAGTGCAGTG-3′ Forward sub-telomeric 
PCR primer for 
amplification of both 
TERRAs and ARRETs. 
See Figure 4.3A 
o4 5′CGGCTGACGGGTGGGGCCCAATA-3′ Reverse sub-telomeric  
PCR primer for 
amplification of  both 
TERRAs and ARRETs. 
See Figure 4.3A 
act1-F 5′-ATGGAAGAAGAAATCGCAG-3′ Forward primer inside  
act1 
act1-R 5′-CAAAACAGCTTGAATAGC-3′ Reverse primer inside  
act1 
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Chapter 3: Results 
Tfx1-Tsn1: a role in chromosome stability 
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3. Tfx1-Tsn1: a role in chromosome stability 
3.1 Introduction 
In eukaryotic cells, the accurate segregation of chromosomes ensures that genetic material is 
properly transmitted to daughter cells (Mutazono et al., 2017; Brouwers et al., 2017). During 
the eukaryotic cell cycle, the failure of this process is associated with a wide range of genetic 
diseases, including cancer (Santaguida & Amon, 2015; Potapova & Gorbsky, 2017). 
Centromeres and telomeres are eukaryote chromosomal loci that are crucial for proper 
chromosomal segregation and maintenance (Steiner & Henikoff, 2015; Jain & Cooper, 2010; 
Fennell et al., 2015). Centromeres facilitate the link between chromosomes and spindle 
microtubules (Forsburg & Shen, 2017; Moreno-Moreno et al., 2017; Thakur et al., 2015; 
Buhler & Gasser, 2009; Westhorpe & Straight, 2014), and telomeres protect the ends of linear 
chromosomes from degradation and DNA damage response activation (Maestro et al., 2017, 
Vancevska et al., 2017; Schoeftner & Blasco, 2009; Buhler & Gasser, 2009; Lorenzi et al., 
2015). Consequently, proper maintenance of centromere and telomere function is essential for 
genomic integrity (Harland et al., 2014).  
 
Failure to preserve  the structure or function of centromeres can result in mis-segregation via 
loss or gain of chromosomes, an outcome that is associated with cancer (Volpe et al., 2002; 
Lee et al., 2013; Ekwall et al., 1999; Carmichael et al., 2004; Santaguida & Amon, 2015). 
Centromere regions are heterochromatic and are marked by methylation of H3K9, followed by 
capture of heterochromatin protein 1 (Swi6 in S. pombe) (Buhler & Gasser, 2009; Schoeftner 
& Blasco, 2009; Zeng et al., 2010; Stimpson & Sullivan, 2010;  Zocco et al., 2016; Wang et 
al., 2016a; Chan & Wong, 2012; Tadeo et al., 2013). The formation of heterochromatin at the 
centromeres is important for the full function of kinetochores, which are necessary for proper 
segregation of chromosomes (Mutazono et al., 2017; Buhler & Gasser, 2009; Schoeftner & 
Blasco, 2009; Zeng et al., 2010; Stimpson & Sullivan, 2010; Schmidt & Cech, 2015). The 
RNAi machinery is required to mediate heterochromatin formation and maintenance at the 
centromeres in many eukaryotes, including S. pombe. 
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Thus, deletion of key RNAi genes, including ago1, impacts centromeric function by reducing 
H3K9 methylation and Swi6 association and, consequently, chromosomal mis-segragation, 
causing a high rate of cells with aberrant mitosis and a high sensitivity to the microtubule 
disrupting agent TBZ (Buhler & Gasser, 2009; Volpe et al., 2002; Chan & Wong, 2012; Tadeo 
et al., 2013; Holoch & Moazed, 2015; Creamer & Partridge, 2011; Shimada et al., 2016; Volpe 
et al., 2003; Sadeghi et al., 2015; Lee et al., 2013). Translin-TRAX complex (C3PO) is 
involved in the RNAi pathway in humans and D. melanogaster; it mediates the removal of the 
passenger strand from the small interfering RNAs involved in RISC complex-mediated 
silencing (Liu et al., 2009; Ye et al., 2011; Holoch & Moazed, 2015; Tian et al., 2011; Jaendling 
& McFarlane, 2010). Previous studies on the null mutants of S. pombe, tsn1 and tfx1, have 
shown no measureable phenotypic change (Jaendling et al., 2008; Laufman et al., 2005), 
indicating that they are not essential for fission yeast (Jaendling & Mcfarlane, 2010). However, 
more recently, researchers in the McFarlane group found a phenotype associated with tfx1 
mutation, but not tsn1 mutation, in an ago1Δ background. They found that the ago1Δ tfx1Δ 
double mutant is more resistant to TBZ, than the ago1Δ single mutant (N. Al-mobadel, PhD 
thesis, Bangor University; Z. Al-shehri, PhD thesis, Bangor University). In addition, mutation 
of tfx1 is found to partially supress mini-chromosome instability caused by an ago1Δ mutation  
(N. Al-mobadel, PhD thesis, Bangor University). Further work has shown that mutation of 
tsn1Δ in the ago1Δ tfx1Δ background affects TBZ resistance because the ago1Δ tfx1Δ tsn1Δ 
triple mutant exhibits hypersensitivity to TBZ (N. Al-mobadel, PhD thesis, Bangor University). 
These findings are the first to implicate Tfx1 and Tsn1 in chromosome stability control. 
 
The chromosome instability of ago1Δ cells is thought to be caused by defective centromere 
heterochromatin which elevates transcription from centromeric regions normally subjected to 
heterochromatic silencing (Volpe et al., 2003; Holoch & Moazed, 2015). Interestingly, further 
analysis found that there was no suppression of the elevated centromeric transcription in the 
ago1Δ tfx1Δ double mutant relative to the ago1 single mutant (they measured activation of the 
expression of an ura4 marker gene in the centromeric heterochromatic regions of chromosome 
1 for the ago1Δ and ago1Δ tfx1Δ strains; N. Al-mobadel, PhD thesis, Bangor University).  
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These findings indicate that the suppression of the chromosomal instability of ago1Δ cells by 
mutation of tfx1 is not associated with restoring the pericentromeric heterochromatin silencing 
state, and suggesting a distinct suppression mechanism. These results point to the possibility 
that the chromosomal instability observed in an ago1Δ mutant is potentially centromere-
independent. Thus, in order to identify the Tfx1 function, whole genome transcriptional data 
was examined using tiled microarrays to detect any changes of expression at other genomic 
loci when comparing the ago1Δ and the ago1Δ tfx1Δ strains. These analyses determined that 
the only statistically significant difference of note was the activation of one or more of the 
normally silent sub-telomeric RecQ-like genes, tlh1-4 (N. Al-mobadel, PhD thesis, Bangor 
University; Figure 3.7). S. pombe has three chromosomes, and there are only four sub-
telomereic tlh genes located at the ends of chromosome 1 and chromosome 2, as chromosome 
3 contains ribosomal DNA (rDNA) repeats in the sub-telomeric regions (Figure 1.10). The S. 
pombe tlh genes, which are orthologous to the human BLM gene (Hansen et al., 2006), are 
normally transcriptionally inactive, although they have been shown to participate in the 
metabolism of telomeres during telomere crisis initiated by the loss of telomerase (Mandell et 
al., 2005). Morever, the upregulation of tlh genes was also the only notable difference when 
comparing the tfx1Δ single mutant and wild-type (WT) strains. However, similar activation of 
tlh genes was not observed in tsn1Δ relative to the WT strain (N. Al-mobadel, PhD thesis, 
Bangor University; Figure 3.7). 
 
 
Given that sub-telomeric tlh genes are activated in the ago1Δ tfx1Δ double mutant, this led us 
to hypothesise that the suppression of chromosomal instability of an ago1Δ mutant is somehow 
related to the activation of the tlh genes. Therefore, at the onset of this study, the working 
hypothesis postulated that tlh gene activation following mutation of tfx1, but not tsn1, was 
required to partially suppress the chromosome instability phenotype of an ago1Δ mutant. 
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3.2 Results 
3.2.1 Mutation of tfx1 suppresses the chromosomal instability phenotype of the ago1∆ 
mutant in a tsn1-dependent fashion 
We set out to confirm the previous finding that tfx1Δ mutation suppresses the chromosome 
instability defect of ago1∆ cells (all appropriate strains containing single mutants of tsn1Δ and 
tfx1Δ, and double mutants with ago1Δ were constructed by others in the McFarlane group, but 
they were verified here using PCR prior to use). 
 
 
  3.2.1.1 TBZ sensitivity spot assay 
Cells that are defective in chromosome segregation, such as those in the ago1∆ mutant, show 
high sensitivity to TBZ (Sadeghi et al., 2015; Buhler & Gasser, 2009; Volpe et al., 2003; Volpe 
et al., 2002; Lee et al., 2013). Therefore, appropriate strains were exposed to TBZ. Single 
mutants of tfx1∆ and tsn1∆ and the tfx1∆ tsn1∆ double mutant showed no sensitivity to TBZ 
relative to the WT strain (Figure 3.1.A), consistent with previous work of Jaendling et al. 
(2008). Consistent with previous results, the high TBZ sensitivity of the ago1Δ mutant was 
found to be significantly suppressed by the tfx1∆ mutation, but not by tsn1∆ (Figure 3.1.B). 
The ago1∆ tfx1∆ tsn1∆ triple mutant was hypersensitive to TBZ in comparison to the ago1Δ 
single mutant (Figure 3.1.B).  
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Figure 3.1 Mutation of tfx1, but not tsn1, suppressed TBZ sensitivity of ago1Δ. 
Serial dilutions of the indicated S. pombe mutants were made and exposed to different concentrations 
of TBZ. The plates were then incubated at 30°C for 3 days. A. A Single mutants of tfx1∆ and tsn1∆ 
and the tfx1∆ tsn1∆ double mutant showed no sensitivity to TBZ in comparison to the isogenic WT 
strain.  The ago1Δ strain was utilised as a positive control, which displayed high sensitivity to TBZ. 
B. The ago1∆ tfx1∆ double mutant has significantly suppressed sensitivity relative to the ago1∆ 
mutant, whereas the ago1∆ tsn1∆ double mutant exhibited TBZ sensitivity similar to that seen in the 
ago1∆ single mutant. The ago1∆ tfx1∆ tsn1∆ triple mutant is hyper sensitive to TBZ, with a 
sensitivity greater than the ago1Δ single mutant. 
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3.2.1.2 Colony growth test  
The chromosome instability defects of ago1∆ cells can be observed when they are streaked to 
single colonies on yeast extract agar (YEA), as the growth of ago1∆ was found to be less than 
the WT growth (Figure 3.2). However, we noticed that the growth of the ago1∆ tfx1∆ double 
mutant, but not the ago1tsn1double mutant was much better than the growth of the 
ago1∆ single mutant and more similar to the WT growth (Figure 3.2), which is consistent with 
the TBZ sensitivity pattern (Figure 3.1). The growth phenotype of the ago1tfx1∆ tsn1∆ triple 
mutant was similar to that of the ago1∆ single mutant (Figure 3.2).  These results further 
support the suggestion that the tfx1 mutation partially restores genome stability to ago1Δ cells, 
which is apparently dependent on the presence of Tsn1 in a Tfx1-free context. 
 
 
   
Figure 3.2 Colony forming capacity of ago1Δ is enhanced by mutating tfx1. 
The indicated S. pombe strains were streaked on YEA plate and then incubated at 30°C for 3 
days. The tfx1∆ and tsn1∆ single mutants and the tfx1∆ tsn1∆ double mutant have a growth 
phenotype similar to the WT. The ago1∆ single mutant growth was significantly lower than the 
WT, whereas the ago1∆ tfx1∆ double mutant growth was much higher than the ago1∆ single 
mutant and more similar to the WT. Similar growth phenotype defects of an ago1Δ single mutant 
were observed in the ago1∆ tsn1∆ double mutants and the ago1∆ tfx1∆ tsn1∆ triple mutant. 
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3.2.1.3 Microscopy analysis of aberrant mitoses 
The ago1∆ mutant was found to have high rates of cells with aberrant mitoses (Volpe et al., 
2003). In the present study, mitotically dividing cells were stained with 4',6-diamidino-2-
phenylindole (DAPI) and monitored for the frequency of anaphase defects (Figure 3.3). We 
found that aberrant mitosis occurred less frequently in the tfx1Δ and tsn1Δ single mutants, 
which was statistically indistinguishable from the frequency of the aberrant mitosis seen in the 
WT (Figure 3.3.B) (examples of WT phenotypes are shown in Figure 3.3.A, left-hand panel). 
As previously reported, we found that, in the ago1Δ mutant, the chromosomes frequently failed 
to segregate normally at anaphase, which resulted in abnormal mitosis (examples of ago1Δ 
phenotypes are shown in Figure 3.3.A, right-hand panel). Interestingly, we found that the 
mutation of tfx1, but not tsn1, strongly reduced the high number of aberrant mitosis events 
observed in the ago1Δ background (Figure 3.3.B), which is consistent with its TBZ sensitivity 
phenotype (Figure 3.1) and growth phenotype (Figure 3.2). The ago1∆ tfx1∆ tsn1∆ triple 
mutant had abnormal mitosis that was statistically indistinguishable from the abnormal mitosis 
levels seen in the ago1∆ single mutant (Figure 3.3.B). These results indicate that the loss of 
Tfx1 partially suppresses the chromosomal segregation defects of Ago1-deficient cells.  
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Figure 3.3 Fluorescence microscope analyses of the S. pombe strains grown at 30°C and 
stained with DAPI showing the percentage of aberrant mitosis.   
A. Example phenotypes of WT (left) and ago1∆ (right) cells in anaphase with DAPI stain using 
a fluorescence microscope.  
B. The plot shows that the tfx1∆ and tsn1∆ single mutants exhibited no measureable increase in 
the percentage of aberrant mitosis in comparison to the WT. However, the ago1∆ single 
mutant displayed a high level of abnormal mitosis (approximately 65%). The ago1∆ tfx1∆ 
double mutant had significantly reduced numbers of abnormal mitosis events compared to 
the ago1∆ mutant, whereas both the ago1∆ tsn1∆ double mutant and the ago1∆ tfx1∆ tsn1∆ 
triple mutant had an aberrant mitosis statistically indistinguishable from that seen in the 
ago1∆ single mutant. * = P value <0.05; Student’s t-test; error bars are standard deviation. 
The percentage of aberrant mitosis was obtained from the average of three independent 
experiments by observing at least 100 cells per sample in each experiment. 
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3.2.2 Loss of Tfx1 does not restore centromeric heterochromatin 
As indicated, analysis of silencing the marker genes in the centromeric heterochromatic regions 
showed that activation of expression of a ura4+ marker gene in the heterochromatic regions in 
an ago1Δ mutant is not suppressed by mutating tfx1 (N. Al-mobadel, PhD thesis, Bangor 
University). Based on this finding, we set out to ask whether the marker expression assay that 
we used was accurate enough to discern precise alterations in ura4+ expression. To address 
this, we applied a quantitative method to analyse transcriptional activity in the centromeric 
regions for appropriate mutants. We conducted microarray analysis using tilted arrays covering 
the whole S. pombe genome to examine the centromeric expression profiles for all three S. 
pombe centromeres (the previous marker expression study only covers cenI). The array analysis 
showed that both the tsn1Δ and tfx1Δ single mutants exhibit similar levels of silencing of the 
WT strain. Importantly, while mutation of ago1 significantly elevates the centromeric 
heterochromatic transcription relative to the WT strain, the ago1∆ tfx1∆ double mutant was 
indistinguishable from the ago1∆ single mutant for transcription from both forward and reverse 
strands and for all regions of all three S. pombe centromeres (Figure 3.4, Figure 3.5 and Figure 
3.6).  
 
Taken together, these results further confirm that the partial suppression of the ago1Δ mutant 
chromosomal instability by tfx1Δ is not due to full or partial re-establishment of the centromeric 
heterochromatic state; this suggests a centromere-independent suppression mechanism. 
Microarray analysis was performed by a colleague (Julia Feichtinger; currently based at the 
Graz University of Technology, Austria).  
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Figure 3.4 The high levels of centromere 1 transcripts in the ago1Δ mutant are not altered by 
mutating tfx1.  
The transcriptional profiles of the forward (left) and reverse (right) strands from the centromeric regions for 
cen1 are shown for the indicated S. pombe strains. The plot showed that the ago1Δ single mutant had elevated 
transcription in the centromeric heterochromatic region in comparison to the WT (and tsn1Δ and tfx1Δ single 
mutants, which were indistinguishable from the WT). The centromeric transcript levels of the ago1Δ tfx1Δ 
and ago1Δ tfx1Δ tsn1Δ mutants were indistinguishable from the ago1Δ single mutant from both strands. The 
centromere core region, which associates with Cnp1 (CENP-A), and heterochromatic region are indicated (the 
S. pombe nucleotide coordinates shown for cen1 are chromosome 1: 3,754,000–3,790,000). 
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Figure 3.5 The high levels of centromere 2 transcripts in the ago1Δ mutant are not altered by 
mutating tfx1. 
The transcriptional profiles of the forward (left)  and reverse (right)  strands from the centromeric 
regions for cen2 are shown for the indicated S. pombe strains. The plot showed that the ago1Δ single 
mutant had elevated transcription in the centromeric heterochromatic region in comprison to the WT 
(and tsn1Δ and tfx1Δ single mutants, which were indistinguishable from the WT). The centromeric 
transcript levels of the ago1Δ tfx1Δ and ago1Δ tfx1Δ tsn1Δ mutants were indistinguishable from the 
ago1Δ single mutant from both strands.  The centromere core region, which associates with Cnp1 
(CENP-A), and heterochromatic region are indicated (the S. pombe nucleotide coordinates shown 
for cen2 are chromosome 2: 1,600,000 – 1,645,000). 
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Figure 3.6 The high levels of centromere 3 transcripts in the ago1Δ mutant are not altered by 
mutating tfx1. 
The transcriptional profile of the forward (left) and reverse (right) strands from the centromeric regions for 
cen3 are shown for the indicated S. pombe strains. The plot showed that the ago1Δ single mutant had 
elevated transcription in the centromeric heterochromatic region in comparison to the WT (and tsn1Δ and 
tfx1Δ single mutants, which were indistinguishable from the WT). The centromeric transcript levels of the 
ago1Δ tfx1Δ and ago1Δ tfx1Δ tsn1Δ mutants were indistinguishable from the ago1Δ single mutant from both 
strands.  The centromere core region, which associates with Cnp1 (CENP-A), and heterochromatic region 
are indicated (the S. pombe nucleotide coordinates shown for cen3 are chromosome 3: 1,070,000 – 
1,137,000). 
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3.2.3 Investigation of whether tlh gene activation by tfx1 mutation can suppress the Ago1 
requirement 
As explained, when comparing the ago1Δ and ago1Δ tfx1Δ strains, the tiled microarrays 
revealed no measurable alterations of the transcript levels in the centromeric heterochromatic 
regions (Figure 3.4, Figure 3.5 and Figure 3.6). These results indicate that the observed rescue 
of the chromosome instability phenotype of the ago1Δ mutant, following mutation of tfx1, is 
not due to the restoration of the heterochromatin function in the centromeres. Extending this 
led to the finding that the normally silent sub-telomeric tlh genes are upregulated in the ago1Δ 
tfx1Δ double mutant (N. Al-mobadel, PhD thesis, Bangor University; an example of the plot 
profile for the tlh1 transcript is shown in Figure 3.7). These analyses may suggest that the 
activation of tlh genes drive the ago1Δ suppressor phenotype.  
 
 
In S. pombe, sub-telomeres, like centromeres, are heterochromatic and they undergo H3K9 
methylation, followed by the association of Swi6 (Buhler & Gasser, 2009; Schoeftner & 
Blasco, 2009; Shimada et al., 2016; Tadeo et al., 2013; Zeng et al., 2010). Of the four sub-
telomeric tlh paralogous sequences (tlh1–tlhl4), only tlh1 and tlh2 have been included in the S. 
pombe genome database (http://www.pombase.org) at this time. The sub-telomeric tlh genes 
are normally silenced and they have no known function. Researchers in the Norbury group 
(Oxford University) previously constructed a strain carrying a mutation of all four tlh genes 
(referred to as tlh4); they found no apparent phenotype when these genes were disrupted (C. 
Norbury, personal communication). To test the hypothesis that tlh genes activation, by tfx1 
mutation, suppresses the requirement for Ago1, appropriate mutant strains, containing a 
mutation of all tlh genes (tlh4) (obtained from C. Norbury, Oxford University), were 
constructed (Figures 3.10 and 3.11) and then exposed to TBZ (Figure 3.12).  
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Figure 3.7 The sub-telomeric tlh1 transcript is elevated in the ago1Δ tfx1Δ double mutant.  
Analysis of tiled whole genome expression data comparing ago1Δ with ago1Δ tfx1Δ showed that the 
sub-telomeric tlh1 gene transcript is activated. The tlh1 gene is also upregulated in the tfx1Δ single 
mutants. Similar activation of tlh1 is not seen in the tsn1Δ mutant. The plots show the transcriptional 
activity for the tlh1 open reading frame. Seven pairwise plots of transcriptional signals are shown for 
various strains. The log 2-fold change (lg2FC) for each plot is given as a numerical value within the 
plot (* = P<0.05). Similar results are seen for the other annotated tlh2 paralog (see Appendix 1). 
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3.2.3.1 Constructing appropriate mutant strains 
De novo deletion (direct gene mutation) was used in the present study to construct all the 
appropriate mutation strains. No strains were constructed via genetic crossing, as an early study 
conducted by the McFarlane group observed non-Mendelian patterns of segregation following 
mating involving the tsn1Δ mutation, which suggests an as yet undefined meiotic haplo-
insufficiency for Tsn1 (R. McFarlane, communication), or a role in poison-antidote meiotic 
drive (Nuckolls et al., 2017; Hu et al., 2017; Shropshire et al., 2017). Additionally, another 
recent study aiming to identify non-essential mutants of S. pombe that are defective in mating 
and related processes, such as sporulation, found that tsn1∆ mutants have very high levels of 
sporulation defects (Dudin et al., 2017). These findings indicate that the phenomenon observed 
in tsn1∆ mutants is a post-meiotic defect, and so we opted to make de novo deletion mutants 
(in duplicate, at least), which also facilitated maintaining all four tlhΔ alleles in the background.  
 
To generate the ‘double’ mutant, ago1 and tfx1 were deleted from the parent strain, carrying 
a mutation of all four tlh genes, (tlhΔ4 background, BP3273). To generate the ‘triple’ mutant, 
tfx1 was deleted from the newly constructed ‘double’ mutant tlhΔ4 ago1Δ background 
(BP3274) by replacing it with selectable antibiotic resistant cassettes using polymerase chain 
reaction (PCR)-based gene targeting methods (Bähler et al., 1998) (see Section 2.3) (note: for 
ease of reading I refer to tlhΔ4 as a single mutation; therefore, tlhΔ4 with a second mutation 
will be referred to as a ‘double’ mutant, and so on). Plasmids containing the required antibiotic 
resistant cassettes were isolated from E. coli (see Table 2.3). The hygromycin-resistance gene 
(hphMX6) and the nourseothricin-resistance gene (natMX6) were the replacement cassettes 
used to delete ago1 and tfx1, respectively. The replacement cassettes were amplified using PCR 
with primers containing 80 bp homologous sequences directly flanking, upstream and 
downstream, the ago1 and tfx1 open reading frames (ORFs); they also contained a 20 bp 
homologous sequence to the antibiotic-resistant markers on the hphMX6 and natMX6 genes of 
the plasmids (Figure 3.8). The purified PCR product was then chemically transformed into the 
appropriate S. pombe strains (see Section 2.5.1). To confirm the gene deletion, ago1∆ and tfx1Δ 
candidates were screened via PCR (Figures 3.10 and 3.11) using three sets of primers, as shown 
in Figure 3.9. 
 
 
   
 
89  
 
 
 
 
 
 
 
 
 
 
  
           PYL16 Plasmid   
 
 
  
 
                       
 
 
                                                                                                                                                                                                                                                                                     
 
    
 
  
         80 bp target gene- flanking homologous region 
Figure 3.8 Diagram describing the target gene knockout process.  
Different plasmids were utilised as templates for amplification of selectable antibiotic resistant cassettes 
using PCR primers containing a 20 bp (grey box) homologous sequence to the plasmid that contains a target 
antibiotic resistant marker and 80 bp homologous sequences directly to the upstream and downstream target 
gene ORF to be deleted (blue box). The purified PCR product was then chemically transformed into the S. 
pombe strain; the target gene was replaced by a replacement cassette.  
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All the target genes were deleted by replacement with antibiotic resistant cassettes as described by 
Bähler et al. (1998) (see Figure 3.8). Three sets of checking primers, which are shown at their 
approximate location, were used to confirm the deletion of the target genes. These include the Target 
gene Internal-F/Target gene Internal-R primer set, which should give no PCR products for the 
successfully deleted gene candidates due to the deletion of the target genes by the cassette replacements. 
The External target gene check-F/Cassette-R and Cassette-F/External target gene check-R primer sets 
should give PCR products, at the expected size, for the successfully deleted gene candidates due to the 
presence of the cassettes.  
                                                                                                                                        
  
 
 
 
 
 
  
 
 
Figure 3.9 Diagram demonstrating the primers position used to confirm the correct deletion of 
the gene of interest.  
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Figure 3.10 PCR screening of successful ago1Δ candidates. 
A. Agarose gel image displays the PCR products for the WT strain (BP90) and ago1∆ 1 and 2 
(BP3274 tlh∆4 ago1∆ and BP3275 tlh∆4 ago1∆, respectively) using Ago1-int-F and Ago1-int-R 
primers. The expected PCR product size of the ago1 gene is 845 bp; clearly, the gel image shows no 
PCR products in the successful ago1∆ candidate strains. B. PCR products for the WT and ago1∆ 
candidate strains using Ago1 check-F and HphMX6-R primers. Band sizes of approximately 700 bp 
were seen in the ago1∆ strains, but not in the ago1+ strains (WT). The HphMX6-F and Ago1check-
R primers were utilised to amplify the WT and ago1∆ candidate strains. A product size of 497 bp is 
present in the ago1∆ strains, but not in the ago1+ strains (WT). M = markers. 
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Figure 3.11 PCR screening of successful tfx1Δ candidates. 
A. Agarose gel image displays the PCR products for the WT strain (BP90) and tfx1∆ 1, 2, 3 and 4 
(BP3278 tlh∆4 tfx1∆, BP3279 tlh∆4 tfx1∆, BP3282 tlh∆4 ago1∆ tfx1Δ, BP3283 tlh∆4 ago1∆ tfx1Δ, 
respectively) using Tfx1-int-F and Tfx1-int-R primers. The expected PCR product size of the tfx1 
gene is approximately 626 bp; clearly, the gel image shows no PCR products in the successful 
tfx1∆ candidate strains. B. The PCR products for the WT and tfx1∆ candidate strains using Tfx1 
check-F and NatMX6-R primers. Band sizes of approximately 461 bp were seen in the tfx1∆ 
strains, but not in the tfx1+ strains (WT). NatMX6-F and Tfx1check-R primers were utilised to 
amplify the WT and tfx1∆ candidate strains. A product size of approximately 978 bp is present in 
the tfx1∆ strains, but not in the tfx1+ strains (WT). M = markers. 
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3.2.3.2 TBZ sensitivity tests for the tlhΔ4 ago1Δ and tlhΔ4 tfx1Δ double mutants and the 
tlhΔ4 ago1Δ tfx1Δ triple mutant 
In order to test whether tlh genes activation by loss of Tfx1 might suppress the chromosome 
instability of the ago1Δ background, the appropriate strains were made and exposed to TBZ. If 
the hypothesis is correct, the mutation of tlhΔ4 in the ago1Δ tfx1Δ background will affect the 
TBZ resistance activity of the ago1Δ tfx1Δ cells. However, we found that the tlhΔ4 ago1Δ tfx1Δ 
triple mutant exhibited a TBZ suppression phenotype that was similar to the ago1Δ tfx1Δ 
double mutant (Figure 3.12), indicating that activation of tlh genes per se is not driving the 
ago1Δ suppressor phenotype. Remarkably, we revealed that the mutation of the four tlh genes 
in the ago1Δ background also results in significant suppression of the ago1Δ TBZ sensitivity, 
similar to the level seen with the ago1Δ tfx1Δ double mutant (Figure 3.12). This indicates that 
the tlh genes are also implicated in ago1Δ chromosomal instability suppression, possibly 
suggesting that disruption of the telomeres or sub-telomere structures, caused by mutations of 
the tlh genes, can suppress the Ago1 requirement.   
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Figure 3.12 Mutation of all tlh genes results in suppression of ago1Δ TBZ sensitivity to similar 
levels seen in the ago1Δ tfx1Δ double mutant. 
Serial dilutions of the indicated S. pombe strains were made and exposed to different concentrations 
of TBZ. The plates were then incubated at 30°C for 3 days. Both the tlh∆4 mutant and the tlh∆4 tfx1∆ 
‘double’ mutant displayed no measureable sensitivity to TBZ relative to the WT. Interestingly, the 
tlh∆4 ago1∆ double mutant suppressed the TBZ sensitivity phenotype of the ago1∆ to similar levels 
seen in the ago1∆ tfx1∆ background. A suppression phenotype similar to that seen in the ago1∆ tfx1∆ 
double mutant was observed in the tlh∆4 ago1∆ tfx1∆ ‘triple’ mutant.   
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3.2.4 Investigating whether disruption of the telomere structure can suppress the Ago1 
requirement  
RNAi machinery is required to initiate the heterochromatin state at the sub-telomeres; however, 
for maintenance, it is only necessary at the centromeres (Lorenzi et al., 2015; Buhler & Gasser; 
2009; Kanoh et al., 2005). In addition to RNAi, the telomere‐associated protein Taz1, which is 
an orthologue of mammalian TRF proteins, contributes to heterochromatin formation at 
telomeres (Buhler & Gasser, 2009; Kanoh et al., 2005). The DNA double-stranded binding 
protein Taz1 is implicated in a wide range of functions at the end of chromosomes, including 
telomere length control, DNA damage response and regulation of telomerase recruitment (Pan 
et al., 2015; Harland et al., 2014; Cooper et al., 1997; Cooper et al., 1998; Miller & Cooper, 
2003). To further explore the possibility that compromised telomere structures suppress the 
need for Ago1, taz1 was deleted in the ago1Δ background and tested for TBZ sensitivity. 
Additionally, taz1 and rap1 (another telomere regulator gene) were deleted in the tfx1Δ and 
tsn1Δ backgrounds (we were able to generate tsn1Δ taz1Δ, tsn1Δ rap1Δ and tfx1Δ rap1Δ double 
mutants), and then exposed to TBZ with the aim of investigating whether loss of Tfx1 or Tsn1 
in combination with telomere regulators affected TBZ sensitivity.    
 
3.2.4.1 Constructing appropriate mutant strains 
As indicated, all the S. pombe strains were generated by replacement with antibiotic resistant 
cassettes using PCR-based gene targeting methods (Bähler et al., 1998). The taz1 and rap1 
genes were deleted from the parent strains, which were previously constructed in the 
McFarlane group, to generate the double mutants of ago1Δ taz1Δ, tsn1Δ taz1Δ, tsn1Δ rap1Δ 
and tfx1Δ rap1Δ. The plasmid pYL16-natMX6, carrying the antibiotic resistant cassette natMX6, 
was isolated from E. coli strains (see Table 2.3). The antibiotic resistant natMX6 was the 
replacement cassette used to delete both taz1 and rap1, which was amplified using PCR with 
primers designed with 80 bp homologous sequences directly flanked upstream and downstream 
from the taz1 and rap1 ORFs, and which contained a 20 bp  homologous sequence to the 
plasmid that carries the natMX6 gene. The purified PCR product was then chemically 
transformed into the appropriate S. pombe strains. To confirm the correct gene deletions, the 
taz1∆ and rap1Δ candidates were screened via PCR (Figures 3.13 and 3.14) using three sets of 
primers, as previously shown in Figure 3.9. 
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Figure 3.13 PCR screening of successful taz1Δ candidates. 
A. Agarose gel image displays the PCR products for the WT strain and taz1∆ 1, 2, 3, 4 and 5 (BP3285 
ago1∆ taz1∆, BP3286 ago1∆ taz1∆, BP3287 ago1∆ taz1∆, BP3288 tsn1∆ taz1∆ and BP3289 tsn1∆ 
taz1∆, respectively) using Taz1-int-F and Taz1-int-R primers. The expected PCR product size of the 
taz1 gene is approximately 470 bp. The gel image shows no PCR products in the successful taz1∆ 
candidate strains. B. PCR products for the WT and taz1∆ candidate strains using the Taz1 check-F 
and NatMX6-R primers. Band sizes of approximately 542 bp were seen in the taz1∆ strains, but not 
in the taz1+ strains (WT). NatMX6-F and Taz1check-R primers were utilised to amplify the WT and 
taz1∆ candidate strains. A product size of approximately 1072 bp is seen in the taz1∆ strains, but not 
in the taz1+ strains (WT). M = markers. 
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Figure 3.14 PCR screening of successful rap1Δ candidates. 
A. Agarose gel image displays the PCR products for the WT strain and rap1∆ 1, 2, 3, 4 and 5 (BP3293 
tsn1∆ rap1∆, BP3294 tsn1∆ rap1∆, BP3295 tsn1∆ rap1∆, BP3291 tfx1∆ rap1∆ and BP3296 tfx1∆ 
rap1∆, respectively) using Rap1-int-F and Rap1-int-R primers .The expected PCR product sizes of 
the rap1 gene is approximately 347 bp. The gel image shows no PCR products in the successful 
rap1∆ candidate strains. B. PCR products for the WT and rap1∆ candidate strains using Rap1 check-
F and NatMX6-R primers. Band sizes of approximately 490 bp were seen in the rap1∆ strains, but 
not in the rap1+ strains (WT). NatMX6-F and Rap1 check-R primers were utilised to amplify the 
WT and rap1∆ candidate strains. A product size of approximately 1212 bp is present in the rap1∆ 
strains, but not in the rap1+ strains (WT). M = markers. 
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3.2.4.2 Microtubule destabilizing sensitivity tests for the ago1Δ taz1Δ, tsn1Δ taz1Δ, tsn1Δ 
rap1Δ and tfx1Δ rap1Δ double mutants 
As demonstrated, we found that mutation of tlh genes in the ago1Δ mutant background strongly 
suppresses TBZ sensitivity similar to the ago1Δ tfx1Δ double mutant. Following this discovery, 
we proposed that disruption of the telomere structure can alleviate the Ago1 defects. In order 
to test this hypothesis, the telomere regulator taz1 was deleted in the ago1Δ background and 
exposed to TBZ. Interestingly, the result showed that the taz1Δ mutation also significantly 
suppressed the TBZ sensitivity of the ago1Δ cells (Figure 3.15), demonstrating that disruption 
of telomeric factors can suppress the need for Ago1. Moreover, the tsn1Δ taz1Δ, tsn1Δ rap1Δ 
and tfx1Δ rap1Δ double mutants were tested for their response to TBZ with the aim of 
investigating whether the mutation of tsn1 or tfx1 with telomere regulator genes alters sensitivity 
to TBZ. However, the data showed no increase in sensitivity to TBZ in any strains relative to the 
WT strain (Figure 3.16).  
 
 
 
 
 
Figure 3.15 Mutation of taz1 results in a similar suppression of ago1Δ TBZ sensitivity. 
Serial dilutions of the S. pombe strains were made and exposed to different concentrations of TBZ. 
The plates were then incubated at 30°C for 3 days. The data showed that loss of Taz1 results in 
significant suppression of ago1∆ TBZ sensitivity, as does deletion of tfx1and the four tlh genes. 
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Figure 3.16 TBZ sensitivity spot assay for the taz1∆ tsn1∆, rap1∆ tsn1∆ and rap1∆ tfx1∆ 
double mutants. 
Serial dilutions of the indicated S. pombe strains were made and exposed to different concentrations 
of TBZ. The plates were then incubated at 30°C for 3 days.  No measureable increase in sensitivity 
to TBZ was observed for the taz1∆ tsn1∆, rap1∆ tsn1∆ and rap1∆ tfx1∆ double mutants in 
comparison to the WT strain. The rap1Δ single mutant was already shown to exhibit no sensitivity 
to TBZ relative to WT (Tadeo et al., 2013). 
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3.3 Discussion 
3.3.1 Loss of Tfx1 supresses the chromosome instability of Ago1-defective cells in a Tsn1-
dependent fashion 
Centromeres are partly heterochromatic, and they are required for mediating the link between 
chromosomes and spindle microtubules. Thus, centromeres are necessary for the faithful 
segregation of chromosomes during mitosis and meiosis (Forsburg & Shen, 2017; Moreno-
Moreno et al., 2017; Thakur et al., 2015; Buhler & Gasser, 2009; Westhorpe & Straight, 2014; 
Fennell et al., 2015). In S. pombe, the RNAi machinery is needed to establish heterochromatin 
at centromeres (Shimada et al., 2016; Tadeo et al., 2013; Mutazono et al., 2017). Therefore, 
mutations in RNAi genes, such as ago1, affect centromere function, which results in 
chromosome mis-segragation. Cells that have a chromosome segregation defect show high 
sensitivity to a microtubule destabilizing agent, such as TBZ (Sadeghi et al., 2015; Buhler & 
Gasser, 2009; Volpe et al., 2003; Volpe et al., 2002; Lee et al., 2013). C3PO has been 
implicated in many aspects of the RNA regulation pathway, including the RNAi pathway in D. 
melanogaster and human cells, in which C3PO assists in the removal of the passenger strand 
of siRNA-facilitated silencing (Liu et al., 2009; Ye et al., 2011; Holoch & Moazed, 2015; Tian 
et al., 2011). Previous work on null mutants of S. pombe tsn1 and tfx1 genes did not identify 
any observable change in genome stability (S. cerevisiae has no tsn1/tfx1 orthologous) 
(Jaendling et al., 2008; Laufman et al., 2005). This indicates that they are not involved in the 
primary functions of fission yeast, but they could function in redundant or secondary pathways 
(Jaendling & McFarlane, 2010). Following this finding, the McFarlane group showed that 
mutation of S. pombe tfx1, but not tsn1, partially suppresses the chromosomal instability defect 
of ago1Δ cells, a suppression that requires Tsn1 (N. Al-mobadel, PhD thesis, Bangor 
University). In the present study, multiple routes were used to further confirm this finding. 
Firstly, the TBZ sensitivity tests were repeated and the data were consistent with the previous 
findings; the ago1Δ mutant TBZ sensitivity was found to be partly suppressed by the tfx1Δ 
mutation, but not by tsn1Δ. Consistently, the ago1∆ tfx1∆ tsn1∆ triple mutant was found to be 
very sensitive to TBZ; in fact, the TBZ sensitivity was greater than that of the ago1Δ single 
mutant (Figure 3.1). 
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Secondly, all the appropriate strains were grown to single colonies on non-selective YEA 
plates. We showed that that the growth of the ago1∆ tfx1∆ double mutant, but not the 
ago1tsn1double mutant was much better than the growth of the ago1∆ single mutant and 
more similar to the growth of the WT strain. However, the growth phenotype of the 
ago1tfx1∆ tsn1∆ triple mutant was found to be similar to that of the ago1∆ single mutant 
(Figure 3.2). Thirdly, microscope analysis was used to assess endogenous chromosome 
segregation by monitoring the rate of the anaphase defects of the appropriate strains. We found 
that the mutation of tfx1, but not tsn1, significantly reduced the high levels of aberrant mitosis 
events and chromosomal mis-segragation of the ago1Δ mutant. High rates of aberrant mitoses 
were restored following additional mutation of tsn1 in the ago1∆ tfx1∆ cells; the triple mutant 
had abnormal mitosis statistically indistinguishable from that seen in the ago1∆ single mutant 
(Figure 3.3).  
Collectively, three independent analyses have supported the previous findings that the tfx1Δ 
mutation supresses the requirement of Ago1 in maintaining chromosome stability. The results 
also confirm that the mutation of tsn1 in the ago1∆ tfx1∆ background restores and exacerbates 
Ago1 genomic instability. These results lead us to propose that the loss of Tfx1 may free up 
Tsn1 to mediate a positive function that suppresses the need for Ago1 in maintaining genomic 
stability. Moreover, it is important to note that the TBZ sensitivity of the ago1∆ tfx1∆ tsn1∆ 
triple mutant is higher than the sensitivity observed in the ago1Δ single mutant (Figure 3.1), 
which may indicate the need for a redundant joint function by Tsn1 and Tfx1 to maintain 
genomic integrity in the absence of Ago1. Additionally, the finding that the mutation of tsn1, 
unlike tfx1, cannot suppress the chromosomal instability of the ago1Δ mutant suggests no effect 
for Tsn1 in the absence of Ago1. It also indicates that, in the absence of Tfx1, Tsn1 can make 
a larger contribution to the genome stability of the ago1Δ mutant than can be made by Tfx1 in 
a Tsn1-free background. It has been shown that, in the absence of Tsn1, levels of Tfx1 are 
significantly reduced due Translin’s ability to mediate stabilisation of the Tfx1 levels 
(Jaendling et al., 2008). However, the finding that the ago1∆ tfx1∆ tsn1∆ triple mutant is 
hypersensitive to TBZ, but the ago1∆ tsn1∆ double mutant is not (it is the same as the ago1Δ 
single mutant) (Figure 3.1), indicates that the very low Tfx1 levels found in the tsn1∆ mutant 
are sufficient to avoid TBZ hypersensitivity. Thus, the low levels of residual Tfx1 found in the 
tsn1Δ mutant have a biological function in maintaining chromosomal stability. 
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Additionally, the observation that the loss of Tsn1 cannot restore the chromosome stability of 
ago1Δ cells, to the levels seen for tfx1Δ, is interesting because it shows that, unlike other 
organisms, in S. pombe Tsn1 and Tfx1 can function with some degree of independence.  
 
Remarkably, we revealed a novel aspect of the chromosome biology, which challenges the 
current proposal that the chromosome instability of ago1∆ cells is caused solely due to a defect 
in centromere heterochromatin formation (Volpe et al., 2003; Holoch & Moazed, 2015). Using 
tiled microarrays, we found that the high activation of centromeric transcription caused by loss 
of Ago1 function is not suppressed by mutating tfx1, whilst TBZ sensitivity is suppressed 
(Figures 3.4, 3.5 and 3.6). These interesting results indicate that loss of Tfx1 partially 
suppresses the chromosome instability caused by loss of Ago1 without restoring centromere 
heterochromatin formation, suggesting that an additional scenario is at play.  
 
 
 
3.3.2 Telomeric disruption can suppress the requirement for Ago1 
The lack of centromeric dysfunction suppression in the ago1Δ tfx1Δ double mutant led us to 
propose that the chromosomal instability of Ago1-deficient cells is, in part, due to the inability 
to prevent some function(s) that are mediated by Tfx1 at other sites on the genome. This led us 
to hypothesise that this suppression phenotype could, somehow, be due to activation of the 
normally silent sub-telomeric tlh genes in the ago1Δ tfx1Δ background as these genes become 
activated in the tfx1Δ mutant but not in the tsn1Δ (Figure 3.7). Therefore, appropriate mutants 
were made in the tlhΔ4 strain background, and then tested for TBZ sensitivity with the aim of 
addressing whether the tlh genes were required to suppress the chromosome instability of the 
ago1Δ mutant following loss of Tfx1. However, we found that the mutation of tlhΔ4 in the 
ago1Δ tfx1Δ background exhibited a TBZ sensitivity suppression phenotype similar to that seen 
in the ago1Δ tfx1Δ double mutant (Figure 3.12). This indicates that activation of tlh genes is 
unlikely to be responsible for driving the ago1Δ suppressor phenotype of the ago1Δ tfx1Δ 
double mutant. This suppression may suggest that disruption of the telomere or sub-telomere 
structure (i.e. mutation of the four tlh genes caused structural changes) can suppress the Ago1 
requirement for maintaining chromosomal stability.  
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The findings that Tfx1, but not Tsn1, is necessary for controlling tlh transcript levels is further 
evidence that the function of Tsn1 and Tfx1 can be separated in S. pombe. Importantly, 
Southern blotting analysis was used to assess telomere length in the defects in the tfx1, tsn1, 
ago1 and double mutants; the data showed no measurable extensive alteration in the length of 
the telomeres in any of the strains in comparison to the WT strain although small length changes 
cannot dismissed. This indicates that the activation of tlh genes in a tfx1 mutant is not due to 
measurable alterations in the telomere length (Southern blot analysis was conducted by a 
colleague within our group, see Appendix 2).   
 
 
 
3.3.3 Loss of Taz1 also suppresses the Ago1 requirement 
We deleted the telomere regulator gene taz1 in the ago1Δ background to test the possibility 
that disruption of the telomeric structure can suppress the chromosome instability of the ago1Δ 
mutant. We found that the taz1Δ mutant also partly suppresses the TBZ sensitivity phenotype 
of ago1Δ (Figure 3.15), indicating that disruption of telomeric factors partially suppresses the 
requirement for Ago1. More importantly, these findings demonstrate that Tfx1 shares a 
telomere regulator feature in suppressing TBZ sensitivity of an ago1Δ mutant, indicating that 
Tfx1, and possibly Tsn1, may function in telomeric regulation although not via a gross length 
regulation mechanism, as for Taz1 (Cooper et al., 1997; see Appendix 2).   Consequently, loss 
of the telomere-associated function of Tfx1 might be responsible for the suppression of the 
chromosome segregation defects caused by the loss of Ago1. 
During the course of this project, work from Jia and co-workers also demonstrated that the taz1Δ 
mutation suppresses the TBZ sensitivity of the ago1Δ mutant, and it was demonstrated that this 
is due to a partial reversal of heterochromatin function at the centromere. Thus, a model was 
proposed suggesting that loss of Taz1 function in the ago1Δ background results in the 
redistribution of the heterochromatic factors from the subtelomeric regions to the centromere 
at the heterochromatin regions (Figure 3.17) (Tadeo et al., 2013). Moreover, it has been 
reported that tlh genes are also activated in the taz1Δ mutant (Hansen et al., 2006). However, 
the suppression of the chromosomal instability of the ago1Δ background, by loss of Tfx1, is 
not accompanied by a restoration of centromeric heterochromatin function in our strains as 
measured by centromeric transcripts.  
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This demonstrates that redistribution of heterochromatin factors is unlikely to be responsible 
for the chromosomal stability observed in the ago1Δ tfx1Δ cells. However, it is important to 
note that we only measured centromeric heterochromatin based on the transcription profiles 
(Figures 3.4, 3.5 and 3.6). Therefore, further analysis is needed to confirm these observations 
and to exclude an effect of Tfx1 directly on the centromeric heterochromatin. For example, 
measuring the heterochromatin marks levels at the centromeric heterochromatin regions, 
including H3K9-me and Swi6, as well as RNA Pol II occupancy.  
Collectively, these findings may indicate that when centromere heterochromatin is defective 
(i.e. in an ago1Δ mutant), chromosomes can still segregate relatively efficiently when some 
features of normal chromosome biology, which are facilitated by Tfx1, are disrupted.  This 
implicates Tfx1 in restricting segregation in cells which is counter balanced by Ago1, which 
we hypothesis is a mechanism linked to telomeres. Importantly, these observations also 
indicate a poorly understood association between centromeres and telomeres in preserving 
chromosome stability. 
 
3.3.4 tsn1Δ or tfx1Δ mutants with telomere regulators are not sensitive to TBZ 
We set out to investigating whether the mutation of tfx1 or tsn1 with telomere regulators taz1 
or rap1 is affected by TBZ and causes any defect in chromosome stability. However, the 
analysis showed no alteration of sensitivity to TBZ in any strains relative to the WT strain (Figure 
3.16). This suggests that Tsn1 and Tfx1 have no measurable functions in genome stability when 
disrupted with the shelterin components Taz1 or Rap1. 
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Figure 3.17 A model for restoring centromeric heterochromatin function. 
The model suggests that the loss of RNAi and shelterin components results in a redistribution of 
heterochromatin silencing factors, such as Swi6, from the sub-telomeric regions to the centromeric 
heterochromatin regions (Tadeo et al., 2013). 
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3.4 Conclusion 
1- Mutation of tfx1 suppresses the chromosome instability of the ago1 mutant in a Tsn1-
dependent fashion.  
2- Low levels of Tfx1 in a tsn1Δ background have a biological function in regulating 
chromosomal stability. 
3- Tsn1 and Tfx1 functions can be separated in S. pombe. 
4- Activation of tlh genes per se does not appear to be required for driving the ago1 
suppressor phenotype. 
5- The chromosomal instability of the ago1Δ mutant is not only due to the centromeric 
heterochromatin dysfunction; it might also be linked to telomere dynamics.  
6- Disruption of the telomeric structure can suppress the requirement for Ago1 in 
maintaining chromosomal stability. 
7- Tfx1 and Tsn1 might play a role in regulating telomere dynamics. 
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Chapter 4: Results 
Analysis of novel telomere-associated functions of 
Tfx1 and Tsn1 
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4. Analysis of novel telomere-associated functions of Tfx1 
and Tsn1 
4.1 Introduction 
Telomeres are necessary to protect the ends of chromosomes from degradation and from being 
recognised as DSBs (Buhler & Gasser, 2009; Schoeftner & Blasco, 2009; Lorenzi et al., 2015; 
Maestroni et al., 2017; Vancevska et al., 2017). In addition, telomeres are required for 
connecting the chromosomes to the nuclear envelope (NE), which contributes to the 
chromosomal positioning within the nucleus (Chikashige et al., 2009; Novo & Londoño-
Vallejo, 2013; Kupiec, 2014; Li et al., 2017). Thus, telomeres are critical for the stability of 
chromosomes, and they are associated with shelterin components, including TRF proteins 
(Taz1 in S. pombe), which regulate telomere dynamics (Maestroni et al., 2017; Vancevska et 
al., 2017). Failure in preserving telomere function(s) is associated with various genetic 
diseases, including cancer (Hockemeyer & Collins, 2015; Huang et al., 2017; Sarek et al., 
2015). Telomeres are normally subjected to heterochromatic silencing, although noncoding 
telomeric repeat containing RNA (TERRA) is transcribed by RNA Pol II from the sub-telomere 
toward the ends of chromosome (Maicher et al., 2014; Azzalin & Lingner, 2015; Cusanelli & 
Chartrand, 2015; Fennell et al., 2015; Rippe & Luke, 2015; Wang et al., 2015; Feretzaki & 
Lingner, 2017).  
TERRAs are implicated in a wide range of telomere functions, including DNA damage 
response, telomere length control, telomerase activity regulation and telomeric 
heterochromatin formation (Maicher et al., 2014; Azzalin & Lingner, 2015; Cusanelli & 
Chartrand, 2015; Rippe & Luke, 2015; Wang et al., 2015). The regulation of TERRA 
transcripts is important for preserving genome stability (Cusanelli & Chartrand, 2015). 
However, little is known about regulators of these telomeric RNAs. The Translin-TRAX 
complex possesses RNase activity and has the ability to bind to and process nucleic acids 
(Wang et al., 2004; Eliahoo et al., 2010; Jaendling & McFarlane, 2010; Jaendling & McFarlane, 
2010; Li et al., 2012; Parizotto et al., 2013). Translin and TRAX are implicated in the regulation 
of RNA, and they have been previously proposed to function on telomeric sequences based on 
DNA sequence binding preferences (Jacob et al., 2004; Laufman et al., 2005; Jaendling & 
McFarlane, 2010), although no direct evidence of this was provided  prior to the current study 
(see below).  
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In the present study, it was found that Tfx1 has an apparent telomere regulator feature in 
suppressing TBZ sensitivity of the ago1Δ mutant, indicating that Tfx1, and possibly Tsn1, may 
function in telomeric regulation (see Chapter 3). The work in this chapter aims to determine 
the telomere-associated function of Tfx1, and if any, of Tsn1, by addressing the two following 
possibilities:   
 
1- The partial suppression of chromosomal segregation defects of the ago1Δ mutant is due to 
de-tethering of telomeres from the NE, implying a functional role for Tfx1, and possibly 
Tsn1, in controlling telomere tethering to the NE. 
 
2- Dysregulation of transcription in the sub-telomeric regions may be responsible for the 
partial rescue of the chromosomal instability of the ago1∆ mutant, inferring a role for Tfx1, 
and possibly Tsn1, in controlling telomere-associated transcripts.  
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4.2 Results 
4.2.1 Genetic investigation of whether de-tethering of telomeres from the nuclear 
envelope is responsible for the ago1Δ suppression phenotype 
Centromeres and telomeres are regions of eukaryotic genomes essential for the correct 
segregation and maintenance of chromosomes (Steiner & Henikoff, 2015; Harland et al., 2014). 
In S. pombe, the RNAi machinery is required for the full function of centromeres; thus, 
mutation of ago1 results in centromere dysfunction, and consequently, chromosomal mis-
segregation; this causes a high sensitivity to TBZ and current dogma postulates that it is solely 
the loss of centromeric function that is responsible for the TBZ sensitivity of the ago1Δ mutant 
(Volpe et al., 2003; Buhler & Gasser, 2009; Lee et al., 2013; Tadeo et al., 2013; Lorenzi et al., 
2015; Sadeghi et al., 2015). In the current study, the data suggested that compromised telomere 
structures partially suppress the ago1∆ mutant chromosomal segregation defects, a 
phenomenon that has been recently also revealed for taz1∆ mutant which are defective in 
telomere length regulation (Tadeo et al., 2013; Figure 3.15); concerning this phenomenon, Jia 
and co-workers proposed that compromising telomeric heterochromatin results in the 
redistribution of the silencing factors from the sub-telomeric regions to the centromeric 
heterochromatic regions to compensate for the defective state cause by loss of Ago1 (Tadeo et 
al., 2013). Importantly, in the ago1Δ tfx1Δ background, the rescue of Ago1 loss comes without 
restoring centromeric heterochromatin formation, as measured by centromeric transcripts, 
which differs from the ago1Δ taz1Δ mutant (Figures 3.4, 3.5 and 3.6); this indicates that a 
distinct telomere-dependent suppression mechanism is in play. Extending this led us to 
speculate that the chromosomal mis-segregation of cells defective in Ago1 is partly caused by 
the fact defective centromeres cannot counter a structural feature of chromosomes mediated by 
the tethering of telomeres to the NE. An S. pombe mutant defective in the tethering of the 
telomeres to the NE is bqt4Δ (Chikashige et al., 2009). Therefore, this model can be readily 
tested by deleting bqt4 in ago1Δ cells and exposing the ago1Δ bqt4Δ strain to TBZ; if the 
hypothesis is correct, then de-tethering of telomeres from the NE should partly suppress the 
ago1Δ TBZ sensitivity. These experiments may indicate whether loss of Tfx1 causes de-
tethering of telomeres from the NE. 
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4.2.1.1 Construction of the bqt4Δ mutant strains  
The bqt4Δ strains were generated by replacement of the bqt4 ORF with the antibiotic resistant 
cassette natMX6 using PCR-based gene targeting methods (Bähler et al., 1998). The bqt4 gene 
was deleted from both the WT and ago1Δ backgrounds to generate the single mutant bqt4Δ and 
double mutant ago1Δ bqt4Δ, respectively. The natMX6 cassette was amplified using PCR with 
primers containing 80 bp homologous sequences immediately flanked upstream and 
downstream from the bqt4 ORF; they also had a 20 bp homologous sequence to the natMX6 
gene (Figure 3.8). The purified PCR product was then chemically transformed into the 
appropriate S. pombe strains (see Section 2.5.1). To confirm the correct gene deletion, bqt4Δ 
candidates were screened via PCR (Figure 4.1) using three sets of primers, as previously shown 
in Figure 3.9. 
 
 
 
  
 
 
A 
Figure 4.1 PCR screening of successful bqt4Δ candidates. 
A. Agarose gel image displays the PCR products for the WT strain and bqt4∆ 1 and 2 (BP3298 bqt4Δ 
and BP3297 ago1Δ bqt4Δ, respectively) using the Bqt4-int-F and Bqt4-int-R primers. The expected 
PCR product sizes of the bqt4 gene was approximately 410 bp. The gel image shows no PCR products 
in the successful bqt4∆ candidate strains. B. PCR products for the WT and bqt4∆ candidates strains 
using the Bqt4 check-F and NatMX6-R primers. Band sizes of approximately 641 bp were seen in the 
bqt4∆ strains, but not in the bqt4+ strains (WT). NatMX6-F and Bqt4 check-R primers were utilised to 
amplify the WT and bqt4∆ candidate strains. A product size of approximately 989 bp was observed in 
the bqt4∆ strains, but not in the bqt4+ strains (WT). M = markers. 
 
B 
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4.2.1.2 TBZ sensitivity tests for ago1Δ bqt4Δ double mutant 
To test whether de-tethering of telomeres from the NE caused the suppression of the 
chromosomal mis-segregation of the ago1Δ mutant, the constructed strains where exposed to 
TBZ. The mutation of bqt4 in the ago1Δ background would supress the TBZ sensitivity of 
ago1Δ if the hypothesis were correct. However, we found that the double mutant of bqt4∆ 
ago1∆ developed sensitivity to TBZ that was greater than that of the ago1Δ single mutant, 
although the single mutant of bqt4∆ showed no sensitivity to TBZ relative to the WT (Figure 
4.2). These results indicate that the suppression of chromosomal segregation defects of the 
ago1 mutant was not due to disconnection of telomeres from the NE, although bqt4Δ mutants 
may have additional defects that mask a suppression phenotype. While the increase of 
sensitivity seen in ago1Δ bqt4Δ is interesting, it does not explain the findings observed in the 
ago1Δ tfx1Δ strain.  
 
 
 
  
 
Figure 4.2 TBZ sensitivity of the ago1Δ mutant is not suppressed by bqt4Δ mutation. 
Serial dilutions of the indicated S. pombe mutants were made and exposed to different concentrations 
of TBZ. The plates were then incubated at 30°C for 3 days. Single mutants of bqt4∆ showed no 
sensitivity to TBZ compared with the WT. However, unexpectedly, the bqt4∆ ago1∆ double mutant 
exhibited hypersensitivity to TBZ that was higher than that of the ago1Δ single mutant. 
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4.2.2 Investigation of whether Tfx1 and Tsn1 control telomere-associated transcripts  
Human and S. pombe telomeres are actively transcribed into TERRA molecules (Bah et al., 
2012; Greenwood & Cooper, 2012; Maicher et al., 2014; Azzalin & Lingner, 2015; Cusanelli 
& Chartrand, 2015; Rippe & Luke, 2015; Wang et al., 2015; Feretzaki & Lingner, 2017). In 
addition to TERRA, S. pombe produce distinct transcripts associated with the telomeres and 
sub-telomeres, including ARIAs, ARRETs and α-ARRETs (Figure 1.12) (Bah et al., 2012; 
Greenwood & Cooper, 2012; Azzalin & Lingner, 2015; Lorenzi et al., 2015; Moravec et al., 
2016). The regulation of these telomeric transcripts in S. pombe depends on the telomere-
binding proteins Taz1 and Rap1; thus, mutation of either of these two proteins causes a 
significant elevation of all telomeric and sub-telomeric transcripts (Greenwood & Cooper, 
2012). Notably, comparable to the loss of Tfx1, mutation of taz1 resulted in activation of the 
sub-telomeric tlh transcript levels (Hansen et al., 2006). Given this finding, it was hypothesised 
that the mutation of tfx1 may activate tlh transcript levels because Tfx1 controls the telomere 
and/or sub-telomeric transcriptome. It should be noted that the tiled arrays used to assess the 
transcriptome of the tfx1Δ mutant did not have coverage of the telomeres, so telomere 
transcripts have not previously been measured in the tfx1Δ mutant. 
 To assess this hypothesis, ARRET (immediate sub-telomeric regions; Figure 4.3A) and 
TERRA (telomeric regions; Figure 4.3A) transcript levels were analysed in a range of S. pombe 
mutant strains using previously developed RT-PCR/qRT-PCR assays (Greenwood & Cooper, 
2012; Lorenzi et al., 2015). RT-PCR products of ARIA and α-ARRET specific transcripts were 
not discernable from those generated by first-strand cDNA primed using endogenous priming 
so they could not be measured. However, endogenous priming was eliminated in the analyses 
of both TERRAs and ARRETs (i.e. the absence of first-strand primers generated no PCR 
products; Figures 4.3 and 4.4).  
Interestingly, as was found for the sub-telomeric tlh transcripts (Figure 3.7), the loss of Tfx1, 
but not Tsn1, results in elevated sub-telomere associated ARRET. This elevation depends on 
Tsn1, as an additional mutation of tsn1 in the tfx1Δ background results in a reduction of the 
levels of ARRET to the WT level (Figures 4.3 and 4.5). These results indicated that in the 
absence of Tfx1, Tsn1 is needed to preserve elevated ARRET levels. Remarkably, we found 
that the loss of Tsn1, but not Tfx1, strongly elevated telomere associated transcripts, TERRA, 
and in reciprocal fashion, this was Tfx1 dependent, as the high levels of TERRAs were restored 
to those seen in the WT following the additional loss of Tfx1 in the tsn1Δ background (Figures 
4.4 and 4.6).  
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These findings indicated that in the absence of Tsn1, Tfx1 is necessary to stabilise the TERRA 
levels. Taken together, these results demonstrated that Tfx1 is required to suppress ARRET 
transcripts in a Tsn1-dependent fashion, and in a reciprocal control mechanism, Tsn1 is 
required to suppress TERRA transcripts in a Tfx1-dependent fashion. Remarkably, these 
observations revealed important novel telomere regulatory factors, and they indicated a 
functional distinction of Tfx1 and Tsn1 in the telomere regions.  
 
In ago1backgrounds, as observed for the tlh transcript (Figure 3.7), mutation of tfx1, but not 
tsn1, resulted in an elevation of the ARRET transcript levels. This elevated level of ARRET 
transcripts was slightly reduced following the additional mutation of tsn1 in the ago1Δ tfx1Δ 
background (Figure 4.3), suggesting that this elevation is Tsn1 dependent. Importantly, these 
results point to the possibility that the transcription defects in the sub-telomeric regions may 
be responsible for the observed suppression of chromosomal segregation defects of Ago1-
defective cells (see Discussion). Analysis of TERRAs in ago1Δ backgrounds showed no 
measurable increase in the telomere transcript levels in the ago1Δ single mutant and ago1Δ 
tfx1Δ double mutant (Figure 4.4). The elevation of TERRA in the tsn1Δ was, however, not as 
pronounced in the ago1Δ tsn1Δ double mutant. Remarkably, the TERRA levels were as highly 
elevated in the ago1Δ tfx1∆ tsn1∆ triple mutant, as seen in the taz1Δ mutant (Figure 4.4). This 
increased accumulation of TERRAs in the triple mutant correlated with hyper-levels of 
chromosome instability, as measured with the TBZ growth assay (Figure 3.1), possibly 
pointing to a functional link. Following this discovery, we hypothesised that the observed 
phenomenon in the triple mutant may be linked to DNA damage response at the telomeres (see 
Section 4.2.3).  
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Figure 4.3 Qualitative analysis of ARRETs in a range of S. pombe mutant strains. 
A. Diagrammatic illustration of S. pombe telomeres exhibiting the sub-telomeric and telomeric 
regions. Transcriptions of ARRETs and TERRAs are shown in their approximate locations. 
Oligonucleotide positions used in the synthesis of first-strand cDNA, and RT-PCR and qRT-PCR are 
indicated as arrows. For example, o3 was used to prime cDNA for ARRETs, whereas oC was used 
to prime cDNA for TERRAs. Moreover, o2/o4 was used for PCR amplification for both ARRETs 
and TERRAs. B. Agarose gel image displaying RT-PCR products utilising primers specific for 
ARRETs. Here, act1 gene expression was used as a control to show the quality of RNA in all samples. 
No primer samples were used as a negative control, and no primers were used in the cDNA synthesis 
step, showing that there was no endogenous priming. The Otrt1Δ strain, which has no telomeres, was 
used as a negative control to show that no band can be detected in Otrt1Δ cells. The taz1Δ mutant 
was used as a positive control, and this has already been shown to exhibit elevation of all telomeric 
transcripts (Greenwood & Cooper, 2012). The data show that loss of Tfx1, but not Tsn1, results in 
an elevation of ARRET levels. The mutation of tsn1 in a tfx1∆ background reduces this elevation. 
The ago1Δ mutant exhibited no measurable increase in ARRET levels. However, the mutation of 
tfx1, but not tsn1, in the ago1Δ background increased the levels of ARRET. These high levels of 
ARRET transcripts were alleviated following the additional mutation of tsn1.  
 
 
 
A 
 B 
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Figure 4.4 Qualitative analysis of TERRAs in a range of S. pombe mutant strains. 
Agarose gel image displays RT-PCR products utilising the primer specific for TERRAs. The act1 
gene expression was used as a control to show the quality of RNA in all samples. No primer samples 
were used as a negative control, which resulted in no primers being used in the cDNA synthesis step, 
showing that there is no endogenous priming. The Otrt1Δ strain, which has no telomeres, was used 
as a negative control to show that no band could be detected in Otrt1Δ cells. The taz1Δ mutant was 
used as a positive control, and this has already been shown to exhibit elevation of all telomeric 
transcripts (Greenwood & Cooper, 2012). The data show that the loss of Tsn1, but not Tfx1, results 
in an increased accumulation of TERRA levels. This elevated level of TERRAs was reduced to the 
WT  level following additional mutation of tfx1. No increase of TERRAs could be detected in the 
ago1Δ single mutant and ago1Δ tfx1Δ double mutant. The elevation of TERRA in the tsn1Δ mutant 
background was somewhat alleviated following the mutation of ago1. However, TERRA levels were 
highly elevated in the ago1Δ tfx1∆ tsn1∆ triple mutant. 
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Figure 4.5 Quantitative real time PCR analysis confirming the reciprocal regulation of 
ARRETs by Tsn1 and Tfx1. 
The plot demonstrates that loss of Tfx1 results in an elevation of ARRETs, whereas no measurable 
increase in the level of ARRET is observed in tsn1∆. Notably, mutation of tsn1 in a tfx1∆ background 
results in a reduction of ARRET levels to those seen in the WT. Here, act1 was used to normalise the 
results, and Bio-RAD CFX Manager was utilised for the data analysis. The error bars show the 
standard error for triplicate repeats. Pairwise Student’s t-tests were performed to determine the p-
values between WT and the indicated mutant stains. All p-values were > 0.05 except WT vs. tfx1∆, 
which was < 0.01. 
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Figure 4.6 Quantitative real time PCR analysis confirming the reciprocal regulation of 
TERRAs by Tsn1 and Tfx1. 
The data show that TERRA levels were highly elevated in tsn1∆, whereas tfx1∆ showed statistically 
indistinguishable levels of TERRA from those observed in the WT. Clearly, mutation of tfx1 in a 
tsn1∆ background restores TERRA to levels comparable to (or slightly lower than) those of WT. 
Here, act1 was used to normalise the results, and Bio-RAD CFX Manager was utilised for the data 
analysis. The error bars show the standard error for triplicate repeats. Student’s t-tests were performed 
to determine p-values between WT and the indicated mutant stains. All p-values were > 0.05 except 
WT vs. tsn1∆, which was < 0.01. 
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4.2.3 DNA damage sensitivity analysis for the ago1Δ tfx1∆ tsn1∆ triple mutant 
A direct role in the DNA damage response has been recently identified for murine TRAX 
(Wang et al., 2016b), and TERRAs have been implicated in protection of telomeres from the 
DNA damage response (Azzalin & Lingner, 2015; Cusanelli & Chartrand, 2015; Maicher et 
al., 2014; Rippe & Luke, 2015; Wang et al., 2015; Schoeftner & Blasco, 2008). In the present 
study, we found that TERRAs were highly elevated in the ago1Δ tfx1Δ tsn1Δ triple mutant, at 
levels comparable to those recorded in cells lacking the telomere associated protein Taz1 
(Figure 4.4). The high elevation of TERRAs in the ago1Δ tfx1Δ tsn1Δ triple mutant correlates 
with the high levels of chromosome instability (as measured by TBZ sensitivity). Here, we set 
out to use genetics to determine whether the observed phenomenon in the triple mutant is linked 
to the DNA damage response. To test this, the appropriate S. pombe mutant strains were 
exposed to a wide range of DNA damaging agents, including the DNA replication inhibitor 
hydroxyurea (HU); phleomycin, which causes DNA double-strand breaks; the DNA-alkylating 
agent methyl methane sulfonate (MMS); the potent DNA crosslinker mitomycin C (MMC); 
the DNA enzyme topoisomerase 1 poison camptothecin (CPT); and ultraviolet irradiation 
(UV).  
The tfx1Δ and tsn1Δ single mutants and tfx1Δ tsn1Δ double mutant exhibited no sensitivity to 
any of the indicated DNA damaging agents relative to the WT strain (Figure 4.7), consistent 
with the findings of Jaendling et al. (2008). Interestingly, we found that the triple mutant ago1Δ 
tfx1Δ tsn1Δ exhibited an increase in sensitivity in response to HU, phleomycin, MMS, MMC 
and UV damaging agents relative to ago1Δ (and the ago1Δ tfx1Δ and ago1Δ tsn1Δ double 
mutants, which were indistinguishable from the ago1Δ single mutant; Figures 4.8, 4.9, 4.10, 
4.11 and 4.12). However, the ago1∆ tfx1∆ tsn1∆ triple mutant was not sensitive to CPT (Figure 
4.13), although we cannot absolutely dismiss the possibility that there might be a mild effect 
for the triple mutant to CPT, as we only used a concentration of CPT (1.2 μg/ml) that does not 
affect the WT strain. Therefore, further analysis is required to confirm this result. Collectivelly, 
these results may indicate that the observed hyper-elevation of TERRAs in the ago1Δ tfx1Δ 
tsn1Δ triple mutant is linked to increased DNA damage sensitivity. 
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Figure 4.7 DNA damaging agents sensitivity spot assays for the tfx1∆ tsn1∆ double mutant. 
Serial dilutions of the indicated S. pombe mutants were made and exposed to a wide range of DNA 
damaging agents, including methyl methane sulfonate (MMS), ultraviolet (UV), camptothecin 
(CPT), mitomycin C (MMC), hydroxyurea (HU) and phleomycin. The plates were then incubated at 
30°C for 3–4 days. Here, rad3-136 cells (check point defective) were utilised as a positive control 
for the damaging agents. Neither the single mutants tfx1Δ and tsn1Δ nor the tfx1Δ tsn1Δ double 
mutant showed any measurable increase in sensitivity relative to the WT strain in response to the 
indicated damaging agents.   
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Figure 4.8 The ago1∆ tfx1∆ tsn1∆ triple mutant is hypersensitive to hydroxyurea (HU). 
Serial dilutions of the indicated S. pombe mutants were generated and exposed to 8 mM HU. The 
plates were then incubated at 30°C for 4 days. Here, rad3-136 cells (check point defective) were 
utilised as a positive control. While the ago1∆ single mutant and ago1∆ tfx1∆ and ago1∆ tsn1∆ 
double mutant displayed similar intermediate sensitivities to HU, the ago1∆ tfx1∆ tsn1∆ triple mutant 
developed an extremely high sensitivity to HU. 
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Figure 4.9 The ago1∆ tfx1∆ tsn1∆ triple mutant is hypersensitive to methyl methane sulfonate 
(MMS). 
Serial dilutions of the indicated S. pombe mutants were set up and exposed to different concentrations 
of MMS. The plates were then incubated at 30°C for 4 days. Here, rad3-136 cells (check point 
defective) were utilised as a positive control for the damaging agent. The ago1∆ single mutant and 
ago1∆ tfx1∆ and ago1∆ tsn1∆ double mutants showed indistinguishable phenotype sensitivities to 
MMS, whereas the ago1∆ tfx1∆ tsn1∆ triple mutant exhibited a marked hypersensitivity to MMS. 
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Figure 4.10 The ago1∆ tfx1∆ tsn1∆ triple mutant is hypersensitive to phleomycin. 
Serial dilutions of the indicated S. pombe mutants were set up and exposed to 3 μg/ml of phleomycin. 
The plates were then incubated at 30°C for 4 days. Here, rad3-136 cells (check point defective) were 
utilised as a positive control for the damaging agent. The data show that the ago1∆ tfx1∆ tsn1∆ triple 
mutant exhibited a higher sensitivity to phleomycin relative to the ago1∆ single mutant and ago1∆ 
tfx1∆ and ago1∆ tsn1∆ double mutants. 
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Figure 4.11 The ago1∆ tfx1∆ tsn1∆ triple mutant is hypersensitive to ultraviolet (UV). 
Serial dilutions of the indicated S. pombe mutants were set up and exposed to 70 J/M2 UV. The plates 
were then incubated at 30°C for 4 days. Here, rad3-136 cells (check point defective) were utilised as 
a positive control for the damaging agent. The data show that ago1∆ tfx1∆ tsn1∆ triple mutant 
displayed increased sensitivity to UV, relative to ago1∆ single mutant, ago1∆ tfx1∆ and ago1∆ tsn1∆ 
double mutants. 
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Figure 4.12 The ago1∆ tfx1∆ tsn1∆ triple mutant is sensitive to Mitomycin C (MMC). 
Serial dilutions of the indicated S. pombe mutants were made and exposed to 0.15 mM MMC. The 
plates were then incubated at 30°C for 4 days. Here, rad3-136 cells (check point defective) were 
utilised as a positive control for the damaging agent. The ago1∆ single mutant and ago1∆ tfx1∆ and 
ago1∆ tsn1∆ double mutants showed a similar phenotype sensitivity to MMS, whereas the ago1∆ 
tfx1∆ tsn1∆ triple mutant exhibited a higher sensitivity, which was comparable to that observed in 
the  rad3-136 strain. 
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Figure 4.13 The ago1∆ tfx1∆ tsn1∆ triple mutant is not sensitive to camptothecin (CPT). 
Serial dilutions of the indicated S. pombe mutants were set up and exposed to 1.2 μg/ml CPT. The 
plates were then incubated at 30°C for 4 days. Here, rad3-136 cells (check point defective) were 
utilised as a positive control for the damaging agent. No measurable increase in sensitivity to CPT 
was observed in any mutants compared with the WT strain, including the ago1∆ tfx1∆ tsn1∆ triple 
mutant. 
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4.3 Discussion 
4.3.1 The ago1Δ bqt4Δ double mutant is hypersensitive to TBZ  
In eukaryotic genomes, each chromosome has distinct loci that ensure the proper segregation 
of chromosomes, including centromeres and telomeres (Steiner & Henikoff, 2015). In S. 
pombe, RNAi machinery is needed for heterochromatin establishment and gene silencing at the 
centromeres, which are required for the accurate segregation of chromosomes (Volpe et al., 
2002; Volpe et al., 2003; Buhler & Gasser, 2009; Lorenzi et al., 2015; Sadeghi et al., 2015). 
The current study showed that the chromosomal segregation defects of Ago1-deficient cells 
can be partially suppressed by the tfx1Δ mutation, without a restoration of heterochromatin 
gene silencing at centromeres. In addition, we revealed that the tlhΔ4 and taz1Δ mutants also 
partially suppress the ago1Δ mutant defects, suggesting that disruption of telomeric factors 
partially rescue ago1∆ mutant chromosome-instability defects. Thus, these findings may 
implicate Tfx1 in restricting segregation in cells via a centromere-independent, telomere-
dependent mechanism. Taking these results together, it is speculated that chromosomes fail to 
segregate normally in the ago1Δ mutant, due, in part, to centromeric heterochromatin 
dysfunction, which is exacerbated by the fact telomeres are tethered to the NE. This hypothesis 
was tested by mutating the bqt4 gene, which is defective in the tethering of the telomeres to the 
NE (Chikashige et al., 2009). The appropriate strains were exposed to TBZ with the aim of 
addressing whether the de-tethering of telomeres from the NE was required to suppress the 
ago1∆ defective phenotype. However, unexpectedly, it was found that the ago1Δ bqt4Δ double 
mutant showed TBZ greater sensitivity than the ago1Δ single mutant (Figure 4.2). These results 
demonstrated that the observed rescue of chromosomal mis-segregation in the ago1Δ mutant 
may not be due to de-tethering of telomeres from the NE, and they suggested that another 
telomere- dependent mechanism is at play in rescuing Ago1 defects. However, another function 
for Bqt4 that is required for proper segregation in the absence of Ago1 cannot be ruled out; this 
might mask the effect of de-tethering, so we cannot conclude tfx1Δ is defective in telomere 
tethering. Thus, further work is needed to confirm these results. For example, fluorescent 
localisation analysis can be conducted to determine whether telomeres are released from the 
NE when tfx1 is disrupted.  
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4.3.2 Tfx1 and Tsn1 (C3PO) differentially regulate telomere transcripts 
Translin and TRAX have mainly been implicated in the regulation of RNA, rather than DNA 
regulation, in various biological pathways (Wu et al., 1997; Liu et al., 2009; Jaendling & 
McFarlane, 2010; Ye et al., 2011; Li et al., 2012; Asada et al., 2014; Asada et al., 2016). S. 
pombe Tsn1 and Tfx1 were proposed to function on telomeric sequences (Jacob et al., 2004; 
Laufman et al., 2005), although no evidence of this was established prior to the present study. 
The phenotypic similarities found in this study between tfx1∆ and other telomere dysregulation 
mutations indicated a possible functional role of S. pombe Tfx1, and possibly Tsn1, in 
regulating telomere dynamics. To determine the nature of the function of Tfx1, and if any, of 
Tsn1 at the telomeres, levels of ARRET and TERRA transcripts were analysed in a range of S. 
pombe mutants. Remarkably, it was found that Tfx1 suppresses sub-telomeric ARRET 
transcripts in a Tsn1-dependent fashion (Figures 4.3 and 4.5), and in contrast, Tsn1 is required 
to suppress telomeric TERRA transcripts in a Tfx1-dependent fashion (Figures 4.4 and 4.6). 
This indicates that there is a reciprocal mechanism to control telomere- and sub-telomere-
associated transcripts by Tfx1 and Tsn1. For example, in the absence of Tfx1, Tsn1 is required 
to stabilise ARRET levels, and Tfx1 is necessary to maintain elevated TERRA levels in the 
absence of Tsn1. These findings not only identify novel telomere regulatory factors (Tfx1 and 
Tsn1), but also further evidence that there is a functional distinction between Tsn1 and Tfx1, 
at least in S. pombe.  
Earlier, it was shown that in the absence of Tsn1, levels of Tfx1 are greatly reduced (Jaendling 
et al., 2008). Thus, these current findings demonstrate that the residual Tfx1 in the tsn1Δ 
background is sufficient to regulate the telomere-associated transcripts. This finding is 
interesting, as it provides additional evidence that the low levels of residual Tfx1 found in the  
tsn1Δ mutant provide biological functions in regulating chromosomal stability. Furthermore, 
murine TRAX was found to prevent murine Translin from binding to mRNA (Chennathukuzhi 
et al., 2001), and there may be a similar control regulation by Tfx1 to inhibit Tsn1 from binding 
to telomeric RNAs. TERRA was recently found to be required for telomerase association and 
telomere length control in several organisms, including S. pombe (Wang et al., 2015; Moravec 
et al., 2016). 
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In S. cerevisiae, mutation of the rat1 gene leads to an increased accumulation of TERRAs and 
telomere shortening because of telomerase dysfunction (Luke et al., 2008). However, the 
accumulation of TERRAs observed in tsn1Δ is not associated with large-scale telomere length 
changes (Gomez-Escobar, personal communication; see Appendix 2). This indicates that the 
elevated transcript levels in tsn1∆mutant are not due to a measurable change in the lengths of 
telomeres. 
 
The necessity of Tsn1 and Tfx1 for the proper regulation of telomere-associated transcription 
is an indication of the fundamental importance of this protein pair. Up to now, no measurable 
phenotypic change in genome stability has been found when these genes are disrupted, in S. 
pombe at least, suggesting that Tsn1 and Tfx1 may play auxiliary or redundant functions in 
centrally essential processes. 
Supporting the possibility that Tsn1 and Tfx1 play auxiliary or redundant functions, we 
revealed that the mutations of both tsn1 and tfx1 in ago1Δ cells exhibited high sensitivity to the 
TBZ, at levels greater than the sensitivity observed in the ago1Δ single mutant – although 
deletion of both tfx1 and tsn1 together caused no measurable alteration in chromosome stability 
(Figure 3.1). Interestingly, the high levels of genomic instability of cells lacking Ago1 and 
Tsn1/Tfx1 correlated with the high elevation of telomeric TERRA levels in the triple mutant 
(Figure 4.4), suggesting a functional redundancy.  
Interestingly, we found that mutation of tfx1, but not tsn1, in an ago1Δ background increased 
the levels of sub-telomere-associated transcripts ARRET. This elevation was slightly decreased 
when tsn1 was mutated in the ago1Δ tfx1Δ background (Figure 4.3), suggesting that this 
elevation depends on Tsn1. These results are somewhat consistent with the TBZ sensitivity 
data (Figure 3.1). Using a quantitative approach, tiled microarrays, we found that the silenced 
sub-telomeric tlh genes were activated in the ago1∆ tfx1∆ background (Figure 3.7). 
Importantly, we revealed that mutating all four tlh genes partially suppressed the chromosomal 
segregation defects of ago1∆ cells (i.e. measured by TBZ growth assay; Figure 3.12) to levels 
comparable to those seen in the ago1Δ tfx1Δ background (Figure 3.1). Taken together, these 
results suggest that modulating the transcriptional status in the sub-telomere regions may have 
been responsible for the observed suppression of Ago1 defects of the ago1Δ tfx1Δ double 
mutant. Our results imply the existence of a counterbalance between centromeres and telomeres 
to maintain chromosome stability.  
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Since the dysregulation of ARRET and TERRA transcripts is the only notable defect phenotype 
recorded up to date for S. pombe tsn1Δ and tfx1Δ single mutants, S. pombe represents a perfect 
model for studying this important function of these paralogues. Additional work by a co-worker 
in the McFarlane group demonstrated that this function may be partially conserved in humans, 
albeit in a telomere-specific fashion (Gomez-Escobar et al., 2016). However, further work is 
required to determine the precise mechanism by which TSN and TSNAX control the telomere 
transcript levels (stability vs. production), for example, by measuring the H3K9-me levels and 
RNA Pol II occupancy in sub-telomeric regions. In addition, fluorescence localisation analysis 
is needed to determine whether Tsn1 and Tfx1 function directly or indirectly on these RNAs 
(i.e. TERRAs and ARRETs) and the telomeric regions. 
It has been recently proposed that TSN and TSNAX could be druggable targets for miRNA 
function restoration in tumours and emerging Dicer deficiencies (Asada et al., 2014; Asada et 
al., 2016). However, the finding that Tsn1 and Tfx1 are required for the control of telomere 
transcription levels should be taken into consideration before targeting these factors as 
anticancer agents.  
 
 
4.3.3 The ago1Δ tfx1Δ tsn1Δ triple mutant is hypersensitive to DNA damaging agents 
 TRAX has recently been shown to have a direct role in the DNA damage response (Wang et 
al., 2016b), and TERRAs have been linked to the DNA damage response at telomeres (Maicher 
et al., 2014; Azzalin & Lingner, 2015; Cusanelli & Chartrand, 2015; Rippe & Luke, 2015; 
Wang et al., 2015). The finding that the ago1Δ tfx1Δ tsn1Δ triple mutant exhibits significant 
elevation in the TERRA transcripts, comparable to the elevation seen in taz1Δ (Figure 4.4) – 
which is associated with hyper-levels of genomic instability (Figure 3.1) – led us to ask whether 
the observed phenomenon in the triple mutant is linked to the DNA damage response. 
Therefore, the appropriate mutants were exposed to a wide range of DNA damaging agents, 
including HU, phleomycin, MMS, MMC, UV and CPT. Interestingly, we found that the ago1∆ 
tfx1∆ tsn1∆ triple mutant exhibited increased sensitivity in response to HU, phleomycin, MMS, 
MMC and UV damaging agents relative to the ago1∆ mutant (and ago1∆ tfx1∆ and ago1∆ 
tsn1∆ double mutants, which showed similar phenotype sensitivities of the ago1∆; Figures 4.8, 
4.9, 4.10, 4.11 and 4.12). 
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Interestingly, the taz1∆ mutant also had significantly elevated TERRAs (Greenwood & 
Cooper, 2012; Figure 4.4), and it exhibited increased sensitivity to several DNA damaging 
agents, including HU, MMS, and bleomycin (Miller & Cooper, 2003). Taken together, these 
results suggest that the elevated telomeric TERRA transcripts in the ago1∆ tfx1∆ tsn1∆ triple 
mutant may be linked to compromised DNA repair. However, further experiments are required 
to confirm these interesting results and determine their underlying mechanism.  
 
S. pombe TERRA was recently shown to be required for telomere length control (Moravec et 
al., 2016). However, the hyper-elevation of TERRAs found in the ago1∆ tfx1∆ tsn1∆ triple 
mutant was not accompanied by a measurable large change in telomere length (see Appendix 
2). Thus, there is no current evidence to link this phenomenon to telomeric length alteration. 
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 4.4 Conclusion  
1- Tfx1 and Tsn1 are novel telomere regulatory factors. 
2- Tsn1 and Tfx1 can function independently of one another. 
3- Tfx1 controls sub-telomeric ARRET transcript levels. 
4- Tsn1 functions to control telomeric TERRA transcripts. 
5- There is a reciprocal control of telomere-associated transcripts by Tsn1 and Tfx1. 
6- Modulation of the transcriptional status at the sub-telomere regions may be responsible 
for driving the ago1 suppressor phenotype. 
7- The hyper-elevation of telomeric TERRAs in the ago1Δ tfx1Δ tsn1Δ triple mutant may 
be linked to increased DNA damage sensitivity. 
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Chapter 5: Results 
Analysis of Tfx1 and Tsn1 functions in a Dcr1-
deficient background  
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5. Analysis of Tfx1 and Tsn1 functions in a Dcr1-deficient 
background 
5.1 Introduction 
The correct segregation of chromosomes is essential for ensuring that the genetic information 
is transferred into new daughter cells with high fidelity (Brouwers et al., 2017; Mutazono et 
al., 2017). Errors in this process can lead to cancers (Santaguida & Amon, 2015; Potapova & 
Gorbsky, 2017). The formation and maintenance of heterochromatin are vital for controlling 
many genomic functions, including gene silencing and chromosome segregation (Lejeune et 
al., 2010; Li & Zhang, 2012; Tadeo et al., 2013; Cusanelli & Chartrand, 2015; Zocco et al., 
2016). In S. pombe, the RNAi machinery is necessary for heterochromatin establishment at 
several genomic loci, such as centromeres and sub-telomeres; however, for maintenance, it is 
only essential in the centromeres (Kanoh et al., 2005; Buhler & Gasser; 2009; Lorenzi et al., 
2015). The loss of the key component genes of the RNAi machinery, including ago1 and dcr1, 
influences centromeric heterochromatin function, leading to mis-segregation of chromosomes 
and a high sensitivity to the microtubule inhibitor TBZ (Volpe et al., 2002; Volpe et al., 2003; 
Buhler & Gasser, 2009; Creamer & Partridge, 2011; Chan & Wong, 2012; Lee et al., 2013; 
Tadeo et al., 2013; Holoch & Moazed, 2015; Sadeghi et al., 2015; Shimada et al., 2016). 
 In higher eukaryotes, the TRAX and Translin (C3PO) complex is involved in the removal of 
the passenger strand during RNAi-facilitated mRNA regulation (Liu et al., 2009; Ye et al., 
2011). Analysis of S. pombe Tfx1 and Tsn1 functions in an ago1∆ mutant background has 
revealed that mutation of tfx1, but not tsn1, partially rescues the chromosome segregation 
defect of ago1∆ cells (see Chapter 3). Therefore, we also wanted to determine whether this 
genetic interaction is true in terms of the other RNAi regulatory genes, such as dcr1. However, 
Dcr1 was recently shown to have an RNAi-independent function, in which Dcr1, but not Ago1, 
promotes transcription termination at sites of replication stress and DNA damage (Castel et al., 
2014; Ren et al., 2015). These findings demonstrate that there is a functional separation 
between Dcr1 and Ago1 in S. pombe. Given the above, the work in this chapter aims to analyse 
the function of Tsn1 and Tfx1 in a Dcr1-deficient background.  
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5.2 Results 
5.2.1 Mutation of tfx1 and tsn1 increases the chromosomal instability of the dcr1Δ cells  
We set out to explore the relationship between Tfx1 and Tsn1 and the RNAi component Dcr1. 
(all appropriate strains used in this study were constructed by others in the McFarlane group, 
but they were verified here using PCR of the appropriate loci prior to use).  
 
 
5.2.1.1 TBZ sensitivity spot assay 
TBZ is a microtubule-disrupting drug, and cells that are defective in full centromere function, 
such as dcr1mutants, display sensitivity to it (Volpe et al., 2002; Volpe et al., 2003; Buhler 
& Gasser, 2009; Lee et al., 2013; Sadeghi et al., 2015). To determine whether Tfx1 and Tsn1 
have a redundant role with the RNAi regulatory gene dcr1, appropriate mutants were tested for 
their response to TBZ (Figure 5.1). As expected, the dcr1Δ single mutant showed sensitivity to 
TBZ relative to the WT strain. Interestingly, we found that the dcr1∆ tfx1∆ double mutant is 
more sensitive to TBZ than the dcr1Δ single mutant is (Figure 5.1). Remarkably, the dcr1∆ 
tsn1Δ double mutants were hypersensitive to TBZ in comparison with the dcr1∆ mutant (and 
the dcr1∆ tfx1∆ double mutant; we tested two independently constructed dcr1∆ tsn1∆ double 
mutant strains; Figure 5.1). Notably, a few colonies were found to supress the high TBZ 
sensitivity in both the dcr1Δ tfx1Δ and dcr1Δ tsn1Δ background strains, especially at 33°C (this 
is discussed in Section 5.3.1; Figure 5.1). Collectively, the results suggest that Tfx1 and Tsn1 
are required to maintain chromosome stability in the absence of Dcr1. 
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Figure 5.1 Mutation of tfx1 and tsn1 increases TBZ sensitivity of the dcr1Δ mutant. 
Serial dilutions of the indicated S. pombe mutants were made and exposed to different concentrations 
of TBZ. The plates were then incubated at 30°C and 33°C for approximately 3 days. The dcr1∆ single 
mutant displayed increased sensitivity to TBZ in comparison with the WT strain. Mutation of tfx1 
increased the dcr1Δ TBZ sensitivity. In addition, both dcr1∆ tsn1∆ double mutant strains (BP2748 
and BP2749) were hypersensitive to TBZ, with a sensitivity greater than that of the dcr1∆ single 
mutant (and dcr1∆ tfx1∆ double mutant). 
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5.2.1.2  Microscopic analysis of aberrant mitoses 
Sensitivity to TBZ is not a direct measure of chromosome stability. Loss of RNAi component 
Dcr1 results in a high incidence of unsegregated chromosomes (Volpe et al., 2003; Figure 
5.2.A). To further explore the possibility that tfx1 and tsn1 mutation increases the chromosomal 
instability of the dcr1 mutant, we stained DNA in mitotically dividing cells and monitored 
for the frequency of anaphase defects. As previously reported, it was found that mutation of 
dcr1 displayed high levels of cells with abnormal mitoses (Figure 5.2.B). As observed for the 
TBZ sensitivity, dcr1∆ tfx1∆ exhibited more aberrant mitotic events than the dcr1 single 
mutant (Figure 5.2.B). In addition, mutation of tsn1 significantly increased the abnormal 
mitosis events of the dcr1Δ cells (Figure 5.2.B), which is consistent with its TBZ sensitivity 
phenotype (Figure 5.1; examples of the WT and dcr1Δ phenotypes are shown in Figure 5.2.A). 
These analyses indicate that the chromosome segregation defects caused by the loss of Dcr1 
increases following tfx1 and tsn1 mutation. 
Collectively, the findings suggest that the tfx1 and tsn1 mutation increased the chromosomal 
instability of the dcr1∆ cells, with a greater effect seen in the dcr1Δ tsn1Δ double mutant. This 
provides new evidence of the functions of Tfx1 and Tsn1 in maintaining genomic stability. 
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Figure 5.2 Fluorescence microscope analysis of S. pombe strains, grown at 30°C and stained 
with DAPI, showing the percentage of aberrant mitosis.   
A. Example phenotypes of WT (left) and dcr1Δ (right) cells in the anaphase with DAPI stain under 
the fluorescence microscope. 
B. The plot shows that the dcr1∆ single mutants exhibited approximately 40% mitotic (anaphase) 
defects. However, both the dcr1Δ tfx1∆ and dcr1Δ tsn1∆ double mutants had significantly increased 
numbers of aberrant anaphase events due to the loss of Dcr1. * = p-value < 0.05; Student’s t-test; 
error bars show the standard deviation. The percentage of aberrant mitosis was obtained from the 
average of three independent experiments by counting at least 100 cells per sample in each 
experiment. 
        
A 
B 
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5.2.2 Investigation of whether Tfx1 and Tsn1 have roles in the DNA damage response in 
the absence of Dcr1 
Distinct from what was observed with the ago1∆ background (see Chapter 3), analysis of Tfx1 
and Tsn1 functions in the dcr1∆ mutant background revealed that tfx1 and tsn1 mutation 
increased the chromosomal instability of the dcr1∆ mutant (as measured by TBZ sensitivity, 
Figure 5.1, and assessed by monitoring endogenous chromosome segregation, Figure 5.2). 
These results suggest that Tfx1 and Tsn1 are required for maintaining chromosome stability in 
the absence of Dcr1. Translin and TRAX have been implicated in the DNA repair response 
(Jaendling & McFarlane, 2010), although direct evidence for this assertion is limited. More 
recently, however, Wang et al. (2016) found that murine TRAX is associated with the ATM-
mediated pathway for DSB repair. Given this, as well as the finding that Dcr1 – but not Ago1 
– is required in the DNA damage response (Castel et al., 2014), we set out to determine whether 
Tfx1 and Tsn1 have any redundant roles in the DNA damage response pathway in the absence 
of Dcr1 that contribute to genome stability. To address this, the appropriate S. pombe mutant 
strains were tested for their response to an extensive range of DNA-damaging agents; this 
allowed us to test a variety of DNA damage repair pathways. These damaging agents included 
hydroxyurea (HU; Figure 5.3), phleomycin (Figure 5.4), ultraviolet (UV) irradiation (Figure 
5.5), camptothecin (CPT; Figure 5.6), methyl methane sulfonate (MMS; Figure 5.7) and 
mitomycin C (MMC; Figure 5.8). 
Interestingly, we found that the dcr1Δ tsn1Δ double mutant, but not dcr1Δ tfx1Δ, exhibits 
increased sensitivity, relative to the dcr1∆ mutant, to HU, phleomycin, UV and CPT (mild 
effect) agents. However, neither the dcr1∆ tfx1∆ nor dcr1∆ tsn1∆ double mutant showed any 
increased sensitivity compared to the dcr1∆ single mutant in response to MMS or MMC drugs. 
Taken together, these analyses indicate that Tsn1, but not Tfx1, is required in the DNA damage 
recovery response in the absence of Dcr1, revealing a presently unknown function of Tsn1 in 
the DNA damage response pathway.    
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Figure 5.3 Mutation of tsn1, but not tfx1, increased the dcr1Δ hydroxyurea (HU) sensitivity.  
Serial dilutions of the indicated S. pombe mutants were generated and exposed to different concentrations 
of HU. The plates were then incubated at 30°C and 33°C for 4 days. Here, rad3-136 cells (checkpoint 
defective) were used as a positive control. Mutation of tsn1 in a dcr1Δ background increased HU 
sensitivity (we tested two independently constructed dcr1∆ tsn1∆ double mutant strains), whereas a tfx1Δ 
mutation did not.  
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Figure 5.4 Mutation of tsn1, but not tfx1, increased dcr1Δ phleomycin sensitivity. 
Serial dilutions of the indicated S. pombe mutants were set up and exposed to 4 μg/ml of phleomycin. 
The plates were then incubated at 30°C for 4 days. Here, rad3-136 cells (checkpoint defective) were 
used as a positive control for the drug. The data show that the dcr1∆ tsn1∆ double mutant, but not 
dcr1∆ tfx1∆, displayed increased sensitivity to phleomycin relative to the dcr1∆ mutant.  
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Figure 5.5 The dcr1∆ tsn1∆ double mutant, but not dcr1∆ tfx1∆, is sensitive to ultraviolet 
(UV). 
Serial dilutions of the indicated S. pombe mutants were set up and exposed to different doses of UV 
irradiation. The plates were then incubated at 25°C and 30°C for 4 days. Here, rad3-136 cells 
(checkpoint defective) were used as a positive control. The data show that the dcr1∆ tsn1∆ double 
mutant, but not dcr∆1 tfx1∆, exhibited increased sensitivity to UV in comparison with the dcr1∆ 
single mutant. 
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Figure 5.6 Camptothecin (CPT) sensitivity spot assay for a range of S. pombe mutants.  
Serial dilutions of the indicated S. pombe mutants were set up and exposed to different concentrations 
of CPT. The plates were then incubated at 30°C for 4 days. Here, rad3-136 cells (checkpoint 
defective) were used as a positive control for the drug. The data show that the dcr1Δ tsn1Δ double 
mutant, but not dcr1Δ tfx1Δ, may have displayed a slight increase in sensitivity to CPT in comparison 
with the dcr1Δ mutant. 
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Figure 5.7 Methyl methane sulfonate (MMS) sensitivity spot assay. 
Serial dilutions of the indicated S. pombe mutants were set up and exposed to different concentrations 
of MMS. The plates were then incubated at 30°C for 4 days. Here, rad3-136 cells (checkpoint 
defective) were utilised as a positive control for the drug. None of the dcr1Δ tfx1Δ or dcr1Δ tsn1Δ 
double mutants exhibited increased sensitivity to MMS relative to the dcr1∆ strain.   
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  Figure 5.8 Mitomycin C (MMC) sensitivity spot assay. 
Serial dilutions of the indicated S. pombe mutants were made and exposed to 0.15 mM MMC. The 
plates were then incubated at 30°C for 4 days. Here, rad3-136 cells (checkpoint defective) were 
utilised as a positive control for the drug. Neither the dcr1Δ tfx1Δ nor dcr1Δ tsn1Δ double mutants 
displayed a measurable increase of sensitivity to MMC in comparison with the dcr1∆ strain. 
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5.2.3 Levels of telomeric transcriptome in dcr1∆ backgrounds 
The historical analysis of sub-telomeric heterochromatin regions to determine a role for the 
RNAi machinery was carried out based on a study of the dcr1Δ mutant (Kanoh et al., 2005). 
To further explore the behaviour of Tsn1 and Tfx1 in the absence of Dcr1, ARRET (sub-
telomeric regions; Figure 4.3.A) and TERRA (telomeric regions; Figure 4.3.A) transcript levels 
were analysed in the dcr1∆ single mutant and dcr1∆ tsn1∆ and dcr1∆ tfx1∆ double mutants 
using previously developed RT-PCR/qRT-PCR assays (Greenwood & Cooper, 2012; Lorenzi 
et al., 2015). 
Analysis of the sub-telomeric ARRET transcript levels showed no elevation in levels of 
ARRET, relative to the WT strain, in the dcr1∆ single mutant; indeed, a small decrease was 
observed but this was statistically insignificant (Figures 5.9 and 5.10). Interestingly, the 
mutation of tsn1 in the dcr1∆ background resulted in an increased accumulation of ARRET 
levels (Figures 5.9 and 5.10); this elevation of ARRET transcript levels correlated with 
increased DNA damage sensitivity in  dcr1Δ tsn1Δ cells (this is discussed in Section 5.3.3). 
However, the elevation of ARRET in the tfx1was not as pronounced in the 
dcr1tfx1double mutant, as measured qualitatively by RT-PCR assay (Figure 5.9) and 
quantitatively by qRT-PCR assay (Figure 5.10); the functional implications of this result are 
unclear.  
Analysis of TERRAs in dcr1Δ backgrounds exhibited no measurable elevation in the transcript 
levels of TERRA in the dcr1Δ single mutant and dcr1Δ tfx1Δ double mutant relative to the WT 
strain (Figure 5.11). Notably, however, the elevated level of TERRAs in the tsn1Δ mutant 
background was somewhat suppressed following the additional mutation of dcr1, as measured 
qualitatively by RT-PCR (Figure 5.11); the functional consequences of this result are not clear 
at this stage. 
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Figure 5.9 Qualitative analysis of sub-telomeric ARRET transcripts in dcr1∆ mutant 
backgrounds. 
The agarose gel image displays RT-PCR products utilising the primer specific for ARRETs (Figure 
4.3.A). The act1 gene expression was used as a positive control to show the quality of RNA in all 
samples. No primer samples were used as a negative control, and no primers were used in the cDNA 
synthesis step, showing that there was no endogenous priming. The Otrt1Δ strain, which has no 
telomeres, was used as a negative control to show that no band could be detected in the Otrt1Δ cells. 
The taz1Δ mutant was used as a positive control, and this has already been shown to exhibit elevation 
of all telomeric transcripts (Greenwood & Cooper, 2012). No measurable increase of ARRETs could 
be detected in the dcr1Δ and tsn1∆ single mutants relative to the WT strain. However, the ARRET 
levels were stabilised in the dcr1∆ tsn1∆ double mutant in comparison with the single mutants. In 
addition, the data showed that the elevation of ARRETs in the tfx1∆ strain was somewhat reduced by 
the loss of dcr1. 
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Figure 5.10 Quantitative real-time PCR analysis of ARRETs in dcr1∆ mutant backgrounds. 
The plot demonstrates that the dcr1∆ and tsn1∆ single mutants showed statistically indistinguishable 
levels of ARRET from that observed in the WT strain. However, ARRET levels were significantly 
elevated in the dcr1Δ tsn1∆ double mutant compared with the dcr1∆ and tsn1∆ single mutants. The 
dcr1Δ mutation in a tfx1∆ background resulted in a reduction of ARRETs relative to the tfx1∆ single 
mutant. Here, act1 was used to normalise the results, and Bio-RAD CFX Manager was employed for 
the data analysis. The error bars are the standard error for triplicate repeats. Pairwise Student’s t-tests 
were performed to determine the p-values of WT vs. dcr1Δ, p = 0.2; tfx1Δ vs. dcr1Δ tfx1∆, p = 0.09; 
dcr1Δ vs. dcr1Δ tfx1∆, p < 0.01 and dcr1Δ vs. dcr1Δ tsn1∆, p < 0.01. 
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Figure 5.11 Qualitative analysis of telomeric TERRA transcripts in the dcr1∆ mutant 
backgrounds. 
The agarose gel image displays the RT-PCR products utilising the primer specific for TERRA (Figure 
4.3.A). The act1 gene expression was used as a positive control to show the quality of RNA in all 
samples. No primer samples were used as a negative control, which resulted in no primers being used 
in the cDNA synthesis step, showing that there was no endogenous priming. The Otrt1Δ strain, which 
has no telomeres, was used as a negative control to show that no band could be detected in the Otrt1Δ 
cells. The taz1Δ mutant was used as a positive control, and this has already been shown to exhibit 
elevation of all telomeric transcripts (Greenwood & Cooper, 2012). While TERRA levels were not 
detectable in the WT strain, no measurable elevation of TERRAs could be detected in either the 
dcr1Δ single mutant or dcr1Δ tfx1Δ double mutant. However, the elevation of TERRAs observed in 
the tsn1∆ mutant was clearly somewhat suppressed following additional mutation of dcr1. 
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5.3 Discussion 
5.3.1 Loss of Tfx1 and Tsn1 increases the chromosome instability of Dcr1-defective cells  
During mitosis and meiosis, establishment of centromeric heterochromatin is essential for the 
correct segregation of chromosomes (Buhler & Gasser, 2009; Schoeftner & Blasco, 2009; 
Stimpson & Sullivan, 2010; Zeng et al., 2010; Schmidt & Cech, 2015; Mutazono et al., 2017). 
In S. pombe, heterochromatin formation and maintenance in centromeres depend on the RNAi 
pathway (Volpe et al., 2002; Volpe et al., 2003; Buhler & Gasser, 2009; Creamer & Partridge, 
2011; Chan & Wong, 2012; Lee et al., 2013; Tadeo et al., 2013; Holoch & Moazed, 2015; 
Sadeghi et al., 2015; Shimada et al., 2016; Mutazono et al., 2017). Cells that are defective in 
the RNAi system, such as those in the ago1∆ and dcr1∆ mutants, display a high incidence of 
aberrant mitoses and high sensitivity to the microtubule toxin TBZ (Volpe et al., 2002; Volpe 
et al., 2003; Buhler & Gasser, 2009; Lee et al., 2013; Sadeghi et al., 2015). Deletion of the S. 
pombe tfx1 was found to partly suppress the chromosomal segregation defect of ago1Δ cells 
(see Chapter 3). Elsewhere, it has been demonstrated that mutation of taz1 also rescues the 
defect phenotype of ago1∆ cells and other RNAi regulatory genes, including dcr1, (Tadeo et 
al., 2013). Thus, we set out to determine whether mutation of tfx1, and if any, of tsn1 in the 
Dcr1-defective cells could also result in a similar rescue phenotype. We found, however, that 
the loss of tfx1 increases the dcr1∆ TBZ sensitivity (Figure 5.1); this differs from the observed 
rescue phenotype in the dcr1Δ taz1Δ cells (Tadeo et al., 2013), suggesting a distinct mechanism 
is at play. In addition, the dcr1∆ tsn1∆ double mutant was hypersensitive to TBZ relative to 
the dcr1∆ single mutant; indeed, the TBZ sensitivity was greater than that for the dcr1∆ tfx1∆ 
double mutant (Figure 5.1). Taken together, these results provide further evidence of the need 
for C3PO functioning in preserving chromosome stability. In addition, the finding that the 
mutation of tsn1 in a dcr1∆ background is much more sensitive to TBZ than the mutation of 
tfx1 suggests a more central function for Tsn1 in the absence of Dcr1 when it comes to 
maintaining genomic stability.   
Following the TBZ sensitivity results, microscopic analysis was used to measure the frequency 
of nonsegregated chromosomes in anaphase cells in appropriate strains. We found that 
chromosomal segregation defects caused by the loss of Dcr1 also increased following the 
mutation of tfx1 and tsn1 (Figure 5.2.B), with more significant segregation defects seen in the 
dcr1∆ tsn1∆ double mutant. This is consistent with the TBZ sensitivity pattern. 
  
   
 
151  
Collectively, our data demonstrated that the chromosomal instability of dcr1∆ cells is enhanced 
following mutation of tfx1 and tsn1. Moreover, they indicated that the observed rescue of Ago1 
defects, by the loss of tfx1 is distinct and may reflect a very different mechanistic defect. 
Supporting the findings that loss of Tsn1 increases the chromosomal instability defect of dcr1∆ 
cells, co-workers in the McFarlane group also revealed that the mutation of tsn1, but not tfx1, 
is found to increase mini-chromosome instability caused by the loss of Dcr1 (Z. Al-shehri, PhD 
thesis, Bangor University; N. Al-mobadel, PhD thesis, Bangor University). These results 
further support the suggestion that Tsn1 makes a more significant contribution than Tfx1 does 
to maintaining chromosome stability in the absence of Dcr1.  
Importantly, further analysis found that centromeric heterochromatin transcription is identical 
for the dcr1∆ and dcr1Δ tsn1Δ strains (Z. Al-shehri, PhD thesis, Bangor University; R. 
McFarlane, personal communication). These results indicate that the increases in chromosome 
mis-segregation and instability defects observed in the dcr1∆ tsn1∆ double mutant are not due 
to increased centromeric heterochromatin dysfunction, suggesting that a distinct pathway is 
compromised by the loss of Tsn1 function; this pathway appears to be independent of RNAi, 
but related to genome stability regulation.  
 
It is important to note that there are a few colonies in the dcr1∆ tfx1∆ and dcr1∆ tsn1∆ mutant 
backgrounds that suppress the high TBZ sensitivity (Figure 5.1). These suppressor cells were 
mostly seen at 33°C, suggesting a temperature-suppression phenotype. This could suggest a 
possible factor activated in these few cells that resulted in the genome instability suppression 
phenotype. Thus, further analysis, such as a cDNA library screen, is needed to decipher the 
factor that results in the rescue effect.  
  
5.3.2 Tsn1, but not Tfx1, is required in the DNA damage response in the absence of Dcr1 
Translin and TRAX have been implicated in the DNA repair response (Jaendling & McFarlane, 
2010; Wang et al., 2016b), and Dcr1, but not other RNAi components, has recently been shown 
to have a role in the DNA damage response (Castel et al., 2014; Ren et al., 2015). Given these 
findings, we set out to determine whether the increase in chromosomal instability observed in 
the dcr1∆ tfx1∆ and dcr1∆ tsn1∆ strains is due to defects in the DNA repair pathways. To test 
this, appropriate mutants were exposed to a wide range of DNA damaging agents, including 
HU, phleomycin, UV, CPT, MMS and MMC.  
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Interestingly, we found that the dcr1∆ tsn1∆ double mutant, but not the dcr1∆ tfx1∆ double 
mutant, exhibited increased sensitivity to HU, phleomycin, CPT and UV relative to the dcr1∆ 
mutant. However, neither the dcr1∆ tfx1∆ nor dcr1∆ tsn1∆ double mutant showed increased 
sensitivity in response to MMS and MMC agents in comparison with the dcr1∆ mutant, 
although we cannot absolutely dismiss the possibility that there might be a slight effect for the 
double mutants to MMS and/or MMC, as we only used concentrations of MMS and MMC that 
do not affect the WT strain. Thus, further work is required to confirm these results. These 
interesting results suggest that the increase in chromosomal instability observed in the dcr1∆ 
tsn1∆ double mutant is due to the failure to repair DNA damage; moreover, they indicate that 
Tsn1, but not Tfx1, is required in the DNA damage response in the absence of Dcr1. In addition, 
the failure of the tfx1 mutation to have a similar increase of sensitivity to any of the DNA-
damaging agents indicates further evidence of the functional separation between Tfx1 and Tsn1 
in S. pombe, and it suggests that the increase in chromosomal instability observed in the dcr1∆ 
tfx1∆ double mutant is not due to a DNA repair defect. Importantly, most of the DNA-
damaging reagents used suggest that the hypersensitivity of the dcr1∆ tsn1∆ double mutant is 
somehow related to the S phase. Supporting this, the non–S phase–related agent, MMS (a 
mismatch repair–type mechanism) did not show measurable sensitivity to phenotype 
differences between the dcr1∆ and dcr1 tsn1∆ mutants (Figure 5.7). In addition, the finding 
that the dcr1∆ tsn1∆ double mutant is hypersensitive to the ribonucleotide reductase (RN) 
inhibitor HU agent is an indication that this phenomenon may indeed be related to replication. 
Supporting this, Castel et al. (2014) found that Dcr1 is required to remove RNA Pol II–
mediated transcription from sites of collision between transcription and replication, which 
preserves the genomic stability (Ren et al., 2015). However, in the absence of Dcr1, there are 
more collisions caused between the DNA replication machinery and RNA Pol II–mediated 
RNA:DNA hybrids. This results in DNA replication fork collapses and DSB formation, which 
may lead to chromosomal instability and rearrangements (Figure 1.4; Castel et al., 2014; 
Brambati et al., 2015). This may explain the dcr1∆ mutant sensitivity to HU (Figure 5.3).  
To date, Translin has been shown to have a great affinity for controlling RNA species; 
therefore, it may be the case that Tsn1 plays a role in reducing the stability of RNA:DNA 
hybrids in the absence of Dcr1, which suppresses recombination and maintains genome 
stability. Consequently, mutation of tsn1 in the dcr1∆ background may stimulate 
recombination that results in chromosomal translocations, causing a hypersensitivity to HU 
(Figure 5.3).  
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Taking the findings together, we propose that Tsn1 serves to suppress transcription-DNA 
replication-associated recombination in the absence of Dcr1, which could account for the 
original proposed role for Translin in driving chromosomal translocations (Aoki et al., 1995). 
Castel et al. (2014) separated the Dcr1 function in this specific mechanism from the RNAi 
regulation mechanism; moreover, we found that the ago1∆ and ago1∆ tsn1∆ strains show 
similar HU sensitivities (Figure 4.8), representing further support for the postulated role of 
Tsn1 secondary to Dcr1 in the RNA regulation of breakage. 
 
The phleomycin agent is generally known to create DSBs in the cell cycle, and the increased 
sensitivity of the dcr1∆ tsn1∆ double mutant compared with the dcr1∆ mutant to HU and 
phleomycin agents (Figures 5.3 and 5.4) suggests that these breaks occurred in the S phase, 
which is further evidence for the involvement of Tsn1, in the absence of Dcr1, in the repair of 
DSBs that induce recombination. A similar hypersensitivity phenotype of the dcr1∆ tsn1∆ 
double mutant, relative to the dcr1∆ mutant, was found using a more specific chromosomal 
breaking agent, bleomycin (data not shown).  
MMC is known to cause interstrand crosslinks. Therefore, in the presence of MMC, the two 
strands of DNA became crosslinked; consequently, the replication fork is strongly blocked and 
cannot proceed. Thus, unlike in HU, replication fork collapse and DSBs are not consequently 
created in the presence of MMC. We found no increased sensitivity to MMC in the dcr1∆ tsn1∆ 
double mutant relative to the dcr1∆ single mutant, which was indistinguishable from the WT 
strain (Figure 5.8). The lack of sensitivity to MMC of cells that are defective in dcr1∆ and 
dcr1∆ tsn1∆ is important because in MMC-mediate cross-link damage, RNA:DNA hybrids are 
not important, and at present, it seems that dcr1∆ and dcr1∆ tsn1∆ mutant cells can survive as 
well as the WT cells in the presence of MMC (Figure 5.8). However, Dcr1, and possibly Tsn1, 
are required to remove RNA:DNA hybrids in the presence of HU-induced replication fork 
stalling, and the dcr1∆ mutant exhibited a sensitivity to HU relative to the WT, which further 
increased following the mutation of tsn1 (Figure 5.3). Therefore, the different phenotype 
responses to DNA damage reagents in these mutants provide further evidence to support the 
suggestion that the phenomenon observed in the dcr1∆ tsn1∆ double mutant is related to the 
transcription replication collision mechanism, and it is also consistent with our proposal that, 
in the absence of Dcr1, Tsn1 may be involved in removing RNA:DNA hybrids and suppressing 
recombination.  
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In the next chapter, the possibility that the hypersensitivities of the dcr1∆ tsn1∆ double mutant 
to the chromosomal breaking and DNA replication inhibitor drugs are due to an elevation of 
recombination will be addressed directly. 
5.3.3 Sub-telomeric transcripts are dysregulated in the dcr1∆ tsn1∆ double mutant 
Dcr1 is implicated in sub-telomeric heterochromatin formation, which is necessary for 
transcription silencing, recombination suppression and the maintenance of telomere integrity 
(Kanoh et al., 2005; Bisht et al., 2008; Tadeo et al., 2013; Zocco et al., 2016). To further explore 
the behaviour of Tfx1 and Tsn1 in Dcr1-deficiency cells, RT-PCR/qRT-PCR analysis was used 
for assessing levels of telomere-associated transcripts in mutants that were defective in the 
dcr1Δ single mutant and dcr1Δ tfx1Δ and dcr1Δ tsn1Δ double mutants. Remarkably, we found 
that sub-telomeric ARRET levels were highly elevated in the dcr1∆ tsn1∆ double mutant 
relative to the tsn1∆ and dcr1∆ single mutants, which were statistically indistinguishable from 
the WT (Figures 5.9 and 5.10). The sub-telomeric tlh genes were consistently de-repressed in 
the dcr1∆ tsn1∆ cells (R. McFarlane, communication). This dysregulation of the sub-telomeric 
transcripts tlh and ARRET in the dcr1∆ tsn1∆ double mutant correlates with defects in the 
DNA damage response pathway observed in cells lacking both dcr1 and tsn1 (see Section 
5.2.2), possibly pointing to a functional link. Therefore, we cannot dismiss the possibility that 
the increased dcr1∆ tsn1∆ sensitivity to damaging agents, relative to dcr1∆, is due to a failure 
to repair telomeric DNA. One possible approach can be taken to test this: The dcr1∆ and dcr1∆ 
tsn1∆ mutant strains can be constructed in the Otrt1∆ strain background, which has no 
telomeres, or alternatively in a HAATI strain (Jain et al., 2010), and these constructed strains 
can be exposed to the DNA damaging agents. For example, if the dcr1∆ and dcr1∆ tsn1∆ 
strains exhibit similar sensitivities to the DNA-damaging reagents, then this may indicate that 
the observed phenomenon in the dcr1∆ tsn1∆ cells is a telomere-specificity effect. 
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5.4 Conclusion  
1. The mutation of tfx1 or tsn1 increases the chromosomal instability of the dcr1∆ mutant. 
2. Tsn1, but not Tfx1, is required in the DNA damage response in the absence of Dcr1. 
3. Tsn1 may serve to suppress transcription-DNA replication–associated recombination in the 
absence of Dcr1. 
4. The hypersensitivity of the dcr1∆ tsn1∆ double mutant to damaging agents may be due to a 
failure to repair telomeric DNA. 
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Chapter 6: Results 
 Tsn1 suppresses recombination in the absence of 
Dcr1 
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6. Tsn1 suppresses recombination in the absence of Dcr1 
6.1 Introduction 
One significant oncogenic element responsible for cancer initiation and progression is genetic 
alteration, including chromosomal translocations. Translocations take place due to abnormal 
recombination events between nonhomologous chromosomes (Tucker, 2010; Nambiar & 
Raghavan, 2011; Zheng, 2013; Harewood & Fraser, 2014; Roukos & Misteli, 2014). Translin 
was initially implicated in chromosomal translocation formation in human leukaemia cells 
(Aoki et al., 1995), but it has subsequently been found to be involved in the control of different 
RNA processing mechanisms (Wu et al., 1997; Liu et al., 2009; Ye et al., 2011; Li et al., 2012; 
Asada et al., 2014; Gomez-Escobar et al., 2016). However, the link between these mechanisms 
and cancer-associated chromosomal translocations has not yet been elucidated. Previous 
analysis of tsn1∆ null mutants in S. pombe showed no measurable defects in mechanisms 
involving recombination, such as DNA damage recovery (Jaendling et al., 2008). Prior to the 
current study, however, it had not yet been tested whether Translin has a redundant role in the 
recombination and DNA repair processes, which could account for its proposed function in 
oncogenic translocation formation (Jaendling & Mcfarlane, 2010). In the present study, it was 
found that Tsn1 is required in the DNA damage response in the absence of Dcr1 (see Chapter 
5). Given the role of Dcr1 in removing RNA Pol II-mediated RNA:DNA hybrids from 
replication-pausing sites, such as rDNA and tRNA genes – where collisions occur between the 
replication fork and transcription in the absence of Dcr1 (Castel et al., 2014; Molla-Herman et 
al., 2015; Ren et al., 2015; Loya & Reines, 2016; Gadaleta & Noguchi, 2017) – and because 
RNA:DNA hybrids at these sites are highly recombinogenic (Castel et al., 2014; Loya & 
Reines, 2016; Aguilera & Gómez-González, 2017), we speculated that the increased sensitivity 
of the dcr1Δ tsn1Δ double mutant to the replication-stressing agent (e.g., HU) and 
chromosomal breaking agent (e.g., phleomycin), relative to the dcr1∆ single mutant, was due 
to increased formation of recombination stimulating lesions in the dcr1Δ tsn1Δ cells, suggested 
a role for Tsn1 in suppressing the transcription–DNA replication–associated recombination in 
the absence of Dcr1. Therefore, the work in this chapter aims to explore this possibility by 
measuring the recombination frequency at a tRNA gene (tDNA) in a dcr1Δ single mutant and 
a dcr1Δ tsn1Δ double mutant.  
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6.1.1 An overview of the genetic assay used in this study 
tRNA genes, which are the template for RNA Pol III transcribed tRNAs, accumulate RNA Pol 
II in dcr1Δ cells compared to wild-type (Castel et al., 2014). This suggests that antisense 
transcription by RNA Pol II is taking place at tRNA genes (Castel et al., 2014). The McFarlane 
team previously established a plasmid-by-chromosome recombination system to monitor 
recombination frequency at tRNA genes inserted into the ade6 locus (Pryce et al., 2009; Figure 
6.1). This system was previously utilised to show that S. pombe tRNA genes inserted in ade6+ 
slowed DNA replication fork progression, demonstrating that tRNA genes provide strong 
replication fork barrier (RFB) activity (Pryce et al., 2009). In brief, a single tRNA gene, 
tRNAGLU, was introduced independently in both orientations into the BstXI site in the S. pombe 
genomic ade6 locus, thereby rendering the strains auxotrophic for adenine (Figure 6.1.A). In 
addition, the pSRS5 plasmid was created, which carries a distinct ade6 mutant allele, ade6-
∆G1483. This allele has a point mutation distal to the position into which tRNAGLU was 
introduced (Figure 6.1.B). Recombination between the S. pombe chromosome-borne 
ade6::tRNAGLU allele and plasmid-borne ade6-∆G1483 allele can result in an adenine 
prototroph (Ade+), which can be used to genetically measure the frequency of recombination 
events.  
Based on the work of Castel et al. (2014), we hypothesised that RNA Pol II–mediated 
RNA:DNA hybrids would be generated at the ade6::tRNAGLU locus ;  it is known this tRNA 
gene insert generates a RFB, although it is unknown whether RNA Pol II/III transcription 
occurs at this tRNA gene. Therefore, we set up this system to ask whether recombination 
increases at a tDNA site when drc1 and tsn1 are mutated. To explore this, appropriate mutant 
strains, containing ade6::tRNAGLU, were constructed (see Section 6.2.1; Figures 6.2, 6.3 and 
6.4). Following this, these constructed strains were transformed with the pSRS5 plasmid (see 
Section 2.5.2), and they were then subjected to fluctuation tests to quantify the recombination 
frequencies (see Section 6.2.3; Figures 6.8, 6.9).   
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Figure 6.1 Schematic illustration of the plasmid-by-chromosome intermolecular recombination 
system used to measure a recombination frequency at ade6::tRNAGLU. 
A. tRNAGLU was inserted independently in both orientations 1 and 2 (black arrows above the BstXI 
site) into the ade6 ORF (open rectangle) at the BstXI site. The expression of ade6 is from left to right; 
the angular arrow shows the promoter. The predominant direction of DNA replication is indicated by 
the large open arrow. In orientation 1, a head-to-head collision between the RNA Pol III and DNA 
replication is expected. In contrast, orientation 2 would be predicted to generate head-to-tail collisions 
between the Pol III and replication machinery. Conversely, orientation 1 would generate a head-to- 
tail collision between the replication fork and RNA Pol II, and orientation 2 would generate a head-
to-head collision between the replication fork and RNA Pol II. B. The three chromosomes of S. pombe 
are indicated by the vertical lines. The ade6 locus is found on the smallest chromosome, Chr III, 
where the inserted tRNAGLU (depicted in A) is located. The large open circle represents the pSRS5 
plasmid, which carries a second ade6 allele (ade6-∆G1483) with a point mutation at the 3′ end of 
ade6, distal to the position where tRNAGLU was inserted. The mutations in the chromosomal and 
plasmid alleles will be recombined to produce a prototroph (Ade+). The prototroph production 
frequency can be used to quantify the recombination frequency (adapted from Pryce et al., 2009).  
 
A 
B 
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6.2 Results 
6.2.1 Constructing appropriate mutant strains 
As previously indicated, all the S. pombe strains were generated by replacement with antibiotic-
resistant cassettes using PCR-based gene-targeting methods (Bähler et al., 1998; see Section 
2.3). The tsn1 and dcr1 genes were deleted from the parent ade6::tRNAGLU strains (BP1478 
and BP1508) to generate the single mutants tsn1∆ in orientation 1 (BP3335), tsn1∆ in 
orientation 2 (BP3336), dcr1∆ in orientation 1 (BP3313) and dcr1∆ in orientation 2 (BP3343; 
Figures 6.2, 6.3 and 6.4). To generate the double mutant in orientation 1 (BP3314), tsn1 was 
deleted from the newly constructed single mutant dcr1∆ background (BP3313; Figure 6.2), and 
to generate the double mutant in orientation 2 (BP3362), dcr1 was deleted from the newly 
constructed single mutant tsn1∆ background (BP3336; Figure 6.3).  
 
Plasmids containing the required antibiotic-resistant cassettes were isolated from E. coli (see 
Table 2.3). Here, kanMX6 and natMX6 were the replacement cassettes used to delete tsn1 and 
dcr1. For example, kanMX6 was utilised for the tsn1∆ mutants (BP3335, BP3336 and BP3314) 
and dcr1∆ mutant (BP3343), and natMX6 was used for the dcr1∆ mutants (BP3313 and 
BP3362). The replacement cassettes were amplified using PCR with primers designed with 80 
bp homologous sequences directly flanking the tsn1 and dcr1 ORFs upstream and downstream; 
they also contained a 20 bp homologous sequence to the antibiotic-resistant markers on the 
kanMX6 and natMX6 genes of the plasmids (Figure 3.8). The purified PCR product was then 
chemically transformed into the appropriate S. pombe strains (see Section 2.5.1). To confirm 
the correct gene deletions, the tsn1∆ and dcr1∆ candidates were screened via PCR (Figures 
6.2, 6.3 and 6.4) using three sets of primers, as previously shown in Figure 3.9. 
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Figure 6.2 PCR screening of successful tsn1Δ candidates. 
A. Agarose gel image displays PCR products for the WT strain and tsn1∆ 1, 2 and 3 (BP3335 tsn1∆ 
in ori 1, BP3336 tsn1∆ in ori 2 and BP3314 dcr1Δ tsn1∆ in ori 1, respectively) using the Tsn1-int-F 
and Tsn1-int-R primers. The expected PCR product sizes of the tsn1 gene was 475 bp. The gel image 
shows no PCR products in the successful tsn1∆ candidate strains. B. PCR products for the WT and 
tsn1∆ candidate strains using Tsn1 check-F and KanMX6-R primers. Band sizes of approximately 
619 bp were seen in the tsn1∆ strains, but not in the tsn1+ strains (WT). C. KanMX6-F and Tsn1 
check-R primers were utilised to amplify the WT and tsn1∆ candidate strains. A product size of 
approximately 1200 bp was present in the tsn1∆ strains, but not in the tsn1+ strains (WT). M = 
markers and ori = orientation. 
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Figure 6.3 PCR screening of successful dcr1Δ candidates. 
A. Agarose gel image displays PCR products for the WT strain, and dcr1∆ 1 and 2 (BP3313 dcr1∆ 
in ori 1 and BP3362 tsn1Δ dcr1∆ in ori 2, respectively) using Dcr1-int-F and Dcr1-int-R primers. 
The expected PCR product sizes of the dcr1 gene was 1139 bp. The gel image shows no PCR products 
in the successful dcr1∆ candidate strains. B. PCR products for the WT and dcr1∆ candidate strains 
using the Dcr1 check-F and NatMX6-R primers. Band sizes of approximately 487 bp were seen in 
the dcr1∆ strains, but not in the dcr1+ strains (WT). C. NatMX6-F and Dcr1 check-R primers were 
utilised to amplify the WT and dcr1∆ candidate strains. A product size of approximately 969 bp was 
present in the dcr1∆ strains, but not in the dcr1+ strains (WT). M = markers and ori = orientation.  
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Figure 6.4 PCR screening of successful dcr1Δ candidates.  
A. Agarose gel image displays PCR products for the WT strain and dcr1∆ strains (BP3343 dcr1∆ in 
ori 2) using the Dcr1-int-F and Dcr1-int-R primers. The expected PCR product size of the dcr1 gene 
was approximately 1139 bp. The gel image shows no PCR products in the successful dcr1∆ candidate 
strain. B. PCR products for the WT and dcr1∆ candidate strains using Dcr1 check-F and KanMX6-
R primers. A band size of approximately 550 bp was seen in the dcr1∆ strain, but not in the dcr1+ 
strain (WT). KanX6-F and Dcr1 check-R primers were utilised to amplify the WT and dcr1∆ 
candidate strains. A product size of approximately 1298 bp was present in the dcr1∆ strain, but not 
in the dcr1+ strain (WT). M = markers and ori = orientation.  
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6.2.2 TBZ and DNA damaging agent sensitivity tests for the newly constructed strains  
The data in Chapter 5 showed that the dcr1∆ tsn1∆ double mutant displayed increased 
sensitivity, relative to the dcr1∆ mutant, in response to the microtubule destabilizing drug TBZ, 
as well as HU and phleomycin DNA damaging drugs. Here, we set out to further confirm this 
by repeating these experiments with the newly constructed strains (i.e. appropriate mutants 
were generated in both orientations of the ade6::tRNAGLU strains). Consistent with the data in 
Chapter 5, the dcr1Δ tsn1Δ double mutants exhibited more sensitivity, relative to the dcr1Δ 
mutants, to TBZ (Figure 6.5), as well as the DNA damaging agents, HU and phleomycin 
(Figures 6.6 and 6.7). Taken together, these results further confirm that Tsn1 is required in the 
DNA damage recovery response in the absence of Dcr1, and they support the proposed role of 
Tsn1 in suppressing recombination in the absence of Dcr1, which will be addressed directly in 
the next section. 
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Figure 6.5 TBZ sensitivity spot test confirming the increased sensitivity of the dcr1Δ tsn1Δ cells. 
Serial dilutions of the indicated S. pombe mutants were set up and exposed to different concentrations 
of TBZ. The plates were then incubated at 30°C for approximately 3 days. The dcr1∆ tsn1∆ double 
mutants (BP2748, BP2749, BP3314 and BP3362) exhibited increased sensitivity to TBZ relative to 
the dcr1Δ mutants.  
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Figure 6.6 HU sensitivity spot assay confirming the increased sensitivity of the dcr1Δ tsn1Δ cells. 
Serial dilutions of the indicated S. pombe mutants were made and exposed to 10 mM HU. The plates 
were then incubated at 30°C for approximately 4 days. Here, rad3-136 cells (checkpoint defective) were 
used as a positive control for the damaging agent. The dcr1∆ tsn1∆ double mutants (BP3314 and 
BP3362) showed increased sensitivity to HU in comparison with the dcr1∆ single mutants. 
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Figure 6.7 Phleomycin sensitivity spot assay confirming the hypersensitivity of the dcr1Δ tsn1Δ 
double mutant. 
Serial dilutions of the indicated S. pombe mutants were made and exposed to different concentrations 
of the phleomycin agent. The plates were then incubated at 30°C for approximately 4 days. Here, 
rad3-136 cells (checkpoint defective) were used as a positive control for the damaging agent. The 
dcr1∆ tsn1∆ double mutants (BP3314 and BP3362) displayed increased sensitivity to phleomycin 
compared with the dcr1∆ single mutants. 
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6.2.3 Analysis of recombination frequencies for the tsn1∆, dcr1∆ and dcr1∆ tsn1∆ mutants 
at tRNA genes  
To test whether the increased sensitivity of the dcr1Δ tsn1Δ double mutant to the DNA 
damaging agents is related to elevated recombination at a known RFB, the tsn1∆, dcr1∆ and 
dcr1∆ tsn1∆ in both tRNA gene orientations were assessed for plasmid-by-chromosome 
recombination frequency. Fluctuation analysis was performed on these mutant strains 
alongside the WT strains using the pSRS5 plasmid to measure the recombination frequency 
(adenine prototrophs per 106 viable cells; see Section 2.14).  
In orientation 1 of the ade6::tRNAGLU strains, the fluctuation test showed no statistically 
significant increase in the recombination frequency in the tsn1∆ and dcr1∆ single mutants or 
the dcr1∆ tsn1∆ double mutant compared with the WT strain (Figure 6.8). swi1∆ strains, which 
exhibit elevated recombination in this assay (Pryce et al., 2009) were used as a positive control. 
These results indicate that recombinogenic lesions are not stimulated in the dcr1∆ mutants for 
orientation 1. In orientation 2, loss of tsn1 displayed no statistically meaningful increase of 
recombination frequency compared with the WT strain. However, we found that the dcr1∆ 
mutation exhibited an approximately two-fold increase in recombination frequency compared 
with the WT, suggesting an orientation-specific effect (Figure 6.9). Interestingly, this elevated 
level of recombination was further increased following the additional mutation of tsn1 in the 
dcr1∆ background (Figure 6.9), and the increase between dcr1∆ and dcr1∆ tsn1∆ is statistically 
significant. Comparing the WT to the dcr1∆ tsn1∆   gives a statistically significant increase of 
almost 4-fold. These results demonstrate that the hypersensitivity to damaging agents observed 
in the dcr1∆ tsn1∆ double mutant, relative to the dcr1Δ mutant, is linked to orientation-
dependent increased recombination at a known RFB. 
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Figure 6.8 Plasmid-by-chromosome intermolecular recombination assay for the ade6::tRNAGLU 
–orientation 1 strains. 
A. The plot displays the mean values of at least four independent median values obtained from the 
fluctuation test for plasmid-by-chromosome intermolecular recombination frequencies for the 
indicated S. pombe mutants. The data showed that the recombination frequency of tsn1∆, dcr1∆ and 
dcr1∆ tsn1∆ mutants exhibited no statistically significant change from that obtained for the WT 
strain. Here, the swi1∆ mutant (BP1685) was used as a positive control, and this has already been 
shown to exhibit elevation of recombination at ade6::tRNAGLU (Pryce et al., 2009). B. Same data with 
the swi1∆ values removed. The error bars show the standard deviation. Pairwise Student’s t-tests 
were performed to determine the p-values between the WT and indicated mutant strains. All p-values 
were > 0.05 except WT vs. swi1∆, which was < 0.01. 
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Figure 6.9 Plasmid-by-chromosome intermolecular recombination assay for the ade6::tRNAGLU 
–orientation 2 strains.    
A. The plot displays the mean values of at least four independent median values obtained from 
fluctuation test for plasmid-by-chromosome intermolecular recombination frequencies for the 
indicated S. pombe mutants. The data showed that the tsn1∆ mutant had a recombination frequency 
that was statistically indistinguishable from that of the WT strain. However, mutation of dcr1∆ 
resulted in an approximately two-fold increase in the recombination frequency in comparison with 
the WT strain. In addition, the recombination frequency of the dcr1Δ tsn1∆ double mutant was 
significantly elevated compared with the dcr1∆ mutant (and the WT strain). Here, the swi1∆ mutant 
(BP1687) was used as a positive control, and this has already been shown to exhibit elevation of 
recombination at ade6::tRNAGLU (Pryce et al., 2009). B.  Same data with the swi1∆ values removed. 
The error bars are the standard deviation. Pairwise Student’s t-tests were performed to determine the 
p-values of WT vs. tsn1Δ, p > 0.05; WT vs. dcr1Δ, p < 0.01; dcr1Δ vs. dcr1Δ tsn1∆, p < 0.01; and 
WT vs. dcr1Δ tsn1∆, p < 0.01. 
 A 
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6.3 Discussion 
6.3.1 The newly constructed dcr1∆ tsn1∆ double mutants are hypersensitive to TBZ, HU 
and phleomycin  
In Chapter 5, we showed that the mutation of tsn1 in a dcr1Δ background increased TBZ 
sensitivity. Moreover, the sensitivity of the dcr1Δ mutant to the HU and phleomycin damaging 
agents is increased by a tsn1∆ mutation, but not a tfx1∆ mutation. Given these results, we set 
out to repeat these experiments with newly constructed strains containing two independently 
isolated tsn1∆ single mutants (BP3335 and BP3336), dcr1∆ single mutants (BP3313 and 
BP3343) and dcr1∆ tsn1∆ double mutants (BP3314 and BP3362; Figures 6.2, 6.3 and 6.4). 
Consistently, all the dcr1Δ tsn1Δ double mutant strains displayed increased sensitivity, relative 
to the dcr1Δ mutant strains, to TBZ, as well as the DNA damaging agents HU and phleomycin 
(Figures 6.5, 6.6 and 6.7). The fact that the four independent knockout dcr1Δ tsn1Δ strains (i.e. 
BP2748, BP2749, BP3314 and BP3362) behaved in a similar fashion validate this finding. 
However, while the dcr1∆ tsn1∆ double mutants (BP2748 and BP2749) constructed in the 
BP90 strain background appear to exhibit a slightly higher level of sensitivity than that for the 
dcr1∆ tsn1∆ double mutants (BP3314 and BP3362) constructed in the ade6::tRNAGLU 
background to some of the indicated agents, this suggests that the strain background may have 
a minor influence on this phenomenon. Collectively, these findings further support the 
suggestion that the phenomenon observed in the dcr1Δ tsn1Δ double mutant may be due to an 
increase of replication–associated recombination initiating lesions, e.g., replication fork 
blockage. 
 
 
6.3.2 The dcr1∆ tsn1∆ double mutant elevates recombination  
The accumulation of RNA:DNA hybrids is a central internal cause of DNA damage; these 
hybrids block the progression of the replication fork, causing the fork to collapse and inducing 
genomic instability (Aguilera & Garcia-Muse, 2012; Bermejo et al., 2012; Lin & Pasero, 2012; 
Castel et al., 2014; Felipe-Abrio et al., 2015; Brambati et al., 2015; Santos-Pereira & Aguilera, 
2015; Ohle et al., 2016; Aguilera & Gómez-González, 2017). 
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Moreover, the RNA:DNA hybrids that stabilise at the sites of collision between the replication 
and transcription machineries can be highly recombinogenic; if they are not removed, they may 
cause translocations (Lin & Pasero, 2012; Wahba et al., 2013; Castel et al., 2014; Brambati et 
al., 2015). As indicated, Dcr1 was recently found to remove RNA:DNA hybrids from sites of 
collision, such as rDNA and tRNA genes, which resolves the transcription-replication 
collisions and maintains genomic stability (Castel et al., 2014; Ren et al., 2015). However, in 
the absence of Dcr1, it was found that there is accumulation of these hybrids at these 
transcription sites (Castel et al., 2014), which may explain the sensitivity of the dcr1Δ single 
mutant to the DNA replication–pausing HU agent and chromosome–breaking phleomycin. 
Interestingly, it was found that the sensitivity of the dcr1Δ mutant to these agents greatly 
increased following the additional mutation of tsn1. Given the original proposed role for 
Translin in generating chromosomal translocations (Aoki et al., 1995), and the great affinity 
known for this protein in targeting RNA molecules (Jaendling & Mcfarlane, 2010; Gomez-
Escobar et al., 2016), we speculated that Tsn1 may be required in the absence of Dcr1 to reduce 
the stability of RNA:DNA hybrids, limiting the induction of recombinogenic lesions that 
preserve genomic stability. If this hypothesis is correct, then the mutation of tsn1 in the dcr1Δ 
background will result in a further increase of RNA:DNA hybrid levels, accompanied with an 
elevation of recombination frequency, that could result in translocations. Interestingly, a 
parallel biochemical analysis, DNA:RNA immunoprecipitation (DRIP), by a co-worker in our 
group showed that the level of RNA:DNA hybrids in the dcr1∆ tsn1∆ double mutant is higher 
than that of the dcr1∆ single mutant; this was found at certain transcribed loci, including in 
rDNA and natural tRNA genes (Gomez-Escobar, personal communication; data not shown). 
These results indicate that Tsn1 can partly substitute for Dcr1 function in reducing RNA:DNA 
hybrid levels.  
 To explore whether the increased level of RNA:DNA hybrids observed in the double mutant 
correlates with an increase in recombination frequency, the tsn1Δ, dcr1Δ and dcr1Δ tsn1Δ 
mutants were constructed in distinct strains that had the tRNAGLU inserted individually in both 
orientations in the genomic ade6 locus, as described in Section 6.2.1. Using this recombination 
assay system, fluctuation analyses were conducted on the indicated strains alongside the WT 
strains. In both orientations of the tRNAGLU strains, the recombination frequency of the tsn1Δ 
single mutants was found to be statistically indistinguishable from the frequency of 
recombination events seen in the WT strain (Figures 6.8 and 6.9), which is consistent with the 
previous work of Jaendling et al. (2008).   
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However, we do observe elevated RNA:DNA hybrids in this background (Gomez-Escobar, 
personal communication), suggesting RNA:DNA hybrids alone do not increase recombination 
when Dcr1 is present. In orientation 1, where RNA Pol III – which mediates the transcription 
of tRNA genes – is expected to collide head-to-head with replication machinery (Pryce et al., 
2009; Figure 6.1), mutation of dcr1 showed no statistically meaningful increase in 
recombination frequency compared to the WT strain (Figure 6.8). In this orientation, we 
hypothesised that RNA Pol II could mediate the transcription of the other strand, which is in 
the same direction as the replication fork (i.e. a co-directional collision between RNA Pol II 
and the replication fork). If this is the case, this suggests that a head-to-tail collision between 
the replication fork and RNA Pol II (i.e. RNA:DNA hybrids) does not generate substrates for 
recombination. However, in the opposite orientation (orientation 2), where a head-to-head 
collision is predicted to occur between replication fork and RNA Pol II, the loss of Dcr1 
resulted in a roughly two-fold elevation in recombination frequency compared with the WT 
strain (Figure 6.9). Interestingly, in orientation 2, the mutation of tsn1 in the dcr1Δ background 
resulted in a further increase in the frequency of recombination events (Figure 6.9). In contrast, 
in orientation 1, we saw no measurable increase of recombination frequency in the dcr1Δ tsn1Δ 
double mutant compared with the dcr1Δ mutant, which had a level of recombination frequency 
that was statistically indistinguishable from that of the WT strain (Figure 6.8). These data 
showed an orientation-dependent increase of recombination occurring at ade6::tRNAGLU in the 
dcr1∆ mutant, which is further exacerbated in the dcr1Δ tsn1Δ mutant (Figure 6.9).  
The results are somewhat consistent with the work of Castel et al. (2014), who reported that 
the antisense transcription by RNA Pol II takes place at some tRNA genes. However, 
unfortunately, we do not know if it is actually RNA Pol II transcription (i.e. RNA:DNA 
hybrids) causing the barrier to DNA replication that stimulates recombination of the dcr1Δ 
mutants at this specific site, ade6::tRNAGLU, or if RNA Pol II/III transcription even occurs at 
this tRNA gene. It may be that RNA Pol III binding alone causes the barrier, or even just the 
DNA sequence (with no RNA polymerases bound or any type of transcription). Therefore, at 
this stage, we cannot conclude that a transcription causes the barrier that induces recombination 
in the Dcr1-deficient strains, and thus, additional experiments – for example, assess RNA Pol 
II occupancy by CHIP at ade6::tRNAGLU – are required to determine whether RNA Pol II binds 
at this locus. 
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Nevertheless, our results showed that the dcr1∆ tsn1∆ double mutant exhibited a greater 
recombination frequency than the dcr1∆ mutant did, indicating that the hypersensitivity of the 
dcr1Δ tsn1Δ cells to the DNA damaging agents could be due to an increase of recombination 
initiating lesions in the S. pombe genome, or a failure to process lesions correctly. However, 
this should be investigated further in a physical analysis of RFB activity (i.e. 2D gel 
electrophoresis analysis for Dcr1-deficient strains containing tRNAGLU elements), which would 
address whether the elevation of the recombination level in the dcr1Δ tsn1Δ double mutant, 
relative to the dcr1Δ single mutant, is concomitant with an increase in RFB intensity. 
Moreover, further DRIP analysis is needed at this specific locus, ade6::tRNAGLU, to investigate 
whether the elevation of recombination frequency in the double mutant is associated with an 
increase of RNA:DNA hybrids.   
Taken together, the observations from our experiments suggest a role for Tsn1 secondary to 
Dcr1 in reducing the stability of the RNA:DNA hybrids, which results in suppressing 
transcription–DNA replication–associated recombination in the absence of Dcr1. Thus, it 
maintains chromosomal stability, although it cannot fully compensate for the loss of Dcr1, 
since the single mutant of dcr1Δ displays some sensitivity to the damaging agents and exhibits 
an increased recombination level. Importantly, these observations may provide a credible 
explanation for why Translin was associated with translocations in cancer and other genetic 
diseases. In addition, these findings may indicate that the phenomenon observed in the dcr1Δ 
tsn1Δ double mutant occurs generally throughout the genome and is unlikely to be restricted to 
telomeres.  
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6.4 Conclusion 
1. The hypersensitivity of the dcr1∆ tsn1∆ cells to DNA damaging agents is linked to increase 
in recombination stimulating lesions.  
2. Tsn1 is required to suppress recombination in the absence of Dcr1. 
3. The increased recombination observed in Dcr1-deficient strains at tDNA is an orientation-
specific effect, suggesting it is linked to RNA polymerase (II or III) activity. 
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Chapter 7: Final Discussion 
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7. Final Discussion 
7.1 Introduction  
The human protein Translin was first found associated with the break point junctions of 
chromosomal translocations in lymphoid malignancies in humans (Aoki et al., 1995). Since it 
was first identified, it has been shown to be associated with a range of chromosomal 
rearrangements in different human diseases (Kanoe et al., 1999; Hosaka et al., 2000; Chalk et 
al., 1997; Abeysinghe et al., 2003; Wei et al., 2003; Visser et al., 2005; Gajecka et al., 2006a; 
Gajecka et al., 2006b; Jaendling & Mcfarlane, 2010). Translin can form an octameric ring 
(Kasai et al., 1997), and such structures are often linked to DNA repair and recombination 
(Jaendling et al., 2008; Fukuda et al., 2008; Ishida et al., 2002; Jaendling & Mcfarlane, 2010; 
VanLoock et al., 2001), suggesting a possible involvement of Translin in chromosome 
dynamics and the DNA repair processes. Subsequently, numerous studies have implicated 
Translin in DNA damage responses (Kasai et al., 1997; Hasegawa & Isobe, 1999; Fukuda et 
al., 2008; Jaendling & Mcfarlane, 2010), although direct evidence for this is limited. Translin 
and its partner TRAX are highly conserved sets of proteins from humans to S. pombe, 
indicating that they probably play a fundamentally important biological role in the cell 
(Martienssen et al., 2005; Laufman et al., 2005; Jaendling & Mcfarlane, 2010). However, the 
single mutations of S. pombe, tsn1 and tfx1, show no obvious phenotypic alteration (Laufman 
et al., 2005; Jaendling et al., 2008), suggesting that they could function in redundant or 
secondary pathways (Jaendling & Mcfarlane, 2010). The Translin-TRAX complex has been 
shown to bind nucleic acids, with a preference for RNA, and it has RNase activity (Eliahoo et 
al., 2010; 2015; Jaendling & McFarlane, 2010; Li et al., 2011; Parizotto et al., 2013; Wang et 
al., 2004; Martienssen et al., 2005; Laufman et al., 2005; Jaendling & Mcfarlane, 2010). It has 
been demonstrated that there is a close functional relationship between the two proteins, for 
example, Translin is required to maintain the stability of TRAX levels (Jaendling et al., 2008; 
Claussen et al., 2006; Yang et al., 2004; Jaendling & Mcfarlane, 2010; Chennathukuzhi et al., 
2003). Moreover, from their nucleic acid sequence binding preferences, it has been proposed 
that Translin and TRAX might play a role at telomeres (Jacob et al., 2004; Laufman et al., 
2005; Jaendling & McFarlane, 2010), although no direct evidence has been provided to support 
this prior to the current study.   
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Studies in distinct organisms have shown that there is great diversity in the function of TRAX 
and Translin, including their mRNA dynamics in neurons and spermatogenesis, genome 
stability, DNA damage response, cell growth regulation, tRNA maturation, and most recently, 
in the oncogenic degradation of pre-miRNAs (Aoki et al., 1995; Wu et al., 1997; Jaendling et 
al., 2008; Li et al., 2012; Jaendling & McFarlane, 2010; Wang et al., 2016b; Asada et al., 2014). 
Importantly, in humans and Drosophila, Translin and TRAX have been shown to make up the 
C3PO complex, which enhances the cleavage of the passenger strand from siRNA involved in 
Argonaute (Ago1)-mediated heterochromatin formation and gene silencing (Liu et al., 2009; 
Ye et al., 2011; Holoch & Moazed, 2015; Tian et al., 2011). Currently, the chromosomal 
instability observed in Ago1-deficient cells is believed to be caused solely by centromere 
heterochromatin disruption leading to compromised centromere function (Volpe et al., 2003; 
Holoch & Moazed, 2015). However, the work reported here challenges this proposal by 
demonstrating that the chromosomal instability of ago1∆ cells can be partially suppressed by 
a tfx1∆ mutation without restoring the pericentromeric heterochromatin gene silencing. 
Extending the analysis of Tsn1 and Tfx1 function has identified important new insights into 
distinct functions for these factors in controlling the telomere and sub-telomere-associated 
transcript levels, a role that seems to be conserved in human cells. Further, this work has 
revealed differential roles for these conserved proteins in the DNA damage response in the 
absence of the RNAi regulator Dcr1. These observations not only provide a clear functional 
distinction between Tsn1 and Tfx1 in S. pombe, but also reveal a counter balance between 
centromeres and telomeres in preserving chromosomal stability. Additionally, our data provide 
several lines of evidence to show that the residual Tfx1 found in a tsn1Δ background could 
play a functional role. These fundamental observations are discussed in more detail below.  
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7.2 Tsn1-Tfx1 (C3PO) function in regulating telomere transcription 
Translin and TRAX are implicated in different biological functions that seem to require the 
regulation of RNA molecules rather than DNA. Here, we add to their known functional roles 
by showing that Tsn1 and Tfx1 function in regulating telomeric RNAs. Tfx1 functions to 
control sub-telomeric ARRET transcript levels in a Tsn1-dependent fashion, and, in a reciprocal 
control mechanism, Tsn1 serves to suppress telomeric TERRA transcript levels in a Tfx1-
dependent fashion. These findings reveal important and novel telomere-associated regulatory 
factors (Tsn1 and Tfx1), and identify a novel mechanism for telomeric transcriptome regulation 
(Figure 7.1). Interestingly, further analysis by a co-worker in the McFarlane group found that 
some human TERRAs are regulated by Tsn1/TSNAX in humans, demonstrating a degree of 
conservation of this function at some telomeres in humans (Gomez-Escobar et al., 2016). 
However, a recent work aimed at identifying the proteins that interact with telomere DNA and 
TERRA did not show TSN or TSNAX (Luo et al., 2015), suggesting an indirect regulation of 
telomere-associated transcripts by these proteins in humans. Future work could focus on 
investigating whether mutation of tsn1 (TSN) or tfx1 (TSNAX) alters the levels of methylated 
histone H3 lysine 9 (H3K9-me) and/or pol II occupancy in sub-telomeric regions, thus 
addressing how Translin and TRAX contribute to sub-telomeric gene silencing. Importantly, 
the current study found that the centromeric transcript levels of both tsn1∆ and tfx1∆ single 
mutants were indistinguishable from the WT strain, demonstrating that Tsn1 and Tfx1 function 
in regulating telomeric, but not centromeric, transcript levels. 
 
The finding that Translin and TRAX are required for controlling telomere-associated 
transcripts indicates the importance of these conserved proteins, and yet their disruption is 
tolerated, in fission yeast at least, suggesting that these factors may have a redundant crucial 
function in essential processes. This is supported by the fact that cells lacking the RNAi 
regulator Ago1 and Tsn1/Tfx1 exhibit a phenotype consistent with high levels of genome 
instability (as measured by the TBZ sensitivity assay) and highly elevated levels of telomeric 
TERRA. 
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These findings suggest that Tsn1-Tfx1 together provide a redundant joint function to maintain 
genome stability in the absence of Ago1, pointing to a direct link between the C3PO complex 
and chromosome stability regulation. The fact that dysregulation of the TERRA transcript is 
the only measurable defect phenotype recorded to date for S. pombe tsn1∆ single mutant 
indicates that alteration of the levels of telomeric TERRA alone in S. pombe has limited or no 
influence on cell proliferation. However, the hyper-elevation of TERRAs observed in the 
ago1∆ tsn1∆ tfx1∆ triple mutant is correlated with increased DNA damage sensitivity. This 
phenomenon has also been seen for the taz1∆ mutant, which also has elevated TERRA levels, 
(Miller & Cooper, 2003; Greenwood & Cooper, 2012; Figure 4.4), suggesting that the 
significant elevation of TERRA levels may result in compromised DNA repair. From these 
analyses we propose that telomere functional fidelity may be preserved via an interplay 
between the C3PO (Tsn1/Tfx1) complex and Ago1. However, further analysis is required to 
confirm these results and determine their underlying mechanism.  
 
To date, Translin has been shown to be necessary for maintaining the TRAX level, and several 
studies demonstrate that loss of Translin results in a total loss of the TRAX level (Yang et al., 
2004; Jaendling et al., 2008; Park et al., 2017). However, we now challenge this long-standing 
belief by finding that Tfx1 is required to maintain the elevated levels of TERRA in the absence 
of Tsn1 (Figure 7.1), demonstrating that the very low Tfx1 levels found in the tsn1∆ 
background are sufficient to provide the function for the regulation of telomere-associated 
transcript level. Additionally, the fact that the ago1∆ tfx1∆ tsn1∆ triple mutant has a hyper TBZ 
sensitive phenotype relative to the ago1∆ tsn1∆ phenotype (which is indistinguishable from 
that of the ago1∆ mutant) indicates that the residual Tfx1 in the tsn1∆ background is sufficient 
to suppress TBZ hypersensitivity. So, our data demonstrate that the very low level of residual 
Tfx1 existing in a tsn1∆ mutant remains adequate to fulfil a biological role in genome stability 
maintenance.  
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Translin (TSN) and TRAX (TSNAX) have recently been found to play an oncogenic role, and 
have been proposed as potential chemotherapeutic targets (Asada et al., 2014, Asada et al., 
2016). Therefore, an understanding of their normal functions is of fundamental importance 
before targeting these factors as anticancer agents. The finding that Translin and TRAX 
function to control the telomeres, which are vital in cancer progression, adds new insight to our 
understanding of these important proteins. 
 
 
 
 
 
 
 
 
Figure 7.1 Schematic model of the reciprocal control mechanism of telomere and sub-
telomere-associated transcripts by Tsn1 and Tfx1.  
Tfx1 negatively controls sub-telomeric tlh and ARRET transcript levels (upper red full/broken lines), 
but positively maintains (upper green arrow) elevated levels of telomeric TERRAs observed in the 
tsn1Δ background. The inverse is true for Tsn1, it negatively suppresses TERRAs (lower red line), 
but positively preserves (lower green arrow) elevated levels of sub-telomeric ARRET (but not the 
sub-telomeric tlh transcript levels, suggesting a possible transcript/positional specificity to this 
regulation) observed in the tfx1Δ background (adapted from Gomez-Escobar et al., 2016). 
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7.3 Tfx1 function enforces a restriction on chromosome segregation 
This study revealed a novel aspect of chromosome/centromere biology, which challenges the 
current belief that the chromosome instability of Ago1-deficient cells is imposed solely by a 
dysfunction of the centromeres caused by a defect in the centromeric heterochromatin (Volpe 
et al., 2003; Holoch & Moazed, 2015). It was found that mutation of tfx1, but not of tsn1, 
partially suppress the chromosome instability phenotype of the ago1∆ cells, a phenomenon that 
has also been demonstrated for taz1∆ mutants (Tadeo et al., 2013; Figure 3.15). It was shown 
that suppression caused by loss of Taz1 is due to a restoration of heterochromatin gene 
silencing at the centromere and a model proposed that loss of Taz1 function results in a re-
distribution of heterochromatin factors from the sub-telomeres to the centromeric 
heterochromatin regions to compensate for the defective state caused by the loss of Ago1 
(Tadeo et al., 2013; Figure 3.17). However, in the case of the ago1∆ tfx1∆ strain, we found that 
mutation of tfx1 in an ago1Δ background resulted in no diminishment in the activation of 
centromeric heterochromatin transcription caused by loss of Ago1, indicating that loss of Tfx1 
does not restore centromeric heterochromatin function. Therefore, the heterochromatin 
redistribution model is unlikely to be operating in this case, suggesting that a distinct 
centromere-independent suppression mechanism is in play. From this, we demonstrated that 
chromosomal instability due to loss of Ago1 was not solely due to disruption of the centromeric 
heterochromatin. Further, we found that the chromosome instability phenotype caused by the 
loss of the other RNAi regulator, Dcr1, was enhanced following the additional mutation of tfx1 
(and tsn1), which differs from the reported rescue of the Dcr1 defect by the taz1∆ mutation 
(Tadeo et al., 2013), further indicating Tsn1 and Tfx1 function in an as yet unidentified role to 
control genome stability. Moreover, these findings not only reveal that Tfx1 and Tsn1 are 
necessary for maintaining chromosome stability in the absence of Dcr1, but they also 
demonstrate that there is a functional distinction between Ago1 and Dcr1 in S. pombe, which 
supports the work of Castel et al. (2014) in which they separated the Dcr1 function in the DNA 
damage recovery response from the RNAi regulation mechanism (i.e. Ago1; see below). 
Remarkably, we revealed that the mutation of the four sub-telomeric tlh genes also caused 
suppression of the ago1 chromosomal instability. 
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This demonstrates that the compromised telomeres suppressed the chromosome instability 
defects of the ago1∆ mutant, and points to a possible relationship between the centromeres and 
telomeres that maintains chromosome stability. Importantly, the lack of heterochromatin gene 
silencing restoration at centromeres in the ago1∆ tfx1∆ cells indicates that cells can cope with 
a defective centromeric heterochromatin (i.e. in an ago1∆ mutant) when some features of the 
normal chromosome biology—which are facilitated by Tfx1—are disrupted. This indicates that 
Tfx1 imposes a segregational restriction mechanism on cells, obviously via a centromere-
independent, telomere-dependent function, which we hypothesise may be related to 
chromosomal architecture within the nucleus. 
 
 
 
7.4 Tsn1 is required to suppress recombination in the absence of Dcr1 
The initial discovery that Translin binds to the breakpoint junctions of chromosomal 
translocations in human cancers led to the proposal that Translin is implicated in the initiation 
and regulation of recombination (Jaendling & Mcfarlane, 2010; Parizotto et al., 2013), although 
its direct mechanistic role in this process has not yet been demonstrated. However, previous 
analyses of the S. pombe Tsn1 and Tfx1 demonstrate that they do not play a primary role in 
recombination and its related processes such as DNA damage recovery (Jaendling et al., 2008). 
Recent work in different organisms has implicated the two pairing proteins in the control of 
RNA metabolism, including the RNAi pathway (Liu et al., 2009; Ye et al., 2011). However, 
what links Translin and TRAX to cancer-associated chromosomal translocations and how this 
relates to RNA metabolism has not yet been elucidated. In more recent times, the S. pombe 
RNAi regulator Dcr1 was shown to have an RNAi-independent role in the RNA regulation of 
breakage in which it removes RNA Pol II-mediated highly recombinogenic RNA:DNA hybrids 
from distinct sites of collision between transcription and replication, such as rDNA and tRNA 
genes, which maintains genomic stability (Castel et al., 2014; Ren et al., 2015). Following this, 
we revealed that the sensitivity of the dcr1Δ mutant to the DNA double-strand breaks and the 
replication inhibitor agents is greatly increased following the additional mutation of tsn1. 
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This remarkable finding implicates Tsn1 in DNA damage recovery response in the absence of 
Dcr1, linking Translin function to the chromosome maintenance mechanism, which is the first 
link of this important conserved protein to a cancer causing mechanism. Based on the original 
proposed role of Translin in mediating chromosomal rearrangement breakpoints (Aoki et al., 
1995; Gajecka et al., 2006), and the stronger affinity of S. pombe Tsn1 for RNA than DNA 
(Jaendling & Mcfarlane, 2010), we proposed that Tsn1 may play a secondary role to Dcr1 in 
reducing the stability of RNA:DNA hybrids throughout the genome, which suppress 
transcription-DNA replication-associated recombination in the absence of Dcr1, rescuing 
chromosomal stability.  However, further analysis of the Tsn1 function in the absence of Dcr1 
revealed that the sub-telomere-associated transcripts tlh and ARRET are de-repressed in the 
dcr1Δ tsn1Δ double mutant. Thus, the fact that the defects in DNA damage recovery response 
in dcr1Δ tsn1Δ cells correlate with dysregulation of sub-telomeric transcription led us to think 
that the observed phenomenon in the double mutant might be a telomere-specific effect (i.e. a 
failure to repair telomeric DNA). However, this possibility was questioned by the later finding 
within our group that the dcr1Δ tsn1Δ double mutant exhibits an increase in RNA:DNA hybrids 
relative to the dcr1Δ single mutant at distinct genomic loci including in the rDNA and natural 
tRNA genes. Interestingly, these hybrids are also elevated in the tsn1Δ single mutant at these 
transcribed loci (Gomez-Escobar, personal communication), demonstrating that Tsn1 plays a 
novel role in regulating RNA:DNA hybrid levels. Future work could confirm this observation 
by performing whole genome RNA:DNA immunoprecipitation (DRIP)-seq analysis, which 
would also indicate whether the Tsn1 function in removing RNA:DNA hybrids is extended to 
other genomic loci. Remarkably, the elevated level of RNA:DNA hybrids found in the dcr1Δ 
tsn1Δ double mutant is accompanied with a statistically significant increase in recombination 
relative to the dcr1Δ single mutant (which exhibited a roughly two-fold increase in the level of 
recombination frequency compared with the WT). This was observed at a known RFB, 
ade6::tRNAGLU locus. Interestingly, the elevated recombination seen in Dcr1-deficient strains 
at this tRNA gene was an orientation-specific effect, suggesting it is related to the activity of 
RNA Pol II or III. However, tsn1Δ single mutant showed no statistically significant increase of 
recombination frequency in comparison to the WT (Jaendling et al., 2008; Figures 6.8 and 6.9), 
suggesting that RNA:DNA hybrids alone are not sufficient to generate substrates for 
recombination in the presence of Dcr1. 
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Our findings suggested that the hypersensitivity of dcr1Δ tsn1Δ cells to the DNA damaging 
drugs is linked to the increased formation of recombination stimulating lesions in the S. pombe 
genome, or it may be due to a failure to repair lesions accurately, possibily leading to 
translocations. This proposes a novel mechanistic role for Tsn1 in suppressing replication-
associated recombination in the absence of Dcr1. This remarkable new finding may address 
the outstanding question of over two decades of why Translin is linked to chromosomal 
translocation formation in human cancers. Consequently, no doubt, it will result in significant 
follow-up studies in human cells to investigate whether Translin (TSN), similarly to S. pombe, 
is involved in the initiation or regulation of recombination in Dicer-deficient cells. 
 
 
 
7.5 Distinct functions for Tsn1 and Tfx1 
To date, almost all studies that have identified a function for Translin and TRAX have indicated 
a close functional relationship between these conserved proteins. Here, we show that in S. 
pombe Tsn1 and Tfx1 can function independently of each other, demonstrating that these 
factors do not function only as a heteromeric complex. First, the elevation of sub-telomeric 
transcripts tlh and ARRET occurred only upon loss of Tfx1 not of Tsn1. In contrast, loss of 
Tsn1, but not Tfx1, resulted in increased transcript levels of the telomere-associated TERRA 
(Figure 7.1). Similarly, in the ago1Δ backgrounds, the tlh and ARRET transcript levels were 
only up-regulated when tfx1 was mutated, but not tsn1, from which it is proposed that the 
dysregulation of transcription in the sub-telomeric regions may be responsible for the partial 
rescue of chromosome instability caused by loss of Ago1. Further, the fact that loss of Tsn1 
could not supress the chromosome instability caused by loss of Ago1 to the high levels 
observed for tfx1Δ, together with the finding that Tsn1, but not Tfx1, is required in DNA 
damage recovery response in the absence of Dcr1 provide additional evidence that the functions 
of Tsn1 and Tfx1 can be separated in S. pombe.  
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7.6 Closing remarks  
Over the past two decades, since the initial discovery of Translin, Translin and TRAX have 
been implicated in a number of distinct biological processes, including RNA interference 
control.  In this study, we used a model experimental system (fission yeast) to report two major 
findings that offer new insight into the functions of these important proteins. First, Tsn1 and 
Tfx1 play differential roles in controlling transcript levels from the telomeres and sub-
telomeres. Second, Tsn1, but not Tfx1, is required in the DNA damage recovery response in 
the absence of Dcr1. Evidence has been presented to propose a new fundamental role for Tsn1 
in suppressing replication-associated recombination in the absence of Dcr1, which could 
account for its original proposed role in generating chromosomal translocations in human 
cancers. In addition, this study identified a novel fundamental aspect of 
chromosome/centromere biology. The study showed that the chromosomal instability of ago1∆ 
cells is not solely due to the disruption of centromeric heterochromatin formation and may be 
linked to telomere dynamics. Given the fact that Translin and TRAX functions are linked to a 
diverse range of important biological activities, as well as being oncogenic drug targets, these 
findings provide new insight into the complexity of basic biological function and drug targeting 
of these highly conserved factors. Further studies will now be required to further elucidate the 
molecular mechanisms of the novel pathways revealed here. 
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9. Appendecies  
  
 
Appendix 1 The sub-telomeric tlh2 transcript is elevated in the ago1Δ tfx1Δ double mutant.  
Analysis of tiled whole genome expression data comparing ago1Δ with ago1Δ tfx1Δ showed that the 
sub-telomeric tlh2 gene transcript is activated. The tlh2 gene is also upregulated in the tfx1Δ single 
mutants. Similar activation of tlh2 is not seen in the tsn1Δ mutant. The plots show the transcriptional 
activity for the tlh2 open reading frame. Seven pairwise plots of transcriptional signals are shown for 
various strains. The log 2-fold change (lg2FC) for each plot is given as a numerical value within the 
plot (* = P<0.05).  
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Appendix 2 Mutation of tfx1 or tsn1 does not alter telomere length.  
a. Example of a southern blot of digested genomic DNA probed with a telomere-specific probe 
demonstrating that mutation of tfx1 or tsn1 does not display any measurable length change 
compared to the WT strain. The Otrt1Δ strain, which has no telomeres, was used as a negative 
control. The taz1Δ mutant was used as a positive control, and this has already been shown to 
exhibit a greatly elongated telomere. 
 
b. Quantification of telomere length in various strains confirms that there is no change in the 
mean length of telomeres following loss of tfx1 or tsn1 in any strains tested as compared to the 
WT strain. Error bars show standard deviation. 
 
